Form 10-Q

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company

0001193125-12-234917.txt : 20120515 0001193125-12-234917.hdr.sgml : 20120515 20120515170536 ACCESSION NUMBER: 0001193125-12-234917 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ESCALON MEDICAL CORP CENTRAL INDEX KEY: 0000862668 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 330272839 STATE OF INCORPORATION: PA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-20127 FILM NUMBER: 12845813 BUSINESS ADDRESS: STREET 1: 435 DEVON PARK ROAD STREET 2: BUILDING 100 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 6106886830 MAIL ADDRESS: STREET 1: 435 DEVON PARK ROAD STREET 2: BUILDING 100 CITY: WAYNE STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: INTELLIGENT SURGICAL LASERS INC DATE OF NAME CHANGE: 19930328 10-Q 1 d335645d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

Mark One

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED March 31, 2012

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO

Commission File Number: 0-20127

Escalon Medical Corp.

(Exact name of registrant as specified in its charter)


Pennsylvania		33-0272839
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

435 Devon Park Drive, Building 100 Wayne, PA 19087		19087
(Address of principal executive offices)		(Zip code)

(610) 688-6830

(Registrant’s telephone number, including area code)

N/A

Former name, former address and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ¨ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 7,526,430 shares of common stock, $0.001 par value, outstanding as of May 14, 2012.

Escalon Medical Corp.

Form 10-Q Quarterly Report

Table of Contents


Part I.	Financial Statements

	Item 1.	Condensed Consolidated Financial Statements (Unaudited)

		Condensed Consolidated Balance Sheets as of March 31, 2012 and June 30, 2011 (Unaudited)	3

		Condensed Consolidated Statements of Operations for the three- and nine- month periods ended March 31, 2012 and 2011 (Unaudited)	4

		Condensed Consolidated Statements of Cash Flows for the nine-month periods ended March 31, 2012 and 2011 (Unaudited)	5

		Condensed Consolidated Statement of Shareholders’ Equity for the nine-month period ended March 31, 2012 (Unaudited)	6

		Condensed Consolidated Statements of Comprehensive (Loss) for the three- and nine-month periods ended March 31, 2012 and 2011 (Unaudited)	7

		Notes to Condensed Consolidated Financial Statements	8

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18

	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	29

	Item 4.	Controls and Procedures	29

Part II.	Other Information		29

	Item 1.	Legal Proceedings	29

	Item 1A.	Risk Factors	29

	Item 5.	Other Information	30

	Item 6.	Exhibits	30

Part I. Financial Statements

Item 1. Condensed Consolidated Financial Statements

ESCALON MEDICAL CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


	March 31, 2012			June 30, 2011
	March 31, 2012			June 30, 2011

ASSETS
Current assets:
Cash and cash equivalents	$	562,880		$	1,684,746
Accounts receivable, net		3,452,402			3,802,316
Inventory, net		4,463,485			5,184,272
Other current assets		173,694			248,642
Assets of discontinued operations		0			2,342,137

Total current assets		8,652,461			13,262,113

Property and equipment, net		373,737			540,919
Goodwill		218,208			218,208
Trademarks and trade names		694,006			694,006
Patents, net		30,277			52,931
Covenant not to compete and customer lists, net		600,391			808,640
Non-current assets of discontinued operations		0			1,699,527

Total assets	$	10,569,080		$	17,276,344


LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt	$	4,149,516		$	278,278
Related party note payable		300,000			0
Accounts payable		1,819,125			1,746,951
Accrued expenses		1,712,712			1,897,441
Liabilities of discontinued operations		0			1,671,422

Total current liabilities		7,981,353			5,594,092


Long-term debt, net of current portion		0			4,506,018
Accrued post-retirement benefits		986,102			986,102

Total long-term liabilities		986,102			5,492,120


Total liabilities		8,967,455			11,086,212

Shareholders equity:
Preferred stock, $0.001 par value; 2,000,000 shares authorized; no shares issued
Common stock, $0.001 par value; 35,000,000 shares authorized; 7,526,430 issued and outstanding at March 31, 2012 and June 30, 2011		7,526			7,526
Common stock warrants		132,114			1,733,460
Additional paid-in capital		69,353,173			67,694,959
Accumulated deficit		(67,368,449	)		(62,404,014	)
Accumulated other comprehensive loss		(522,739	)		(841,799	)

Total shareholders’ equity		1,601,625			6,190,132

Total liabilities and shareholders’ equity	$	10,569,080		$	17,276,344

See notes to condensed consolidated financial statements

ESCALON MEDICAL CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	Three Months Ended March 31,						Nine Months Ended March 31,
	2012			2011			2012			2011

Net revenues:
Product revenue	$	6,065,931		$	6,399,159		$	18,365,885		$	19,075,536
Other revenue		0			0			0			6,933

Revenues, net		6,065,931			6,399,159			18,365,885			19,082,469


Costs and expenses:
Cost of goods sold		3,593,302			4,068,483			11,446,127			12,335,468
Marketing, general and administrative		2,621,482			2,715,690			7,669,231			8,157,077
Research and development		413,874			395,656			1,116,414			1,198,273
Goodwill impairment		0			905,810			0			905,810

Total costs and expenses		6,628,658			8,085,639			20,231,772			22,596,628

Loss from operations		(562,727	)		(1,686,480	)		(1,865,887	)		(3,514,159	)


Other (expense) and income:
Equity in Ocular Telehealth Management, LLC		(532	)		(37,600	)		612			(71,745	)
Loss on disposal of assets		0			0			(86,885	)		0
Interest income		17			83			119			194
Interest expense		(76,544	)		(84,186	)		(247,094	)		(244,064	)

Total other (expense) income		(77,059	)		(121,703	)		(333,248	)		(315,615	)


Loss from continuing operations before taxes		(639,786	)		(1,808,183	)		(2,199,135	)		(3,829,774	)
Provision for income taxes		0			0			0			0

Net loss from continuing operations		(639,786	)		(1,808,183	)		(2,199,135	)		(3,829,774	)
Net income (loss) from discontinued operations		0			(113,302	)		(2,765,300	)		210,525

Net loss	$	(639,786	)	($	1,921,485	)	($	4,964,435	)	($	3,619,249	)


Net income (loss) per share
Basic:
Continuing operations	$	(0.09	)	$	(0.24	)	$	(0.29	)	$	(0.51	)
Discontinued operations		0.00			(0.02	)		(0.37	)		0.03

	$	(0.09	)	$	(0.26	)	$	(0.66	)	$	(0.48	)


Diluted:
Continuing operations	$	(0.09	)	$	(0.24	)	$	(0.29	)	$	(0.51	)
Discontinued operations		0.00			(0.02	)		(0.37	)		0.03

	$	(0.09	)	$	(0.26	)	$	(0.66	)	$	(0.48	)


Weighted average shares - basic		7,526,430			7,526,430			7,526,430			7,526,430


Weighted average shares - diluted		7,526,430			7,526,430			7,526,430			7,526,430

See notes to condensed consolidated financial statements

ESCALON MEDICAL CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	For the Nine Months Ended March 31,
	2012			2011

Cash Flows from Operating Activities:
Net loss	$	(4,964,435	)	$	(3,619,249	)
Adjustments to reconcile net loss to cash provided by operating activities of continuing operations:
Income (loss) from discontinued operations		2,765,300			(210,525	)
Depreciation and amortization		458,921			486,631
Goodwill impairment		0			905,810
Compensation expense related to stock options		56,868			87,156
(Income) Loss from Ocular Telehealth Management, LLC		(612	)		71,745
Change in operating assets and liabilities:
Accounts receivable, net		349,914			622,300
Inventory, net		720,787			(447,958	)
Other current and long-term assets		74,948			251,858
Accounts payable and accrued expenses		(112,555	)		(57,333	)

Net cash used in operating activities from continuing operations		(650,864	)		(1,909,565	)
Net cash used in (provided by) operating activities from discontinued operations		(566,953	)		1,024,365

Net cash used in operating activities		(1,217,817	)		(885,200	)


Cash Flows from Investing Activities:
Investment in Ocular Telehealth Management, LLC		0			(45,000	)
Purchase of fixed assets		(66,723	)		(96,805	)

Net cash (used in) investing activities		(66,723	)		(141,805	)

Cash Flows from Financing Activities:
Principal payments on long-term debt		(155,795	)		(50,538	)
Proceeds from related party note payable		300,000			0

Net cash provided by (used in) financing activities		144,205			(50,538	)


Effect of exchange rate changes on cash & cash equivalents		18,469			205,122

Net decrease in cash and cash equivalents		(1,121,866	)		(872,421	)

Cash and cash equivalents, beginning of period		1,684,746			3,008,485


Cash and cash equivalents, end of period	$	562,880		$	2,136,064


Supplemental Schedule of Cash Flow Information:
Interest paid	$	170,550		$	168,694
Income taxes paid	$	—		$	45,000

See notes to condensed consolidated financial statements

ESCALON MEDICAL CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY

FOR THE NINE MONTHS ENDED MARCH 31, 2012

(Unaudited)


	Common Stock				Common Stock			Additional Paid-in		Accumulated			Accumulated Other Comprehensive			Total Shareholders’
	Shares		Amount		Warrants			Capital		Deficit			(Loss)			Equity

BALANCE AT JUNE 30, 2011		7,526,430	$	7,526	$	1,733,460		$	67,694,959	$	(62,404,014	)	$	(841,799	)	$	6,190,132
Comprehensive Income:
Net loss		0		0		0			0		(4,964,435	)		0			(4,964,435	)
Foreign currency translation		0		0		0			0		0			319,060			319,060

Total comprehensive income		0		0		0			0		(4,964,435	)		319,060			(4,645,375	)
Expired stock warrants		0		0		(1,601,346	)		1,601,346		0			0			0
Compensation expense		0		0		0			56,868		0			0			56,868


BALANCE AT MARCH 31, 2012		7,526,430	$	7,526	$	132,114		$	69,353,173	$	(67,368,449	)	$	(522,739	)	$	1,601,625

See notes to condensed consolidated financial statements

ESCALON MEDICAL CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS)

(Unaudited)


	Three Months Ended March 31,						Nine Months Ended March 31,
	2012			2011			2012			2011

Net loss	$	(639,786	)	$	(1,921,485	)	$	(4,964,435	)	$	(3,619,249	)
Foreign currency translation		(206,446	)		(59,716	)		319,060			(3,269	)


Comprehensive (loss)	$	(846,232	)	$	(1,981,201	)	$	(4,645,375	)	$	(3,622,518	)

See notes to condensed consolidated financial statements

Escalon Medical Corp. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1.	Basis of Presentation

Escalon Medical Corp. (“Escalon” or the “Company” ) is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the “Company” collectively shall mean Escalon and its wholly owned subsidiaries: Sonomed, Inc. (“Sonomed”), Trek, Inc. (“Trek”), Escalon Vascular Access, Inc. (“Vascular”), Escalon Medical Europe GmbH (“EME”), Escalon Digital Vision, Inc. (“EMI”), Escalon Pharmaceutical, Inc. (“Pharmaceutical”), Escalon Holdings, Inc. (“EHI”), Escalon IP Holdings, Inc., Escalon Vascular IP Holdings, Inc., Sonomed IP Holdings, Inc., Drew Scientific, Inc., (“Drew”) and its subsidiaries. All intercompany accounts and transactions have been eliminated.

The Company sold certain assets of the Vascular business for $5,750,000 on April 30, 2010 to Vascular Solutions, Inc. (see footnote 10 to the Notes to Condensed Consolidated Financial Statements for additional information).

The Company operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes and hematology. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the “FDA”). The FDA and other governmental authorities require extensive testing of new products prior to sale and have jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing.

Management reviews financial information allocates resources and manages the business as three segments, Escalon Clinical Diagnostics (“ECD”), Sonomed-Escalon and Escalon Medical Corp (“Corporate”). The ECD segment consists of Drew Scientific, Inc., and its wholly owned subsidiary JAS Diagnostics, Inc. (“JAS”). ECD develops and sells clinical diagnostic instruments, reagents and chemistries. The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations of the consolidated group. The Company began including redesignated reporting segments beginning with Form 10-K for the year ended June 30, 2011, and prior period segment information has been reclassified to conform with the current period presentation.

2.	Stock-Based Compensation

Valuations are based upon highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

The Company has historically granted options under the Company’s option plans with an option exercise price equal to the closing market value of the stock on the date of the grant and with vesting, primarily for Company employees, either in equal annual amounts over a two- to five-year period or immediately, and, primarily for non-employee directors, immediately.

As of March 31, 2012 and 2011 total unrecognized compensation cost related to non-vested share-based compensation arrangements granted to employees under the 2004 Equity Incentive Plan was $71,241 and $152,008 respectively. The remaining cost is expected to be recognized over a weighted average period of 1.42 years. For the three-month periods ended March 31, 2012 and 2011, $16,485 and $23,898 was recorded as compensation expense, respectively. For the nine-month periods ended March 31, 2012 and 2011, $56,868 and $87,156 was recorded as compensation expense, respectively.

The Company did not receive any cash from share option exercises under stock-based payment plans for the three month and nine-month periods ended March 31, 2012 and 2011. The Company did not realize any tax effect, which would be a reduction in its tax rate, on options due to the full valuation allowances established on its deferred tax assets.

The Company measures compensation expense for non-employee stock-based compensation based on the fair value of the options issued, as this is more reliable than the fair value of the services received. Fair value is measured as the value of the Company’s common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty’s performance is complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital. There was no non-employee compensation expense for the three-month and nine-month periods ended March 31, 2012 and 2011.

3.	(Loss) earnings per Share

The following table sets forth the computation of basic and diluted net loss per share:


	Three Months Ended March 31,						Nine Months Ended March 31,
	2012			2011			2012			2011

Numerator:
Numerator for basic and diluted earnings per share
Net loss from continuing operations	$	(639,786	)	$	(1,808,183	)	$	(2,199,135	)	$	(3,829,774	)
Net (loss) income from discontinued operations		0			(113,302	)		(2,765,300	)		210,525

Net loss	$	(639,786	)	$	(1,921,485	)	$	(4,964,435	)	$	(3,619,249	)

Denominator:
Denominator for basic earnings per share - weighted average shares		7,526,430			7,526,430			7,526,430			7,526,430
Effect of dilutive securities:
Stock options and warrants		0			0			0			0
Shares reserved for future exchange		0			0			0			0

Denominator for diluted earnings per share - weighted average and assumed conversion		7,526,430			7,526,430			7,526,430			7,526,430


Net income (loss) per share
Basic:
Continuing operations	$	(0.09	)	$	(0.24	)	$	(0.29	)	$	(0.51	)
Discontinued operations		0.00			(0.02	)		(0.37	)		0.03

	$	(0.09	)	$	(0.26	)	$	(0.66	)	$	(0.48	)


Diluted:
Continuing operations	$	(0.09	)	$	(0.24	)	$	(0.29	)	$	(0.51	)
Discontinued operations		0.00			(0.02	)		(0.37	)		0.03

	$	(0.09	)	$	(0.26	)	$	(0.66	)	$	(0.48	)

The impact of dilutive securities was omitted from the earnings per share calculation in all periods presented as they would reduce the loss per share and thus were anti-dilutive.

4.	Legal Proceedings

The Company, from time to time is involved in various legal proceedings and disputes that arise in the normal course of business. These matters have previously and could pertain to intellectual property disputes, commercial contract disputes, employment disputes, and other matters. The Company does not believe that the resolution of any of these matters has had or is likely to have a material adverse impact on the Company’s business, financial condition or results of operations. (See footnote 10 for details on BHH court proceedings related to the insolvency declaration).

5.	Segmental Information

During the three-month and nine-month periods ended March 31, 2012 and 2011, the Company’s operations were classified into three principal reportable business units that provide different products or services.

Management reviews financial information, allocates resources, and manages the business as three segments: ECD, Sonomed-Escalon and Escalon Medical Corp. (“Corporate”). The ECD segment consists of Drew

Scientific, Inc., and its wholly owned subsidiary JAS. ECD develops and sells clinical diagnostic instruments, reagents and chemistries. The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Corporate segment includes the administrative corporate operations of the consolidated group. The Company began to include redesignated reporting segments beginning with Form 10-K for the year ended June 30, 2011, and prior period segment information has been reclassified to conform with the current period presentation.

Separate management of each unit is required because each business unit is subject to different marketing, production and technology strategies.


	Segment Statements of Operations (in thousands) - Three months ended March 31,
	ECD						Sonomed-Escalon					Corporate						Total
	2012			2011			2012		2011			2012			2011			2012			2011

Revenues, net:
Product revenue	$	2,968		$	3,395		$	3,098	$	3,004		$	0		$	0		$	6,066		$	6,399
Other revenue		0			0			0		0			0			0			0			0

Total revenue, net		2,968			3,395			3,098		3,004			0			0			6,066			6,399

Costs and expenses:
Cost of goods sold		2,094			2,562			1,499		1,508			0			0			3,593			4,070
Research & Development		114			172			300		223			0			0			414			395
Marketing, General & Admin		1,349			1,769			1,147		822			126			124			2,622			2,715
Goodwill impairment		0			0			0		906			0			0			0			906

Total costs and expenses		3,557			4,503			2,946		3,459			126			124			6,629			8,086

(Loss) income from operations		(589	)		(1,108	)		152		(455	)		(126	)		(124	)		(563	)		(1,687	)

Other (expense) and income:
Equity in OTM		0			0			0		0			0			(38	)		0			(38	)
Interest income		0			0			0		0			0			1			0			1
Interest expense		(1	)		(84	)		0		0			(75	)		0			(76	)		(84	)

Total other (expense) income		(1	)		(84	)		0		0			(75	)		(37	)		(76	)		(121	)

(Loss)income before taxes		(590	)		(1,192	)		152		(455	)		(201	)		(161	)		(639	)		(1,808	)
Income taxes		0			0			0		0			0			0			0			0

Net (loss) income from continuing operations	$	(590	)	$	(1,192	)	$	152	$	(455	)	$	(201	)	$	(161	)	$	(639	)	$	(1,808	)


	Segment Statements of Operations (in thousands) - Nine-months ended March 31,
	ECD						Sonomed-Escalon					Corporate						Total
	2012			2011			2012		2011			2012			2011			2012			2011

Revenues, net:
Product revenue	$	9,675		$	10,423		$	8,691	$	8,653		$	0		$	0		$	18,366		$	19,076
Other revenue		0			7			0		0			0			0			0			7

Total revenue, net		9,675			10,430			8,691		8,653			0			0			18,366			19,083

Costs and expenses:
Cost of goods sold		7,261			7,735			4,185		4,601			0			0			11,446			12,336
Research & Development		386			544			730		654			0			0			1,116			1,198
Marketing, General & Admin		4,198			5,284			3,109		2,517			363			356			7,669			8,157
Goodwill impairment		0			0			0		906			0			0			0			906

Total costs and expenses		11,845			13,563			8,024		8,678			363			356			20,232			22,597

(Loss) income from operations		(2,170	)		(3,133	)		667		(25	)		(363	)		(356	)		(1,866	)		(3,514	)

Other (expense) income:
Equity in OTM		0			0			0		0			1			(72	)		1			(72	)
Loss on Disposal of Assets		(87	)		0			0		0			0			0			(87	)		0
Interest income		0			0			0		0			0			0			0			0
Interest expense		(164	)		(244	)		0		0			(83	)		0			(247	)		(244	)

Total other (expense) income		(251	)		(244	)		0		0			(82	)		(72	)		(333	)		(316	)

(Loss) income before taxes		(2,421	)		(3,377	)		667		(25	)		(444	)		(428	)		(2,199	)		(3,830	)

Income taxes		0			0			0		0			0			0			0			0

Net (loss) income from continuing Operations	$	(2,421	)	$	(3,377	)	$	667	$	(25	)	$	(444	)	$	(428	)	$	(2,199	)	$	(3,830	)

The Company operates in the healthcare market, specializing in the development, manufacture and marketing of (1) ophthalmic medical devices and pharmaceuticals; (2) in-vitro diagnostic (“IVD”) instrumentation and consumables for use in human and veterinary hematology. On April 30, 2010, the Company sold its Vascular business. The business segments reported above are the segments for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and assessing performance. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies in Form 10-K for the year ended June 30, 2011. For the purposes of this illustration, corporate expenses, which consist primarily of executive management and administrative support functions, are allocated across the business segments based upon a methodology that has been established by the Company, which includes a number of factors and estimates and that has been consistently applied across the business segments. These expenses are otherwise included in the corporate segment.

During the three- and nine-month periods ended March 31, 2012 and 2011, ECD derived its revenue from the sale of instrumentation and consumables for blood cell counting and blood analysis in the areas of diabetes, cardiovascular diseases and human and veterinary hematology. Sonomed-Escalon derived its revenue from the sale of A-Scans, B-Scans, pachymeters, digital imaging products, ISPAN™ gas products and various disposable ophthalmic surgical products.

6.	Related Party Transaction

The Company and a member of the Company’s Board of Directors are founding and equal members of Ocular Telehealth Management, LLC (“OTM”). OTM is a diagnostic telemedicine company providing remote examination, diagnosis and management of disorders affecting the human eye. OTM’s initial focus is on the diagnosis of diabetic retinopathy by creating access and providing annual dilated retinal examinations for the diabetic population. Through March 31, 2012, the Company has invested $444,000 in OTM. As of March 31, 2012, the Company owned 45% of OTM. The Company provides administrative support functions to OTM. For the three-month periods ended March 31, 2012 and 2011 the Company recorded losses of $532 and $37,600, respectively. For the nine-month periods ended March 31, 2012 and 2011 the Company recorded a gain of $612 and a loss of $71,745, respectively.

At March 31, 2012 OTM had total assets, liabilities and equity of $1,000, $80,000 and ($79,000), respectively.

During the nine-month period ended March 31, 2012, Richard J. DePiano, Sr., the Company’s CEO participated in an accounts receivable factoring program that was implemented by the Company. Under the program, Mr. DePiano advanced the Company $300,000 which represented 100% of an amount due from various Drew customers. The receivables were not eligible to be sold to the Company’s usual factoring agent. Interest on the transaction is 1.25% per month, which is equal to the best price offered by the Company’s usual factoring agent. The transaction excluded fees typically charged by the factoring agent and provided much needed liquidity to the Company.

7.	Recently Issued Accounting Standards

In January 2010, FASB issued ASU No. 2010-06, Improving Disclosures about Fair Value Measurements. This update provides amendments to Subtopic 820-10 that requires new disclosure to include transfers in and out of Levels 1 and 2 and activity in Level 3 fair value measurements. Further, this update clarifies existing disclosures on level of disaggregation and disclosures about inputs and valuation techniques. A reporting entity should provide fair value measurement disclosures for each class of assets and liabilities and should provide disclosures about the valuation techniques and inputs used to measure fair value for both recurring and nonrecurring fair value measurements. Those disclosures are required for fair value measurements that fall in either Level 2 or Level 3. The new disclosures and clarifications of existing disclosures became effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for interim periods within those fiscal years. The adoption of this ASU did not have a material impact on the Company’s consolidated financial statements

In April 2010, the FASB issued ASU 2010-13, “Compensation—Stock Compensation (Topic 718): Effect of Denominating the Exercise Price of a Share-Based Payment Award in the Currency of the Market in Which the Underlying Equity Security Trades,” or ASU 2010-13. ASU 2010-13 provides amendments to Topic 718 to clarify that an employee share-based payment award with an exercise price denominated in currency of a market in which a substantial portion of the entity’s equity securities trades should not be considered to contain a condition that is not a market, performance, or service condition. Therefore, an entity would not classify such an award as a liability if it otherwise qualifies as equity. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2010. The Company does not expect the adoption of ASU 2010-13 to have a significant impact on its consolidated financial statements.

In May 2011, the FASB issued ASU No. 2011-04 which provides a consistent definition of fair value in GAAP and International Financial Reporting Standards and ensures that their respective fair value measurement and disclosure requirements are the same (except for minor differences in wording and style). The amendments change certain fair value measurement principles and enhance the disclosure requirements particularly for level 3 fair value measurements. The standard will become effective for the Company during interim and annual periods beginning after December 15, 2011 and should be applied prospectively. The Company does not believe that the implementation of this standard will have a material impact on its financial position, results of operation and cash flows.

In June 2011, the FASB issued ASU No. 2011-05 which requires an entity to present all non-owner changes in stockholders’ equity either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders’ equity. This standard will become effective for the Company in fiscal years, and interim periods within those years, beginning after December 15, 2011 and should be applied retrospectively. The Company does not believe that the implementation of this standard will have a material impact on its financial position, results of operation and cash flows.

In September 2011, the FASB issued ASU No. 2011-08, Intangibles—Goodwill and Other (Topic 350): Testing Goodwill for Impairment, which simplifies how an entity tests goodwill for impairment. Under that option, an entity no longer would be required to calculate the fair value of a reporting unit unless the entity determines, based on that qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments will be effective for the company for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 and should be applied prospectively. The Company does not believe that the implementation of this standard will have a material impact on its financial position, results of operation and cash flows.

8.	Fair Value Measurements

On July 1, 2008, the Company adopted the FASB-issued authoritative guidance for the fair value of financial assets and liabilities. This standard defines fair value and establishes a hierarchy for reporting the reliability of input measurements used to assess fair value for all assets and liabilities. The FASB issued authoritative guidance defines fair value as the selling price that would be received for an asset, or paid to transfer a liability, in the principal or most advantageous market on the measurement date. The hierarchy established prioritizes fair value measurements based on the types of inputs used in the valuation technique. The inputs are categorized into the following levels:

Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities.

Level 2 - Directly or indirectly observable inputs for quoted and other than quoted prices for identical or similar assets and liabilities in active or non-active markets.

Level 3 - Unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity’s own data.

Certain financial instruments are carried at cost on the condensed consolidated balance sheets, which approximates fair value due to their short-term, highly liquid nature. These instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, related party note payable and other liabilities.

The Company determined that the fair value of the outstanding debt approximates the outstanding balances based on the remaining maturity of the note for the Biocode debt and other Level 3 measurements. By “other level 3 measurements” we are referring to “unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity’s own data”. We included this reference because in determining the estimated fair value of our debt we first attempted to use a “commonly accepted valuation methodology” of applying rates currently available to the Company for debt with similar terms and remaining maturities. The long-term debt currently on our balance sheet is related to the acquisition of certain assets of Biocode Hycell on December 31, 2008. The acquisition was 100% financed by the seller. Management concluded that given the financial state of the Company and the overall state of the credit markets there is no financial institution that would make available funds to us for the 100% financing of a foreign entity with similar terms and remaining maturities, or in fact, on any terms. We then considered whether there was any “level 3” considerations, as defined above, which might aid us in determining the fair market value of this unique form of debt. We determined that there was not and came to the conclusion that given the weakened state of our Company and overall market conditions there was no other source of financing available to us, from any source on any terms, other than the willing seller of the Biocode assets. Therefore, we concluded that the fair market value of the debt remains equal to its book value.

9.	Continuing Operations

The accompanying consolidated financial statements have been prepared on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred recurring operating losses, no longer have the benefit of cash inflows from Vascular and on May 11, 2012 the BHH debtholder informed the Company that it intends to declare the BHH debt, which is guaranteed by Escalon, into default, as such, the entire debt of $4,149,516 is recorded as a current liability (see footnote 10 for further information on the Biocode acquisition debt). These conditions raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unsuccessful in its efforts to raise additional capital in the near term, the Company may be required to significantly reduce its research, development, and administrative activities, including further reduction of its employee base or consider the sale of certain assets. The financial statements do not include any adjustments relating to the realization of the carrying value of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. Our continuance as a going concern is dependent on our future profitability and on the on-going support of our shareholders, affiliates and creditors. In order to mitigate the going concern issues, the Company is actively pursuing business partnerships, managing our continuing operations, and seeking capital funding on an ongoing basis via the issuance of securities and private placements, although the Company may not succeed in these mitigation efforts.

The filing of the insolvency declaration at BHH will have a material effect on results of operations in subsequent periods. BHH’s product line revenues from operations were $4,763,056, $5,254,574 and $2,647,877 in fiscal 2011, 2010 and 2009, respectively. Losses from operations, net of taxes, were ($1,232,904), ($635,952) and ($1,068,040) in 2011, 2010 and 2009, respectively.

As part of ongoing austerity measures that have been implemented over the past two years at Drew, management decided in June 2011 to outsource the manufacturing of Drew’s instruments and cease all manufacturing out of its Dallas facility. Research and development activities performed in Dallas will also be eliminated and will be outsourced on an as needed basis. Management continues to work with outsource partners to perfect the manufacturing of Drew’s instruments and anticipates that the Dallas facility will cease manufacturing activities on or about June 30, 2012.

If the Company is unable to achieve continued improvement in this area in the near term, it is not likely that its existing cash and cash flow from operations will be sufficient to fund activities throughout the next four to six months without curtailing certain business activities. The Company’s forecast of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties, and actual results could vary as a result of a number of factors, including the factors discussed in “Risk Factors” of the Company’s Form 10-K for the year ended June 30, 2011.

If the Company seeks to raise funds in the future, the Company may be required to raise those funds through public or private financings, strategic relationships or other arrangements at prices and other terms that may not be as favorable as they would without such qualification. The sale of additional equity and debt securities may result in additional dilution to the Company’s shareholders. Additional financing may not be available in amounts or on terms acceptable to the Company or at all.

10.

Discontinued Operations

BH Holdings, S.A.S

On January 12, 2012 BHH initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France (“Commercial Court”). The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH’s activity for three months and named an administrator to manage BHH. Since Drew no longer has a controlling financial interest in BHH it was deconsolidated in the December 31, 2011 financial statements and prior period amounts are presented as discontinued operations.

The Company incurred a loss of $2,216,000 related to the deconsolidation of BHH. The disconsolidated loss was calculated by measuring the difference between:

a. The aggregate of:

(1) The fair value of any consideration received, (there was no consideration received);

(2) The fair value of any retained noncontrolling investment in the former subsidiary at the date the subsidiary is deconsolidated; and

(3) The carrying amount of any noncontrolling interest in the former subsidiary (including any accumulated other comprehensive income attributable to the noncontrolling interest) at the date the subsidiary is deconsolidated (there was no noncontrolling interest in the former subsidiary).

b. The carrying amount of the former subsidiary’s assets and liabilities.

The following table summarizes the results of discontinued operations of BHH for the three-month and nine-month periods ended March 31, 2012 and 2011 (in thousands):

		0000000000		0000000000
	For the Three Months Ended March 31,
	2012		2011

Total revenue, net	$	0	$	1,102

Costs and expenses:
Cost of goods sold		0		181
Research & Development		0		0
Marketing, General & Admin		0		1,034

Total costs and expenses		0		1,215

Loss from discontinued operations		0		(113	)

Loss before income taxes		0		(113	)
Income taxes		0		0

Net loss from discontinued operations	$	0	$	(113	)

		0000000000			0000000000
	For the Nine Months Ended March 31,
	2012			2011

Total revenue, net	$	1,970		$	3,499

Costs and expenses:
Cost of goods sold		574			521
Research & Development		0			0
Marketing, General & Admin		1,945			2,938

Total costs and expenses		2,519			3,459

Income (loss) from discontinued operations		(549	)		40
Other income and expenses:
Loss on liquidation of net assets from discontinued operations		(2,216	)		0

Income (loss) before income taxes		(2,765	)		40

Income taxes		0			0

Net (loss) income from discontinued operations	$	(2,765	)	$	40

Assets and liabilities of discontinued operations included in the consolidated balance sheets are summarized as follows at March 31, 2012 and June 30, 2011, (in thousands):


	March 31, 2012		June 30, 2011
Assets
Cash	$	0	$	230
Accounts receivable		0		965
Inventory		0		1,076
Other Current Assets		0		70
Fixed assets		0		110
Covenant not to compete and customer list, net		0		1,481
Other Assets		0		109

Total Assets		0		4,041


Liabilities
Accounts Payable		0		370
Accrued expenses		0		1,147
Other Current Liabilities		0		155

Total Liabilities		0		1,672

Net assets of discontinued operations	$	0	$	(2,369	)

Discontinued operation of Vascular

In an effort to enhance stockholder value, improve working capital and enable the Company to focus on its core in-vitro diagnostics and ophthalmology manufacturing businesses, on April 30, 2010 the Company divested certain Vascular Access assets held by its Vascular Access subsidiaries to Vascular Solutions, Inc. The total sales price was $5,750,000, consisting of cash of $5,000,000 at closing and $750,000 payable in cash upon the successful completion of the transfer of the manufacturing to Vascular Solutions, Inc. plus a one-time earn-out payment in an amount equal to 25% of the net sales of the VascuView TAP products sold by Vascular Solutions, Inc. between July 1, 2010 and June 30, 2011. The manufacturing transfer was completed on August 31, 2010. During this four-month transition, the Company continued to manufacture product in its Wisconsin facility under a supply agreement concurrently entered into with Vascular Solutions, Inc. The supply agreement ended on August 30, 2010, and the Company has had no significant continuing involvement in the operations of Vascular. Vascular Access generated approximately $565,000 in gross profit from May 1, 2010 through August 31, 2010 related to the supply agreement.

There was no activity from discontinued operations for the three-month periods ended March 31, 2012 and 2011 related to Vascular Access.

The following table summarizes the results of discontinued operations of Vascular Access for the nine-month periods ended March 31, 2012 and 2011 (in thousands):


	For the Nine Months Ended March 31,
	2012		2011

Total revenue, net	$	0	$	638

Costs and expenses:
Cost of goods sold		0		283
Research & Development		0		29
Marketing, General & Admin		0		155

Total costs and expenses		0		467

Income from discontinued operations	$	0	$	171

There are no assets and liabilities of discontinued operations included in the consolidated balance sheets at March 31, 2012 and June 30, 2011 related to Vascular Access.

11.

Expiration of commons stock warrant

Common stock warrants in the amount of $1,601,346 have expired and were released to additional paid-in capital.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward Looking Statements

Certain statements contained in, or incorporated by reference in, this report are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which provide current expectations or forecasts of future events. Such statements can be identified by the use of terminology such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “possible,” “project,” “should,” “will,” and similar words or expressions. The Company’s forward-looking statements include certain information relating to general business strategy, growth strategies, financial results, liquidity, discontinued operations, product development, the introduction of new products, the potential markets and uses for the Company’s products, the Company’s regulatory filings with the FDA, acquisitions, the development of joint venture opportunities, intellectual property and patent protection and infringement, the loss of revenue due to the expiration on termination of certain agreements, the effect of competition on the structure of the markets in which the Company competes, increased legal, accounting and Sarbanes-Oxley compliance costs, compliance with Nasdaq continued listing qualifications, defending the Company in litigation matters and the Company’s cost saving initiatives. The reader must carefully consider forward-looking statements and understand that such statements involve a variety of risks and uncertainties, known and unknown, and may be affected by assumptions that fail to materialize as anticipated. Consequently, no forward-looking statement can be guaranteed, and actual results may vary materially. It is not possible to foresee or identify all factors affecting the Company’s forward-looking statements, and the reader therefore should not consider the list of such factors contained in its periodic report on Form 10-K for the year ended June 30, 2011 and this Form 10-Q quarterly report to be an exhaustive statement of all risks, uncertainties or potentially inaccurate assumptions.

Executive Overview – Nine-Month Period Ended March 31, 2012

The following highlights are discussed in further detail within this report. The reader is encouraged to read this report in its entirety to gain a more complete understanding of factors impacting Company performance and financial condition.

•

Product revenue decreased approximately 3.7% during the nine-month period ended March 31, 2012, as compared to the same period last fiscal year. The decrease was related to a decrease in ECD business segment of 7.2% during the nine-month period ended March 31, 2012 compared to the same period last fiscal year.

•

There is no other revenue during the nine-month period ended March 31, 2012 as compared to $7,000 for the same period last fiscal year.

•

Cost of goods sold as a percentage of product revenue decreased to 62.3% during the nine-month period ended March 31, 2012, as compared to approximately 64.7% for the same period last fiscal year mainly due to change of product mix favoring higher-margin products and the continuing process of outsourcing manufacturing and closing the Dallas facility.

•

Marketing, general and administrative expenses decreased approximately 6.0% during the nine-month period ended March 31, 2012, as compared to the same period in the prior fiscal year. The decrease was primarily due to a decrease in administrative expense in the ECD business related to the planned closure of the Dallas facility.

Company Overview

The following discussion should be read in conjunction with interim condensed consolidated financial statements and the notes thereto, which are set forth in Item 1 this report.

The Company operates in the healthcare market specializing in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes, and hematology. The Company and its products are subject to regulation and inspection by the FDA. The FDA requires extensive testing of new products prior to sale and has jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing. The Company’s Internet address is www.escalonmed.com.

Critical Accounting Policies

The preparation of financial statements requires management to make estimates and assumptions that impact amounts reported therein. The most significant of those involve the application of FASB-issued authoritative guidance concerning Revenue Recognition, Goodwill and Other Intangible Assets, discussed further in the notes to consolidated financial statements included in the Form 10-K for the year ended June 30, 2011. The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America, and, as such, include amounts based on informed estimates and judgments of management. For example, estimates are used in determining valuation allowances for deferred income taxes, uncollectible receivables, obsolete inventory, sales returns and rebates, warranty liabilities and purchased intangible assets. Actual results achieved in the future could differ from current estimates. The Company used what it believes are reasonable assumptions and, where applicable, established valuation techniques in making its estimates.

Revenue Recognition

The Company recognizes revenue from the sale of its products at the time of shipment, when title and risk of loss transfer. The Company provides products to its distributors at agreed wholesale prices and to the balance of its customers at set retail prices. Distributors can receive discounts for accepting high volume shipments. The discounts are reflected immediately in the net invoice price, which is the basis for revenue recognition. No further material discounts are given.

The Company’s considerations for recognizing revenue upon shipment of product to a distributor are based on the following:

•

Persuasive evidence that an arrangement (purchase order and sales invoice) exists between a willing buyer (distributor) and the Company that outlines the terms of the sale (company information, quantity of goods, purchase price and payment terms). The buyer (distributor) does not have a right of return.

•

Shipping terms are ex-factory shipping point. At this point the buyer (distributor) takes title to the goods and is responsible for all risks and rewards of ownership, including insuring the goods as necessary.

•

The Company’s price to the buyer (distributor) is fixed and determinable as specifically outlined on the sales invoice. The sales arrangement does not have customer cancellation or termination clauses.

•

The buyer (distributor) places a purchase order with the Company; the terms of the sale are cash, COD or credit. Customer credit is determined based on the Company’s policies and procedures related to the buyer’s (distributor’s) creditworthiness. Based on this determination, the Company believes that collectibility is reasonably assured.

The Company assesses collectibility based on creditworthiness of the customer and past transaction history. The Company performs ongoing credit evaluations of its customers and does not require collateral from its customers. For many of the Company’s international customers, the Company requires an irrevocable letter of credit to be issued by the customer before the purchase order is accepted.

Valuation of Intangible Assets

The Company annually evaluates for impairment its intangible assets and goodwill in accordance with FASB ASC 350, “Goodwill and Other Intangible Assets,” or whenever events or changes in circumstances indicate that the carrying value may not be recoverable, see footnote 4 to consolidated financial statements included in the Company’s Form 10-K for the year ended June 30, 2011 for details on a goodwill impairment charge related to the carrying amount of EMI’s goodwill. These intangible assets include goodwill, trademarks and trade names. Recoverability of these assets is measured by comparison of their carrying amounts to future discounted cash flows the assets are expected to generate. If identifiable intangibles are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the assets exceeds its fair market value. The Company does not amortize intangible assets with indefinite useful lives, rather such assets are required to be tested for impairment at least annually or sooner whenever events or changes in circumstances indicate that the assets may be impaired. The Company performs its intangible asset impairment tests on or about June 30, of each year. Any such impairment charge could be significant and could have a material adverse impact on the Company’s financial statements if and when an impairment charge is recorded.

Income/(Loss) Per Share

The Company computes net income/(loss) per share under the provisions of FASB issued authoritative guidance.

Under the provisions of FASB issued authoritative guidance, basic and diluted net income/(loss) per share is computed by dividing the net income/(loss) for the period by the weighted average number of shares of common stock outstanding during the period. The calculation of diluted net income/(loss) per share excludes potential common shares if the impact is anti-dilutive. Basic earnings per share are computed by dividing net income/(loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are determined in the same manner as basic earnings per share, except that the number of shares is increased by assuming exercise of dilutive stock options and warrants using the treasury stock method.

Taxes

Estimates of taxable income of the various legal entities and jurisdictions are used in the tax rate calculation. Management uses judgment in estimating what the Company’s income will be for the year. Since judgment is involved, there is a risk that the tax rate may significantly increase or decrease in any period.

In determining income/(loss) for financial statement purposes, management must make certain estimates and judgments. These estimates and judgments occur in the calculation of certain tax liabilities and in the determination of the recoverability of certain deferred tax assets, which arise from temporary differences between the tax and financial statement recognition of revenue and expense. FASB issued authoritative guidance concerning accounting for income taxes also requires that the deferred tax assets be reduced by a valuation allowance, if based on the available evidence, it is more likely that not that all or some portion of the recorded deferred tax assets will not be realized in future periods.

In evaluating the Company’s ability to recover the Company’s deferred tax assets, management considers all available positive and negative evidence including the Company’s past operating results, the existence of cumulative losses and near-term forecasts of future taxable income that is consistent with the plans and estimates management is using to manage the underlying businesses.

Through March 31, 2012, the Company has recorded a valuation allowance against the Company’s net operating losses for substantially all of the deferred tax asset due to uncertainty of their realization as a result of the Company’s earnings history, the number of years the Company’s net operating losses and tax credits can be carried forward, the existence of taxable temporary differences and near-term earnings expectations. The amount

of the valuation allowance could decrease if facts and circumstances change that materially increase taxable income prior to the expiration of the loss carryforwards. Any reduction would reduce (increase) the income tax expense (benefit) in the period such determination is made by the Company.

The Company has adopted FASB issued guidance related to accounting for uncertainty in income taxes, which provides a comprehensive model for the recognition, measurement, and disclosure in financial statements of uncertain income tax positions that a company has taken or expects to take on a tax return. Under the FASB guidance a company can recognize the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit can be recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Additionally, companies are required to accrue interest and related penalties, if applicable, on all tax exposures for which reserves have been established consistent with jurisdictional tax laws. The Company has elected to recognize interest expense and penalties related to uncertain tax positions as a component of its provision for income taxes.

Stock-Based Compensation

Stock-based compensation expense for all stock-based compensation awards granted after July 1, 2006 is based on the grant-date fair value estimate in accordance with the provisions of the FASB issued guidance. The Company recognizes these compensation costs on a straight-line basis over the requisite service period of the award.

Valuations are based on highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company’s stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

Three- and Nine-Month Periods Ended March 31, 2012 and 2011

The following table shows consolidated product revenue from continuing operations by business segment as well as identifying trends in business segment product revenues for the three- and nine-month periods ended March 31, 2012 and 2011. Table amounts are in thousands:


	For the Three Months Ended March 31,							For the Nine Months Ended March 31,
	2012		2011		% Change			2012		2011		% Change
Product Revenue:

ECD	$	2,968	$	3,395		-12.6	%	$	9,675	$	10,423		-7.2	%
Sonomed-Escalon		3,098		3,004		3.1	%		8,691		8,653		0.4	%


Total	$	6,066	$	6,399		-5.2	%	$	18,366	$	19,076		-3.7	%

•

Product revenue decreased approximately $333,000, or 5.2%, to $6,066,000 for the three-month period ended March 31, 2012, as compared to the same period last fiscal year.

In the ECD business segment, product revenue decreased $427,000, during the three-month period ended March 31, 2012, or 12.6% to $2,968,000, as compared to the same period last fiscal year. The decrease is related to a decline in sales of instruments and reagents related to decreased availability of instruments due to the decision to outsource the manufacturing of instruments and an increase in the chemistry reagents backlog.

Drew received and sold 32 units from its outsource partner and anticipates receiving approximately 30 units per quarter for the remainder of the year. Drew is investigating outsource partners for its Drew 2280 hematology analyzer, as well as, pursuing alternative hematology instruments from other manufacturers. Drew continues to manufacture its Hemavet analyzer at is Dallas facility and expects to begin outsourcing its manufacture by the end of the current fiscal year.

In the Sonomed-Escalon business segment, product revenue increased $94,000, or 3.1% to $3,098,000 during the three-month period ended March 31, 2012, as compared to the same period last fiscal year. The increase in product revenue was primarily caused by increased sales of Digital imaging systems.

•

Product revenue decreased approximately $710,000, or 3.7%, to $18,366,000 during the nine-month period ended March 31, 2012, as compared to the same period last fiscal year.

In the ECD business segment, product revenue decreased $748,000, or 7.2% to $9,675,000, as compared to the same period last fiscal year. The decrease is related to a decline in sales of diabetes instruments and reagents related to decreased availability of instruments due to the decision to outsource the manufacturing of instruments and an increase in the chemistry reagents backlog.

During the three months ended March 31, 2012, Drew’s outsource partner began to supply DS5 diabetes instruments for sale. Drew received and sold 32 units from its outsource partner and anticipates receiving approximately 30 units per quarter for the remainder of the year. Drew is investigating outsource partners for its Drew 2280 hematology analyzer, as well as, pursuing alternative hematology instruments from other manufacturers. Drew continues to manufacture its Hemavet analyzer at is Dallas facility and expects to begin outsourcing its manufacture by the end of the current fiscal year.

In the Sonomed-Escalon business segment, product revenue increased $38,000, or 0.4% to $8,691,000 during the nine-month period ended March 31, 2012, as compared to the same period last fiscal year. The increase in product revenue was primarily caused by increased sales of Digital imaging systems.

The following table shows consolidated other revenue by business segment as well as identifying trends in business segment other revenues for the three- and nine-month periods ended March 31, 2012 and 2011. Table amounts are in thousands:


	For the Three Months Ended March 31,							For the Nine Months Ended March 31,
	2012		2011		% Change			2012		2011		% Change
Other Revenue:

ECD	$	0	$	0		0.0	%	$	0	$	7		-100.0	%
Sonomed-Escalon		0		0		0.0	%		0		0		0.0	%


Total	$	0	$	0		0.0	%	$	0	$	7		-100.0	%

There was no other revenue during the three-month periods ended March 31, 2012 and 2011.

There was no other revenue during the nine-month period ended March 31, 2012 as compared to $7,000 during the same period last fiscal year.

The following table presents consolidated cost of goods sold from continuing operations by reportable business segment and as a percentage of related segment product revenues for the three- and nine-month periods ended March 31, 2012 and 2011. Table amounts are in thousands:


	For the Three Months Ended March 31,										For the Nine Months Ended March 31,
	2012		%			2011		%			2012		%			2011		%
Cost of Goods Sold:

ECD	$	2,094		70.6	%	$	2,562		75.5	%	$	7,261		75.1	%	$	7,735		74.2	%
Sonomed-Escalon		1,499		48.4	%		1,508		50.2	%		4,185		48.2	%		4,601		53.2	%


Total	$	3,593		59.2	%	$	4,070		63.6	%	$	11,446		62.3	%	$	12,336		64.7	%

•

Cost of goods sold totaled approximately $3,593,000, or 59.2% of product revenue, for the three-month period ended March 31, 2012, as compared to $4,070,000 or 63.6%, of product revenue for the same period last fiscal year.

Cost of goods sold in the ECD business segment totaled $2,094,000, or 70.6% of product revenue, for the three-month period ended March 31, 2012, as compared to $2,562,000, or 75.5% of product revenue, for the same period last fiscal year. The decrease in cost of goods sold as a percentage of product revenue is related to the continuing process of outsourcing manufacturing and closing the Dallas facility. Drew anticipates outsourcing the remaining manufacturing activities at it Dallas facility by June 30, 2012.

Cost of goods sold in the Sonomed-Escalon business segment totaled $1,499,000, or 48.4% of product revenue, for the three-month period ended March 31, 2012, as compared to $1,508,000, or 50.2% of product revenue, for the same period last fiscal year. The decrease in Sonomed’s cost of goods sold as a percentage of revenue was primarily related to the reduced labor costs and change of product mix in favor of higher margin Axis image management systems.

•

Cost of goods sold totaled approximately $11,446,000, or 62.3% of product revenue, for the nine-month period ended March 31, 2012, as compared to $12,336,000, or 64.7% of product revenue, for the same period last fiscal year.

Cost of goods sold in the ECD business segment totaled $7,261,000, or 75.1% of product revenue, for the nine-month period ended March 31, 2012 as compared to $7,735,000, or 74.2% of product revenue, for the same period last fiscal year. The increase of approximately 1% is related to a write-off of slow moving inventory during the second quarter of the current fiscal year offset by decreased costs related to the continuing process of outsourcing manufacturing and closing the Dallas facility.

Cost of goods sold in the Sonomed-Escalon business segment totaled $4,185,000, or 48.2% of product revenue, for the nine-month period ended March 31, 2012 as compared to $4,601,000 or 53.2% of product revenue, for the same period last fiscal year. The decrease in Sonomed’s cost of goods sold as a percentage of revenue was primarily related to the reduced labor costs and change of product mix in favor of higher margin domestic Axis and VuMax sales.

The following table presents consolidated marketing, general and administrative expenses from continuing operations as well as identifying trends in business segment marketing, general and administrative expenses for the three- and nine-month periods ended March 31, 2012 and 2011. Table amounts are in thousands:


	For the Three Months Ended March 31,							For the Nine Months Ended March 31,
	2012		2011		% Change			2012		2011		% Change
Marketing, General and Administrative:

ECD	$	1,065	$	1,286		-17.2	%	$	3,187	$	3,844		-17.1	%
Sonomed-Escalon		781		674		15.9	%		2,286		2,093		9.2	%
Corporate		775		756		2.5	%		2,196		2,220		-1.1	%


Total	$	2,621	$	2,716		-3.5	%	$	7,669	$	8,157		-6.0	%

•

Marketing, general and administrative expenses decreased $95,000, or 3.5% to $2,621,000 during the three-month period ended March 31, 2012, as compared to the same period last fiscal year.

Marketing, general and administrative expenses in the ECD business segment decreased $221,000, or 17.2%, to $1,065,000 for the three-month period ended March 31, 2012, as compared to the same period last fiscal year. The decrease is related to a reduction in force and other administrative expenses related to the planned closure of the Dallas facility.

Marketing, general and administrative expenses in the Sonomed-Escalon business segment increased $107,000, or 15.9%, to $781,000 for the three-month period ended March 31, 2012, as compared to the same period last fiscal year. The increase is due to increased headcount in sales and marketing, exhibition expenses and advertising expenses.

Marketing, general and administrative expenses in the Corporate business segment increased $19,000, or 2.5%, to $775,000 for the three-month period ended March 31, 2012, as compared to the same period last fiscal year. The increase is related to increased printing and legal expense.

•

Marketing, general and administrative expenses decreased $488,000 or 6.0% to $7,669,000 for the nine-month period ended March 31, 2012, as compared to the same period last fiscal year.

Marketing, general and administrative expenses in the ECD business segment decreased $657,000, or 17.1%, to $3,187,000 for the nine-month period ended March 31, 2012, as compared to the same period last fiscal year. The decrease is related to a reduction in force and other administrative expenses related to the planned closure of the Dallas facility.

Marketing, general and administrative expenses in the Sonomed-Escalon business segment increased $193,000, or 9.2%, to $2,286,000 for the nine-month period ended March 31, 2012, as compared to the same period last fiscal year. The increase headcount in sales and marketing, exhibitions expense and advertising expenses partially offset by reduction in commission, royalties and consulting expense.

Marketing, general and administrative expenses in the Corporate business segment decreased $24,000, or 1.1%, to $2,196,000 for the nine-month period ended March 31, 2012, as compared to the same period last fiscal year. The decrease is due to a decrease in accounting, investor relations, director stock option compensation expense and depreciation expense.

The following table presents consolidated research and development expenses from continuing operations as well as identifying trends in business segment research and development expenses for the three- and nine-month periods ended March 31, 2012 and 2011. Table amounts are in thousands:


	For the Three Months Ended March 31,							For the Nine Months Ended March 31,
	2012		2011		% Change			2012		2011		% Change
Research and Development:

ECD	$	114	$	172		-33.7	%	$	386	$	544		-29.0	%
Sonomed-Escalon		300		223		34.5	%		730		654		11.6	%


Total	$	414	$	395		4.8	%	$	1,116	$	1,198		-6.8	%

•

Research and development expenses increased $19,000, or 4.8%, to $414,000 during the three-month period ended March 31, 2012, as compared to the same period last fiscal year.

Research and development expenses in the ECD business segment decreased $58,000, or 33.7% to $114,000 during the three-month period ended March 31, 2012, as compared to the same period last fiscal year. The decrease is due to the cost model implemented in June 2009, which significantly reduced the research and development headcount in favor of outsourcing substantially all future research and development projects on an “as needed” basis.

Research and development expenses in the Sonomed Escalon business segment increased $77,000, or 34.5%, to $300,000 during the three-month period ended March 31, 2012, as compared to the same period last fiscal year. The increase is related to the increased headcount in research and development of digital imaging products.

•

Research and development expenses decreased $82,000, or 6.8%, to $1,116,000 during the nine-month period ended March 31, 2012, as compared to the same period last fiscal year.

Research and development expenses in the ECD business segment decreased $158,000, or 29.0%, to $386,000 during the nine-month period ended March 31, 2012, as compared to the same period last fiscal year. The decrease is due to the cost model implemented in June 2009, which significantly reduced the research and development headcount in favor of outsourcing substantially all future research and development projects on an “as needed” basis.

Research and development expenses in the Sonomed-Escalon business segment increased $76,000, or 11.6%, to $730,000 during the nine-month period ended March 31, 2012, as compared to the same period last fiscal year. The increase is related to increased headcount in research and development of digital imaging products.

The Company recognized a loss of $1,000 and $38,000 related to its investment in OTM during the three-month periods ended March 31, 2012 and 2011, respectively, and recognized a gain of $1,000 and a loss of $72,000 for the nine-month periods ended March 31, 2012 and 2011, respectively.

There was no material interest income for the three-month and nine-month periods ended March 31, 2012 and 2011.

Interest expense was $77,000 and $84,000 for the three-month periods ended March 31, 2012 and 2011, respectively, and $247,000 and $244,000 for the nine-month periods ended March 31, 2012 and 2011, respectively

Liquidity and Capital Resources

Changes in overall liquidity and capital resources as of March 31, 2012 and June 30, 2011 are reflected in the following table (in thousands):


	March 31, 2012			June 30, 2011

Current Ratio:

Current assets	$	8,652,461		$	13,262,113
Less: Current liabilities		7,981,353			5,594,092

Working capital	$	671,108		$	7,668,021


Current ratio		1.1 to 1			2.4 to 1


Debt to Total Capital Ratio:

Notes payable and current maturities	$	4,449,516		$	278,278
Long-term debt		0			4,506,018

Total debt		4,449,516			4,784,296
Total equity		1,601,625			6,190,132

Total capital	$	6,051,141		$	10,974,428


Total debt to total capital		73.5	%		43.6	%

Working Capital Position

Working capital decreased approximately $6,997,000 as of March 31, 2012, and the current ratio decreased to 1.1 to 1 when compared to June 30, 2011. The decrease in working capital is mainly related to the loss from continuing operations of $2,199,000, loss from discontinued operations of $2,765,300, and the increase in the current position of long term debt of $3,840,500 related to the pending default on the BHH debt.

Cash Used in Operating Activities

During the nine-month periods ended March 31, 2012 and 2011, the Company used approximately $1,218,000 and $885,000 of cash for operating activities. The net increase in cash used in operating activities of approximately $333,000 for the nine-month period ended March 31, 2012 as compared to the same period in the prior fiscal year is due primarily to the following factors:

The Company had a net loss from continuing operations of $2,199,000, a loss from discontinued operations of $2,765,000 and experienced cash inflows from non-cash expenditures of depreciation and amortization, compensation expense related to stock operations of $459,000, and $57,000, respectively; and a decrease in accounts receivable, inventory and other current and long-term assets of $350,000, $721,000 and $75,000, respectively. These net cash in-flows were partially offset by a decrease in accounts payable, accrued expenses and other liabilities of $113,000.

In the prior fiscal period the cash used in operating activities of $885,000 was related to the net loss from continuing operations of $3,830,000, a decrease in accounts payable, accrued expenses and other liabilities of approximately $57,000 and an increase in inventory of approximately $448,000. These cash out-flows were partially offset by income from discontinued operations of $211,000, non-cash expenditures of depreciation and amortization, goodwill impairment and compensation expense related to stock option of $487,000, $906,000 and $87,000, respectively; and also a decrease in accounts receivable of $622,000.

Cash Flows (Used in) Investing Activities

Cash flows used in investing activities of $67,000 during the nine-month period ended March 31, 2012 were all related to fixed asset purchases. During the same period of the prior fiscal year cash flow used in investing activities was $142,000. The net cash flows used in investing activities from the prior fiscal period were related to an additional investment in Ocular Telehealth Management of $45,000 and fixed assets purchases of $97,000.

Cash Flows provided by/ (used in) in Financing Activities

Cash flows provided by the financing activities were approximately $144,000 during the nine-month period ended March 31, 2012 attributed to proceeds from a related-party note payable of $300,000 and offset by outflows for principal payments of long-term debt of $156,000. Cash flows used in financing activities for the same period last fiscal year were approximately $51,000 related to principal payments of long-term debt.

Debt History

On December 31, 2008, Drew acquired certain assets of Biocode for $5,900,000 (4,200,000 Euros) plus acquisition costs of approximately $300,000. The sales price was payable in cash of approximately $324,000 (approximately 231,000 Euros) and $5,865,000 in debt from BHH. The seller-provided financing is collateralized by certain assets of Biocode and guaranteed by Escalon. Biocode assets were vertically integrated into the Company’s clinical diagnostics business that includes Drew and JAS.

On April 29, 2011 the Company amended its seller financed debt in connection with the Biocode transaction. Under the terms of the debt refinancing, the Company agreed to pay the balance of the seller provided financing of 3,375,000 Euros by the sum per month in euros having an exchange value of $50,000 United States Dollars as of the date of payment. Interest rate remained unchanged and interest will accrue on the outstanding amount of the purchase price at an interest rate of 7% per year on the basis of the actual days elapsed and a 365 day year. The first payment under the amended agreement was paid on May 31, 2011. Upon the 60th month after this Amendment, the Company has agreed to pay the balance of the outstanding amount in euros in full in one payment.

On January 12, 2012 BH Holdings, S.A.S. (“BHH”) a wholly owned subsidiary of Drew, initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France (“Commercial Court”). The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH’s activity for three months and named an administrator to manage BHH. On April 2, 2012 the Commercial Court appointed a liquidator. Because BHH is no longer controlled by Drew, it was deconsolidated in the December 31, 2011 financial statements and prior period amounts are presented as discontinued operations (see footnote 10 to the Notes to Condensed Consolidated Financial Statements for additional information). This debt was guaranteed by Escalon and as a result of the insolvency declaration the debt was transferred to the Company. Since the liquidation was ordered, the Company was negotiating with the debt holder to reach a mutually agreeable resolution to the outstanding debt. On May 11, 2012, the debt holder informed Escalon that it intended to declare the debt in default under the terms of the agreement, as such; the entire debt of $4,149,516 is recorded as a current liability. The Company will not be able to pay the debt in its current form from existing resources. The Company will need to explore all potential options including raising additional funds or selling certain assets in order to pay the debt; there is no guarantee that the Company will be able to successfully achieve these options.

Continuing Operations

The accompanying consolidated financial statements have been prepared on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred recurring operating losses, no longer have the benefit of cash inflows from Vascular, and on May 11, 2012, the BHH debtholder informed the Company that it intends to declare the BHH debt, which is guaranteed by Escalon, into default, as such, the entire debt of $4,149,516 is recorded as a current liability. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unsuccessful in its efforts to raise additional capital in the near term, the Company may be required to significantly reduce its research, development, and administrative activities, including further reduction of its employee base or consider the sale of certain assets. The financial statements do not include any adjustments relating to the realization of the carrying value of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuance as a going concern is dependent on the Company’s future profitability and on the on-going support of the Company’s shareholders, affiliates and creditors. In order to mitigate the going concern issues, the Company is actively pursuing business partnerships, managing our continuing operations, and seeking capital funding on an ongoing basis via the issuance of securities and private placements although the Company may not succeed in these mitigation efforts.

If the Company is unable to achieve continued improvement in this area in the near term, it is not likely that our existing cash and cash flow from operations will be sufficient to fund activities throughout the next 4 to 6 months without curtailing certain business activities. The Company’s forecast of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties, and actual results could vary as a result of a number of factors, including the factors discussed in “Risk Factors” of the Company’s Form 10-K for the year ended June 30, 2011.

Off-Balance Sheet Arrangements and Contractual Obligations

The Company was not a party to any off-balance sheet arrangements during the three and nine-month periods ended March 31, 2012 and 2011.

The following table presents the Company’s contractual obligations as of March 31, 2012 (excluding interest):


	Total		Less than 1 Year		1-3 Years		3-5 Years		More than 5 Years

Long-term debt	$	4,149,516	$	4,149,516	$	0	$	0	$	0

Operating lease agreements		2,722,952		773,204		1,072,124		735,611		142,013


Total	$	6,872,468	$	4,922,720	$	1,072,124	$	735,611	$	142,013

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

The table below provides information about the Company’s financial instruments consisting of fixed interest rate debt obligations. For debt obligations, the table represents principal cash flows and related interest rates by expected maturity dates.


				Due during the year ending March 31,
	Interest Rate			2012		2013		2014		2015		2016		Total
Note Payable -Drew		7	%	$	4,149,516	$	0	$	0	$	0	$	0	$	4,149,516

Item 4. Controls and Procedures

(A)

Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Principal Financial and Accounting Officer, have established disclosure controls and procedures to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to the officers who certify the Company’s financial reports and to other members of senior management and the Board of Directors.

Based on their evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2012, the Chief Executive Officer and Principal Financial and Accounting Officer of the Company have concluded that such disclosure controls and procedures are effective to ensure that the information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Principal Financial and Accounting Officer, to allow timely decisions regarding required disclosure.

(B)

Internal Control over Financial Reporting

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act), during the third fiscal quarter ended March 31, 2012 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Part II. Other Information

Item 1. Legal Proceedings

See note 4 of the notes to the condensed consolidated financial statements for further information regarding the Company’s legal proceedings (see footnote 10 for details on the court proceedings related to the insolvency declaration at BHH).

Item 1A. Risk Factors

The holder of debt incurred by the Company in connection with its acquisition of BHH intends to declare the entire amount in default.

On May 11, 2012, the holder of debt incurred by the Company in connection with its acquisition of BHH informed the Company that it intends to declare the entire amount in default, seek a judgment from a French Court and then enforce the Company’s guarantee for payment. Consequently the Company has recorded the entire debt of $4,149,516 as a current liability. The Company will not be able to pay the debt in its current form from existing resources. The Company will need to explore all potential options including raising additional funds or selling certain assets in order to pay the debt; there is no guarantee that the Company will be able to successfully achieve these options. The Company’s ability to continue as a going concern is dependent upon reaching a reasonable resolution with the debt holder or the ability to access funds to satisfy the debt obligation, as well as the other factors set forth under “Management’s Discussion and Analysis—Debt History; – Continuing Operations” of this Form 10-Q Report.

Item 5. Other Information

The holder of debt incurred by the Company in connection with its acquisition of BHH intends to declare the debt is in default.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On February 15, 2012, the Company received a letter from the Listing Qualifications Staff of the NASDAQ Stock Market (the “Staff”) notifying the Company that it did not comply with the minimum $2,500,000 stockholders’ equity requirement for continued listing on the NASDAQ Capital Market as set forth in Listing Rule 5550(b). As of December 31, 2011, the Company reported stockholders’ equity of $2,307,284. The Company submitted a plan to regain compliance within the 45 calendar days from February 15, 2012 as required by NASDAQ rules. The Staff accepted the Company’s plan to regain compliance and granted the Company until August 13, 2012 to successfully implement it.

Item 6. Exhibits


31.1		Certificate of Chief Executive Officer under Rule 13a-14(a).

31.2		Certificate of Principal Financial and Accounting Officer under Rule 13a-14(a).

32.1		Certificate of Chief Executive Officer under Section 1350 of Title 18 of the United States Code.

32.2		Certificate of Principal Financial and Accounting Officer under Section 1350 of Title 18 of the United States Code.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	Escalon Medical Corp.
	(Registrant)

Date: May 15, 2012	By:	/s/ Richard J. DePiano
		Richard J. DePiano
		Chairman and Chief Executive Officer

Date: May 15, 2012	By:	/s/ Robert O’Connor
		Robert O’Connor
		Chief Financial Officer

EX-31.1 2 d335645dex311.htm CERTIFICATE OF CHIEF EXECUTIVE OFFICER Certificate of Chief Executive Officer

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECTION 302 OF SARBANES-OXLEY ACT OF 2002

I, Richard J. DePiano, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Escalon Medical Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles,

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2012

/s/ Richard J. DePiano

Richard J. DePiano

Chairman and Chief Executive Officer

EX-31.2 3 d335645dex312.htm CERTIFICATE OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER Certificate of Principal Financial and Accounting Officer

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO

SECTION 302 OF SARBANES-OXLEY ACT OF 2002

I, Robert O’Connor, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Escalon Medical Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2012

/s/ Robert O’Connor

Robert O’Connor

Chief Financial And Accounting Officer

EX-32.1 4 d335645dex321.htm CERTIFICATE OF CHIEF EXECUTIVE OFFICER Certificate of Chief Executive Officer

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Richard J. DePiano, Chief Executive Officer of Escalon Medical Corp., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Quarterly Report of Escalon Medical Corp. on Form 10-Q for the quarterly period ended March 31, 2012 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and

(2) the information contained in the Report fairly presents in all material respects the financial condition and results of operations of Escalon Medical Corp.

Date: May 15, 2012

/s/ Richard J. DePiano

Richard J. DePiano

Chairman and Chief Executive Officer

EX-32.2 5 d335645dex322.htm CERTIFICATE OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER Certificate of Principal Financial and Accounting Officer

EXHIBIT 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert O’Connor, Chief Financial Officer of Escalon Medical Corp., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(2) the information contained in the Report fairly presents in all material respects the financial condition and results of operations of Escalon Medical Corp.

Date: May 15, 2012

/s/ Robert O’Connor

Robert O’Connor

Chief Financial Officer

EX-101.INS 6 esmc-20120331.xml XBRL INSTANCE DOCUMENT 0000862668 us-gaap:WarrantsMember 2012-03-31 0000862668 us-gaap:RetainedEarningsMember 2012-03-31 0000862668 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0000862668 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-03-31 0000862668 us-gaap:WarrantsMember 2011-06-30 0000862668 us-gaap:RetainedEarningsMember 2011-06-30 0000862668 us-gaap:AdditionalPaidInCapitalMember 2011-06-30 0000862668 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-06-30 0000862668 us-gaap:CommonStockMember 2012-03-31 0000862668 us-gaap:CommonStockMember 2011-06-30 0000862668 2012-01-01 2012-03-31 0000862668 2011-01-01 2011-03-31 0000862668 2010-07-01 2011-03-31 0000862668 2011-03-31 0000862668 2010-06-30 0000862668 us-gaap:WarrantsMember 2011-07-01 2012-03-31 0000862668 us-gaap:RetainedEarningsMember 2011-07-01 2012-03-31 0000862668 us-gaap:CommonStockMember 2011-07-01 2012-03-31 0000862668 us-gaap:AdditionalPaidInCapitalMember 2011-07-01 2012-03-31 0000862668 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-07-01 2012-03-31 0000862668 2012-03-31 0000862668 2011-06-30 0000862668 2012-05-14 0000862668 2011-07-01 2012-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares false --06-30 Q3 2012 2012-03-31 10-Q 0000862668 7526430 Smaller Reporting Company ESCALON MEDICAL CORP 808640 600391 0 0 1601346 0 0 -1601346 <div> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="4%" align="left">11.</td> <td valign="top" align="left">Expiration of commons stock warrant </td></tr></table> Common stock warrants in the amount of $1,601,346 have expired and were released to additional paid-in capital. </div>

1746951

1819125

3802316

3452402

1897441

1712712

-841799

-522739

67694959

69353173

17276344

10569080

13262113

8652461

2342137

1699527

3008485

2136064

1684746

562880

-872421

-1121866

1024365

-566953

0.001

35000000

7526430

7526

-3622518

-1981201

-4645375

319060

-4964435

-846232

12335468

4068483

11446127

3593302

22596628

8085639

20231772

6628658

486631

458921

-0.48

-0.26

-0.66

-0.09

-0.48

-0.26

-0.66

-0.09

205122

18469

52931

30277

-86885

218208

905810

-3829774

-1808183

-2199135

-639786

-0.51

-0.24

-0.29

-0.09

-0.51

-0.24

-0.29

-0.09

210525

-113302

-2765300

0.03

-0.02

-0.37

0.00

0.03

-0.02

-0.37

0.00

-71745

-37600

612

-532

45000

-57333

-112555

-622300

-349914

447958

-720787

-251858

-74948

694006

244064

84186

247094

76544

168694

170550

5184272

4463485

194

119

11086212

8967455

17276344

10569080

5594092

7981353

5492120

986102

1671422

278278

4149516

4506018

-50538

144205

-141805

-66723

-885200

-1217817

-1909565

-650864

-3619249

-1921485

-4964435

-639786

-315615

-121703

-333248

-77059

300000

-3514159

-1686480

-1865887

-562727

248642

173694

-3269

-59716

319060

-206446

6933

45000

96805

66723

986102

0.001

2000000

300000

-3829774

-1808183

-2199135

-639786

540919

373737

50538

155795

1198273

395656

1116414

413874

-62404014

-67368449

19075536

6399159

18365885

6065931

19082469

6399159

18365885

6065931

<div> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="4%" align="left">5.</td> <td valign="top" align="left">Segmental Information </td></tr></table> During the three-month and nine-month periods ended March 31, 2012 and 2011, the Company's operations were classified into three principal reportable business units that provide different products or services. Management reviews financial information, allocates resources, and manages the business as three segments: ECD, Sonomed-Escalon and Escalon Medical Corp. ("Corporate"). The ECD segment consists of Drew Scientific, Inc., and its wholly owned subsidiary JAS. ECD develops and sells clinical diagnostic instruments, reagents and chemistries. The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Corporate segment includes the administrative corporate operations of the consolidated group. The Company began to include redesignated reporting segments beginning with Form 10-K for the year ended June 30, 2011, and prior period segment information has been reclassified to conform with the current period presentation. Separate management of each unit is required because each business unit is subject to different marketing, production and technology strategies.   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td width="54%"> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="22" align="center">Segment Statements of Operations (in thousands) - Three months ended March 31,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center">ECD</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center">Sonomed-Escalon</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center">Corporate</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center">Total</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2011</td> <td valign="bottom"> </td></tr> <tr><td height="8"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Revenues, net:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Product revenue</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,968</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,395</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,098</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,004</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,066</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,399</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Other revenue</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total revenue, net</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,968</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,395</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,098</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,004</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,066</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,399</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Costs and expenses:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Cost of goods sold</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,094</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,562</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,499</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,508</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,593</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,070</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Research & Development</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">114</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">172</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">223</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">414</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">395</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Marketing, General & Admin</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,349</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,769</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,147</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">822</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">126</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">124</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,622</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,715</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Goodwill impairment</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total costs and expenses</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,557</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,503</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,946</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,459</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">126</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">124</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,629</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,086</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> (Loss) income from operations</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(589</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,108</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">152</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(455</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(126</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(124</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(563</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,687</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Other (expense) and income:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Equity in OTM</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(38</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(38</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Interest income</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Interest expense</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(84</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(75</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(76</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(84</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total other (expense) income</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(84</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(75</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(37</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(76</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(121</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> (Loss)income before taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(590</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,192</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">152</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(455</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(161</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(639</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,808</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Net (loss) income from continuing operations</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(590</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,192</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">152</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(455</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(201</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(161</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(639</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,808</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table>   <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td width="51%"> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td> <td valign="bottom" width="2%"> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="22" align="center">Segment Statements of Operations (in thousands) - Nine-months ended March 31,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center">ECD</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center">Sonomed-Escalon</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center">Corporate</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="6" align="center">Total</td> <td valign="bottom"> </td></tr> <tr><td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2011</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="border-bottom: #000000 1px solid;" valign="bottom" colspan="2" align="center">2011</td> <td valign="bottom"> </td></tr> <tr><td height="8"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td> <td height="8" colspan="4"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Revenues, net:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Product revenue</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,675</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,423</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,691</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,653</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">18,366</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">19,076</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Other revenue</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total revenue, net</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,675</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,430</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,691</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,653</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">18,366</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19,083</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Costs and expenses:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr><td valign="top"> Cost of goods sold</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,261</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,735</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,185</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,601</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,446</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,336</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Research & Development</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">386</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">544</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">730</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">654</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,116</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,198</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Marketing, General & Admin</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,198</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,284</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,109</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,517</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">363</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">356</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,669</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,157</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Goodwill impairment</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Total costs and expenses</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,845</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13,563</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,024</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,678</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">363</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">356</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">20,232</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">22,597</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> (Loss) income from operations</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,170</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,133</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">667</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(363</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(356</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,866</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,514</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Other (expense) income:</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Equity in OTM</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(72</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(72</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr><td valign="top"> Loss on Disposal of Assets</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(87</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(87</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Interest income</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr><td valign="top"> Interest expense</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(164</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(244</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(83</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(247</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(244</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Total other (expense) income</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(251</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(244</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(82</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(72</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(333</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(316</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> (Loss) income before taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,421</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,377</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">667</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(444</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(428</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,199</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,830</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr bgcolor="#cceeff"><td valign="top"> Income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr> <tr><td valign="top"> Net (loss) income from continuing Operations</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,421</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,377</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">667</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(25</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(444</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(428</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,199</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,830</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="font-size: 1px;"><td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom">  </td> <td> </td></tr></table> The Company operates in the healthcare market, specializing in the development, manufacture and marketing of (1) ophthalmic medical devices and pharmaceuticals; (2) in-vitro diagnostic ("IVD") instrumentation and consumables for use in human and veterinary hematology. On April 30, 2010, the Company sold its Vascular business. The business segments reported above are the segments for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and assessing performance. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies in Form 10-K for the year ended June 30, 2011. For the purposes of this illustration, corporate expenses, which consist primarily of executive management and administrative support functions, are allocated across the business segments based upon a methodology that has been established by the Company, which includes a number of factors and estimates and that has been consistently applied across the business segments. These expenses are otherwise included in the corporate segment. During the three- and nine-month periods ended March 31, 2012 and 2011, ECD derived its revenue from the sale of instrumentation and consumables for blood cell counting and blood analysis in the areas of diabetes, cardiovascular diseases and human and veterinary hematology. Sonomed-Escalon derived its revenue from the sale of A-Scans, B-Scans, pachymeters, digital imaging products, ISPAN™ gas products and various disposable ophthalmic surgical products. </div>

8157077

2715690

7669231

2621482

7526430

6190132

-841799

67694959

7526

-62404014

1733460

1601625

-522739

69353173

7526

-67368449

132114

87156

56868

1733460

132114

7526430

EX-101.SCH 7 esmc-20120331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Consolidated Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statement Of Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - Condensed Consolidated Statements Of Comprehensive (Loss) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Basis Of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - (Loss) Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Legal Proceedings link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Segmental Information link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Related Party Transaction link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Continuing Operations link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Expiration Of Commons Stock Warrant link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 esmc-20120331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 esmc-20120331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 esmc-20120331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and entity information [Abstract]. Document And Entity Information [Abstract] Statement [Table] Statement [Line Items] Document Type Amendment Flag Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Condensed Consolidated Balance Sheets [Abstract] Assets [Abstract] ASSETS Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Accounts Receivable, Net, Current Accounts receivable, net Accounts Receivable, Net, Current, Total Inventory, Net Inventory, net Inventory, Net, Total Other Assets, Current Other current assets Assets of Disposal Group, Including Discontinued Operation, Current Assets of discontinued operations Assets of Disposal Group, Including Discontinued Operation, Current, Total Assets, Current Total current assets Property, Plant and Equipment, Net Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property and equipment, net Property, Plant and Equipment, Net, Total Goodwill Goodwill, Ending Balance Goodwill, Beginning Balance Goodwill, Total Indefinite-Lived Intangible Assets (Excluding Goodwill) Trademarks and trade names Indefinite-Lived Intangible Assets (Excluding Goodwill), Total Finite-Lived Intangible Assets, Net Patents, net Finite-Lived Intangible Assets, Net, Total Covenant not to compete and customer list, net. Covenant Not to Compete and Customer List, Net Covenant not to compete and customer lists, net Assets of Disposal Group, Including Discontinued Operation, Noncurrent Non-current assets of discontinued operations Assets of Disposal Group, Including Discontinued Operation, Noncurrent, Total Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY Long-term Debt, Current Maturities Current portion of long-term debt Long-term Debt, Current Maturities, Total Notes Payable, Related Parties, Current Related party note payable Notes Payable, Total Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Accrued Liabilities, Current Accrued expenses Accrued Liabilities, Current, Total Liabilities of Disposal Group, Including Discontinued Operation, Current Liabilities of discontinued operations Liabilities of Disposal Group, Including Discontinued Operation, Current, Total Liabilities, Current Total current liabilities Long-term Debt, Excluding Current Maturities Long-term debt, net of current portion Long-term Debt, Excluding Current Maturities, Total Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent Accrued post-retirement benefits Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent, Total Liabilities, Noncurrent Total long-term liabilities Total long-term liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Shareholders equity: Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred stock, $0.001 par value; 2,000,000 shares authorized; no shares issued Preferred Stock, Value, Issued, Total Common Stock, Value, Issued Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common stock, $0.001 par value; 35,000,000 shares authorized; 7,526,430 issued and outstanding at March 31, 2012 and June 30, 2011 Common Stock, Value, Issued, Total Warrants and Rights Outstanding Common stock warrants Additional Paid in Capital Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional paid-in capital Additional Paid in Capital, Total Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Accumulated deficit Retained Earnings (Accumulated Deficit), Total Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Stockholders' Equity Attributable to Parent BALANCE BALANCE Total shareholders' equity Liabilities and Equity Total liabilities and shareholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Issued, Total Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Issued, Total Common Stock, Shares, Outstanding Balance, shares Balance, shares Balance, shares Common stock, shares outstanding Common stock, shares outstanding Condensed Consolidated Statements Of Operations [Abstract] Revenue, Net [Abstract] Net revenues: Sales Revenue, Goods, Net Product revenue Sales Revenue, Goods, Net, Total Other Revenue, Net Other revenue Revenue, Net Revenues, net Revenues, net Costs and Expenses [Abstract] Costs and expenses: Cost of Goods Sold Cost of goods sold Cost of Goods Sold, Total Selling, General and Administrative Expense Marketing, general and administrative Selling, General and Administrative Expense, Total Research and Development Expense Research and development Research and Development Expense, Total Goodwill, Impairment Loss Goodwill impairment Goodwill impairment Costs and Expenses Total costs and expenses Operating Income (Loss) Loss from operations Other Income and Expenses [Abstract] Other (expense) and income: Income (Loss) from Equity Method Investments (Income) Loss from Ocular Telehealth Management, LLC Equity in Ocular Telehealth Management, LLC (Income) loss of Ocular Telehealth Management, LLC Loss of Ocular Telehealth Management, LLC Gains (Losses) on Sales of Assets Gain on sales of assets Loss on disposal of assets Gains (Losses) on Sales of Assets, Total Gain on sales of assets Investment Income, Interest Interest income Interest Expense Interest expense Interest expense Interest Expense, Total Nonoperating Income (Expense) Total other (expense) income Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Loss from continuing operations before taxes Income Tax Expense (Benefit) Provision for income taxes Income Tax Expense (Benefit), Total Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss from continuing operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Income (loss) from discontinued operations Income from discontinued operations Net income (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total Income from discontinued operations Net Income (Loss) Attributable to Parent Net loss Net loss Net loss Earnings Per Share, Basic [Abstract] Net income (loss) per share Income (Loss) from Continuing Operations, Per Basic Share Continuing operations Income (Loss) from Continuing Operations, Per Outstanding Share, Total Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share Discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Per Outstanding Share, Total Earnings Per Share, Basic Net income (loss) Earnings Per Share, Diluted [Abstract] Net loss per share Diluted: Income (Loss) from Continuing Operations, Per Diluted Share Continuing operations Income (Loss) from Discontinued Operations, Net of Tax, Per Diluted Share Discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Per Diluted Share, Total Earnings Per Share, Diluted Net income (loss) Weighted Average Number of Shares Outstanding, Basic Weighted average shares - basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Diluted Weighted average shares - diluted Weighted Average Number of Shares Outstanding, Diluted, Total Condensed Consolidated Statements Of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to cash provided by operating activities of continuing operations: Depreciation, Depletion and Amortization Depreciation and amortization Depreciation, Depletion and Amortization, Total Stock or Unit Option Plan Expense Compensation expense related to stock options Compensation expense Increase (Decrease) in Operating Capital [Abstract] Change in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable, net Accounts receivable, net Increase (Decrease) in Inventories Inventory, net Inventory, net Increase (Decrease) in Inventories, Total Increase (Decrease) in Other Operating Assets Other current and long-term assets Other current and long-term assets Increase (Decrease) in Other Operating Assets, Total Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in operating activities from continuing operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Net cash used in (provided by) operating activities from discontinued operations Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Flows from Investing Activities: Payments to Acquire Interest in Subsidiaries and Affiliates Investment in Ocular Telehealth Management, LLC Investment in Ocular Telehealth Management, LLC Payments to Acquire Interest in Subsidiaries and Affiliates, Total Payments to Acquire Productive Assets Purchase of fixed assets Purchase of fixed assets Payments to Acquire Productive Assets, Total Net Cash Provided by (Used in) Investing Activities Net cash (used in) investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows from Financing Activities: Repayments of Long-term Debt Principal payments on long-term debt Principal payments on long-term debt Repayments of Long-term Debt, Total Proceeds from Related Party Debt Proceeds from related party note payable Proceeds from Notes Payable, Total Net Cash Provided by (Used in) Financing Activities Net cash provided by (used in) financing activities Effect of Exchange Rate on Cash and Cash Equivalents Effect of exchange rate changes on cash & cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents, Total Cash and Cash Equivalents, Period Increase (Decrease) Net decrease in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental Schedule of Cash Flow Information: Interest Paid Interest paid Interest Paid, Total Income Taxes Paid, Net Income taxes paid Income Taxes Paid, Net, Total Condensed Consolidated Statement Of Shareholders' Equity [Abstract] Statement, Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Shares, Outstanding BALANCE, shares BALANCE, shares Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Comprehensive Income: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive (loss) Expiration of common stock warrants. Expiration of Common Stock Warrants Expired stock warrants Condensed Consolidated Statements Of Comprehensive (Loss) [Abstract] Basis Of Presentation [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis Of Presentation Stock-Based Compensation [Abstract] Shareholders' Equity and Share-based Payments [Text Block] Stock-Based Compensation (Loss) Earnings Per Share [Abstract] Earnings Per Share [Text Block] (Loss) Earnings Per Share Legal Proceedings [Abstract] Legal Proceedings [Abstract] Legal Proceedings Legal Matters and Contingencies [Text Block] Legal Proceedings Segmental Information [Abstract] Segment Reporting Disclosure [Text Block] Segmental Information Related Party Transaction [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transaction Recently Issued Accounting Standards [Abstract] Accounting Changes and Error Corrections [Text Block] Recently Issued Accounting Standards Fair Value Measurements [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Continuing operations [Abstract]. Continuing Operations [Abstract] Continuing Operations Nature of Operations [Text Block] Continuing Operations Discontinued Operations [Abstract] Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Discontinued Operations Expiration of commons stock warrant [Abstract]. Expiration Of Commons Stock Warrant [Abstract] Expiration of common stock warrants disclosure [Text Block]. Expiration of Common Stock Warrants Disclosure [Text Block] Expiration Of Commons Stock Warrant Warrants [Member] Common Stock Warrants [Member] Additional Paid In Capital [Member] Additional Paid-In Capital [Member] Retained Earnings [Member] Accumulated Deficit [Member] Accumulated Other Comprehensive Income [Member] Accumulated Other Comprehensive (Loss) [Member] EX-101.PRE 11 esmc-20120331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R9.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation

9 Months Ended

Mar. 31, 2012

Stock-Based Compensation [Abstract]

Stock-Based Compensation

2.	Stock-Based Compensation

Valuations are based upon highly subjective assumptions about the future, including stock price volatility and exercise patterns. The fair value of share-based payment awards was estimated using the Black-Scholes option pricing model. Expected volatilities are based on the historical volatility of the Company's stock. The Company uses historical data to estimate option exercise and employee terminations. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

The Company has historically granted options under the Company's option plans with an option exercise price equal to the closing market value of the stock on the date of the grant and with vesting, primarily for Company employees, either in equal annual amounts over a two- to five-year period or immediately, and, primarily for non-employee directors, immediately.

The Company measures compensation expense for non-employee stock-based compensation based on the fair value of the options issued, as this is more reliable than the fair value of the services received. Fair value is measured as the value of the Company's common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty's performance is complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital. There was no non-employee compensation expense for the three-month and nine-month periods ended March 31, 2012 and 2011.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 93-6

-Paragraph 53

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64, 65, A240

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\S,&(W-V,T-5\V.&5A7S0V.#=?.#%D-U\X,S)A M,S!E,#(W,S@B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K0F%S961?0V]M<&5N#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1A;%]);F9O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E;&%T961?4&%R='E? M5')A;G-A8W1I;VX\+W@Z3F%M93X-"B`@("`\>#I7;W)K5])#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-O;G1I;G5I;F=?3W!E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1I#I%>&-E;%=O#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\ M>#I0#I%>&-E;%=O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,CQS<&%N M/CPO'0^15-#04Q/3B!-141)0T%,($-/4E`\2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,#@V M,C8V.#QS<&%N/CPO'0^+2TP-BTS,#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!N;W1E('!A>6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S,&(W-V,T-5\V.&5A7S0V.#=?.#%D M-U\X,S)A,S!E,#(W,S@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M,S!B-S=C-#5?-CAE85\T-C@W7S@Q9#=?.#,R83,P93`R-S,X+U=O'0O:'1M;#L@8VAA M7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA2!O<&5R871I;F<@86-T:79I=&EEF%T:6]N/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-3@L.3(Q/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E(')E;&%T960@=&\@2D@;W!E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5D M(&%S&-H86YG92!R871E(&-H86YG97,@;VX@8V%S:"`F M86UP.R!C87-H(&5Q=6EV86QE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ."PT-CD\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2`H55-$("0I/&)R/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!I'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE#LG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE2(@8V]L;&5C=&EV96QY('-H86QL(&UE86X@17-C86QO M;B!A;F0@:71S('=H;VQL>2!O=VYE9"!S=6)S:61I87)I97,Z(%-O;F]M960L M($EN8RX@*")3;VYO;65D(BDL(%1R96LL($EN8RX@*")42!A8V-O M=6YT2!D96-L87)A=&EO;B!W:71H('1H92!42`Q."P@,C`Q,B!O<&5N960@=&AE M(&QI<75I9&%T:6]N('!R;V-E961I;F=S('=I=&@@8V]N=&EN=6%T:6]N(&]F M($)(2"=S(&%C=&EV:71Y(&9O6QE/3-$)VUA'0M:6YD96YT.B`S,G!X.R!M87)G:6XM8F]T=&]M.B`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`R-S,X+U=O'0O:'1M;#L@8VAA'0^/&1I=CX@/'1A8FQE('-T>6QE/3-$)V)OF4],T0R M/CQB/C(N/"]B/CPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1'1O<"!A;&EG M;CTS1&QE9G0^/&9O;G0@F4],T0R/CQB/E-T;V-K+4)A'0M:6YD96YT.B`V M-'!X.R!M87)G:6XM8F]T=&]M.B`P<'@[)SX\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA2!A;F0@97AE6UE;G0@87=A2!O9B!T:&4@0V]M<&%N>2=S M('-T;V-K+B!4:&4@0V]M<&%N>2!U65E('1E'!E8W1E9"!T;R!B92!O=71S=&%N9&EN9RX@5&AE(')I6QE/3-$)VUA#L@9F]N="US:7IE.B`Q<'@[)SXF;F)S M<#L\+W`^#0H-"CQP('-T>6QE/3-$)VUA#L@=&5X="UI M;F1E;G0Z(#8T<'@[(&UA#LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE2P@86YD+"!P2X@5&AE(')E;6%I;FEN M9R!C;W-T(&ES(&5X<&5C=&5D('1O(&)E(')E8V]G;FEZ960@;W9E65A2X@1F]R('1H92!N:6YE M+6UO;G1H('!E'!E;G-E+"!R97-P96-T:79E;'DN(#PO9F]N=#X\+W`^#0H-"CQP M('-T>6QE/3-$)VUA'0M:6YD96YT.B`V-'!X M.R!M87)G:6XM8F]T=&]M.B`P<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA2=S(&-O;6UO;B!S=&]C M:R!O;B!T:&4@9&%T92!T:&%T('1H92!C;VUM:71M96YT(&9O2!T:&4@8V]U;G1E2=S('!E2!T;R!C;VUP96YS871I;VX@97AP96YS92!A;F0@861D M:71I;VYA;"!P86ED+6EN(&-A<&ET86PN(%1H97)E('=A7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$ M)VUA#L@;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@ MF4],T0R/E1H92!F;VQL;W=I;F<@=&%B;&4@#L@9F]N="US:7IE.B`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`\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!C;&%SF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^(#PO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M/B`\+W1D/CPO='(^#0H\='(^/'1D('9A;&EG M;CTS1'1O<#X-"@T*/'`@3H@ M5&EM97,@3F5W(%)O;6%N.R<@8VQAF4],T0Q/B9N8G-P.R9N8G-P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT^(#PO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B`\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!C;&%SF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT^(#PO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B`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`M,65M.R!M87)G:6XM;&5F=#H@,65M.R<^/&9O;G0@F4],T0Q/B9N8G-P.R9N8G-P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R<@8VQAF4],T0R/C`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`M,65M.R!M87)G:6XM;&5F=#H@,65M.R<^ M/&9O;G0@F4],T0R/CQB/D1E;F]M:6YA=&]R.B`\+V(^/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!C;&%S MF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^(#PO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M/B`\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!C;&%S6QE/3-$)W1E>'0M:6YD96YT.B`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`\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!C;&%S MF4] M,T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X@ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^(#PO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M/B`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`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`C,#`P,#`P(#%P>"!S;VQI9#LG M/B9N8G-P.SPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"@T*/'`@ M6QE M/3-$)V)O6QE M/3-$)V)O"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D M/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B9N8G-P M.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*#0H\<"!S='EL93TS1"=B M;W)D97(M=&]P.B`C,#`P,#`P(#%P>"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"@T*/'`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`C,#`P,#`P(#-P>"!D M;W5B;&4[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^ M#0H-"CQP('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^(#PO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M/B`\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!C;&%S6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UEF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^(#PO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M/B`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`C,#`P,#`P(#%P>"!S;VQI9#LG/B9N8G-P.SPO M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"@T*/'`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`M,65M.R!M87)G:6XM;&5F=#H@,65M.R<^/&9O;G0@ MF4],T0R/CQB/D1I;'5T960Z/"]B/CPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@8VQAF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT^(#PO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B`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`C,#`P,#`P(#%P>"!S;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;3X-"@T*/'`@6QE/3-$)V)O6QE/3-$)V)O"!S M;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M/B9N8G-P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*#0H\<"!S='EL93TS1"=B;W)D97(M=&]P.B`C,#`P,#`P(#%P>"!S M;VQI9#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X- M"@T*/'`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`^/"]T9#X-"CQT9#XF;F)S<#L\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;3XF;F)S<#L\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"@T*/'`@"!D;W5B;&4[)SXF;F)S<#L\+W`^ M/"]T9#X-"CQT9#XF;F)S<#L\+W1D/CPO='(^/"]T86)L93X-"@T*/'`@#L@=&5X="UI;F1E;G0Z(#8T<'@[(&UA M#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'0M:6YD96YT.B`V-'!X.R!M87)G:6XM8F]T M=&]M.B`P<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@ M3F5W(%)O;6%N.R<@8VQA2!D:7-P=71E2!T;R!H879E(&$@;6%T97)I86P@861V97)S92!I;7!A8W0@;VX@=&AE M($-O;7!A;GDG7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE#L@;6%R9VEN+6)O M='1O;3H@,'!X.R<^/&9O;G0@F4],T0R/D1U6QE/3-$ M)VUA'0M:6YD96YT.B`V-'!X.R!M87)G:6XM M8F]T=&]M.B`P<'@[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM M97,@3F5W(%)O;6%N.R<@8VQA2!B96=A;B!T;R!I;F-L=61E(')E9&5S:6=N871E9"!R97!O65A2!S=')A=&5G:65S+B`\+V9O;G0^/"]P/@T*#0H\<"!S M='EL93TS1"=M87)G:6XM=&]P.B`P<'@[(&UA#L@ M9F]N="US:7IE.B`Q,G!X.R<^)FYB3H@5&EM97,@3F5W(%)O;6%N.R<@8VQAF4] M,T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C M;VQS<&%N/3-$,CX\9F]N="!C;&%SF4],T0Q/B9N8G-P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX\ M9F]N="!C;&%SF4],T0Q/B9N8G-P.SPO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!C;&%SF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$-B!A;&EG;CTS1&-E;G1E3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!C;&%SF4],T0Q/B9N8G-P.R9N8G-P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE MF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!C;&%S3H@ M5&EM97,@3F5W(%)O;6%N.R<@8VQAF4],T0Q/B9N M8G-P.R9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UEF4],T0Q/B9N8G-P.SPO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!C;&%S3H@5&EM97,@3F5W(%)O;6%N.R<@8VQAF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)V)O M6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UEF4],T0Q/B9N8G-P.SPO M9F]N=#X\+W1D/CPO='(^#0H\='(^/'1D/B`\+W1D/@T*/'1D(&-O;'-P86X] M,T0T/B`\+W1D/@T*/'1D(&-O;'-P86X],T0T/B`\+W1D/@T*/'1D(&-O;'-P M86X],T0T/B`\+W1D/@T*/'1D(&-O;'-P86X],T0T/B`\+W1D/@T*/'1D(&-O M;'-P86X],T0T/B`\+W1D/@T*/'1D(&-O;'-P86X],T0T/B`\+W1D/@T*/'1D M(&-O;'-P86X],T0T/B`\+W1D/@T*/'1D(&-O;'-P86X],T0T/B`\+W1D/CPO M='(^#0H\='(@8F=C;VQO3H@5&EM97,@3F5W M(%)O;6%N.R<@8VQAF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^(#PO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B`\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!C;&%SF4],T0Q/B9N8G-P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;3X@/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT^(#PO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B`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`\ M+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97,@3F5W(%)O;6%N.R<@8VQAF4],T0R/B9N8G-P M.R9N8G-P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!C;&%S ZIP 15 0001193125-12-234917-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-12-234917-xbrl.zip M4$L#!!0````(`+N(KT!'*9:Z[ET``"D`!P`1`!P`97-M8RTR,#$R,#,S,2YX M;6Q55`D``S'%LD\QQ;)/=7@+``$$)0X```0Y`0``[#QI<]LXLM^W:O\#5CM' M4B7)/'0ZQY;C.#-^FVMM9W??IQ1$0A;>4*0&('W,KW_=#?#091V6X]CC?(@I M$@3Z/L!NO/S'U3AB%T)IF<2O:F[3J3$1!TDHX_-7M4PWN`ZDK/WC]5__\O)O MC<9_WYR\9V$29&,1IRQ0@JDV'C=)TLK^W=WEYV50X5MNAS2`9-QIVM3=]YCNNQ[K[;VW=:[."#&7@U4!$#_&+]JE99$&\W$W4.+SG^GHQU MRN-`U,S(_4C&O]TP'!\/`*Y\^-7<^$N?1KO]?G^/GA9#8:)0%F.K\W;VS,-\ M:"AFQFD1-,^3BSUX@+BZ#<=M^&YU9KD!CD*/@ZGA0@<\2N*Q")$!1$W'+^>7 M.FEY;O>F%__]\/XT&(DQ;Q28 M`'\9>XGDW=?TZ$0,&9%[/[V>B%3"#&F>R,EAJ]JB'EN&KVH'^^FGXU?_JNU]QEJ\6FZ^G*4@CJL31 M[YE,KP^3\22)X:<^N)*Z&/4?KA2'FQ_$>""4P0`6@''PCOT%OV6(=X92*$:8 MB2FRY()P>/S/VFL'_O4Z7J?3>[E7OE9.I<4Y0E7<@%M&SO;%U222@4P-+"R4 M,,Z8``OM_HTXU5[GPZ:1>KFW[N7W\ADJ[[SM.1,IE+,(CKF*PC(^+A8N1>ZRL/`A#B?K-H\]< MAL?Q(9_(E$>/BJ,WXOAH&1M`6))%&!=\2D="X3`E1DC""W$,,HJO[E>K@V=)J9!WSH]5B`)* M*GT+1+>RBGMP0*SB;C%0Q&%EF!'I_-[M*.)6*>)^7Q1QUZ.(NR.*=`U%G.^8 M(D[#Z=X]1:;]UOV38-H>[,Z@.]\39LZ.+%UW@5X_;8W?>2H_:[C64=-=F?)= ML/QI"^!/+P)/\>J?E/%/>T9/`O&TUW0?>TWW("@SFU+?4PB\V]V:[PFSG6PD MMK^ZK>^19^V&V[J;M.7>$?U&^OFW1N-++.=JG3*\AU3"AZY?4".4%X!)N3B. M^YB-!9`R*6T1/!@+KC,E7MMRL/TOIV]?[N4W2YNU^'V:]JV(D[&,ETU,E6[[ M>L25T,MFGI_BY5X%`S-H$<(E^U?BL7R2N3F6@UR=!#AREDTB,9 M?1(*N7\`#T)\^"[BY\RR^`1+W5;)^9!'6KS1VZ*89RS7?VM)2,^0SR>\[N*O-0O7.QE!%`>D/T_49F0X!2#@778B)HE*$0T,!GE\705E:OK9 MM4_$N=0I;C5]Y./-N'QT>GCP_M-']N'H[3%3]"Q!@$4J#N+P,-,IQ*[J/;SU4:0+.%)&2S,<\:HL<6JO>R`<+>#'!LOM M`KZ2."O@ZSB.WW>WA>_H:B(-:SX-*W*6;QENPL05<.8D7+'BG22#>W'@^#,1YH5B#7N2#C?0FP5)1A#GP&6 M;R)XM)'+^RE*7T`V\--Y^H+A="3/ MXU>U-)D4XUL_UIB]'8EA6LN'#P&]'$*\;@SY6$;7^^Q,CH5F'\4E.TG&/`8@ M@XAKH/_7<5IC6OX!+WC%-`.\<-TF7N\-\KM[.&/Q(PTK\,Y`>=>@E8QGR1`H MCZS7,#ER^-)PGZV&W5RJ\A+Y:Y`R:$UR>,=\S!^[M$GK!GE6(]?5V@ MA389+GO`4;`(X#`R$H#`P1]AUXTD M'\@(K*TPOV>FGX<9S?HB8.EMBU!F[;B%J`HD`@.2/`+$@DPI1`Q?C).XO+&4 M*6>C1,_`1)Z#I"2DN9>\:^1IR*,(N2\D\M8*@<>2_-+')<2,M!G,+.L#0IN( MN%`$!B+`#0PQ'**#N##X2O`,2HZ-$,:@:E&%K6:'&]\$)8^)'D,8SMZ"*:)/ M=&Z[#NKG].NP8B`F*4V)7)CGS213P0B8<>!%.HNF*Y0H6JD).3A84IP2WI-C\)PI*BR2P.Y6_4R)ATXB&5)G_E#& M0#HO=FV0\F2D:6L(CJK&TGN^[Z=5:C+9]8DWS_Q,>3 M%W_O>:[W@D(F5GW(GIV1H>ZZO>?[[(AXC40OOED@=W&MHRNA`@G,^JQD($BV M&.U"VE,1/O-KLE4')'I6',T&>W!MV`B.A*O?!%I*]I^1!!N&][X`$55TC>N8 M;`^_*V0*+\X4!]]2KZ%.5_!K5G\L M`,14&*RUP1I-=TIXY]8;17Y`VZ@:\%3&&&.`RM%)XI6)KPUVH"OX0@Y,'34. M%'",=J..A-1"72`FQ7ND<4K`(%$GC(UKNBP6)XE$\NDL()H8"G$@>>%QP,(, MF03105M\B?3Z'2RC<:\\Q]'J=LDG$A.`^(OQR#>;F[IU2FL:DGK%/"'5U3(C M9:"R9H.%B3`4A)P&=2&=L495T0,^6%ND(9(EAP+R4YHCF:YAA)H/S0I]X!1; MNHMMD(TOW8;3LEI0*JB189U23".`&#*G:L4G`3-_.3CX3,P^1F;'W&:/[PKJ ME=\FRD`>QX-5([]%F@#0P:3PHI$#`4,O1,%=1B>J(#9\*E:81FIYM(#J66KD)-$D MCG44F2Q**2Q,)D*5,7_`]8@-H^3R5DJ[0$,9:2/J&0PJ-!;]=CS0DW6G=^XO MY0HXRS)=&EH[1Y>^0$'LTX4=XI.67J9@&L$+4)'-,CH4QRZ M9-*#JK6V#H"0`8$TP8`FO*V7J&""=X-B]YHDBH!="`@W6IP'"-.0WTP$FY5O MJ,YH@#9SL'.>=3,M5R+]\^CYO6CB*3@HPXIUU+%71Q<+DB4'X&LJB<(O21(2 M59$<].TS3Q3\M@.)PIDPV7(Q#D7K&"@N%?*I;M6`HN:PJ.[ROV7GU M;5F\W30Y@>&_T:EJ8!HG+$I`&90-40>530.,C'D4T#=;PKWB_2A$+U-UJI+* M8L!;5^)QB$M`?D"I,Y.>]$204T*((HIQIR,NU0=6$W11YCR&&AI#X-Y!M MO!V3.-OG>BK(T'K3XA+/SZH"%+QMUC6WAVFW(4M]OJ]-ON''0S2VP) MQMK5'&[/[;M>>SLP<(->7N"PCR+=`4W\GN/Y;F<>F$4+W0JDM>GCM]I>R_&V M!$F!R7Y?[NGN0FQZ_6ZK-2TVBU?9'ICUA:?K>EW7VP:8574Y[Q.M@;"?AF?\ MZC;T:O1:;K??GP)QD[5W#?C:M&VT/:_K[PSPQ55!MZ%LI]OIM_KM*H2+%]D6 MDO4KY_I^VW>[_J:0F.\NM[+A7K?CMUJ5A6G.-==97\^<=J?O])QUUMF%C?&] MCN>Z_NQRBW5YQ:IK(]GK@*7MN!LL^FGX5FH(&'CTBTJRR3%]A`3OCM]"30() MJI*'#CN@B^>W/-?OSD*X#1AWB,XFA9S?`2(?DSC8@$/?J^!?(8*\])#F\&8DH'EO'!6ADR.TVOU*B'E6BON!LCR MR(]5NNSZ':?3NA<@-Y#J7JO;ZMPK)5=*:;OC]:JN:6T2WC&;_C>6VW M-P75LG5O">#BPQ=7ABO]GNO-V.8[`G`[O]SJM-I^MWUO`-Y7@Z/O]IV.\V#0 MODV/XX/!QH>!V7:=C8U6O]-J^0]&.3=K;_PFS%M\B/#J3R@=S_>V@D_# M;:PQT*=)%.XR2?1\O]WJ3+FZJ;6V`&0KE]9R.KU6S]\E'%MY+M=MM3IN=0=T M9P393%K\=M_W'6\#..@S_!56M(M=[B-`*-3O=+P9$:DNM@TH6PE)S^FU.]5O M>;N`9"LQ\?`#>[?KW0E1-A,4Y$VGO39[W@JP.8&D!>$Z$G@!HP_&6`_TARD/ MV9WTM'J=CE\)5-=9?L<`;\;95KO7]VX'<%&93!VZ18O)B:``D]A#>1TUC-A^ MD:>>VVTZ6[WOMN>6PDW;$C359_3(^FS_G3=-FAX!4RF801C'1O)\%&&OS.#_ M;*4>S)"-)W9PT78YS-(,.VYD_A7.=MV;/J.+!)3&--90!T#1A<13;(FPY?O3 MU8U+FYDTN\0>')W*,;6A9#KOZGH3<6#7:3!*L-?`UB\C!#A@G(0B:K(C:H2! MUPJ8I*AB;?ON1A+@AS=Y5`7>UC*737F$Y'1I8(:.H?)ZR%..E9PYP#E>]AE=<*M54#R(+M$.&6,I]ZAK/[<=FWE MLH?6+N=C10`]QVGE7;&0*&.).NC^9Y!"LN@_=-VZUS+%V#^X;:_N.+U*PUM> M@JW$F,O8;-=KJE.?L605]*R,7`KP8F3WX#<_K]I(M]GR\E;M=[8&/1V!U6N, M@06CPN0)P")<1MDZP-NIMWIM`[OGUWO]'N&$L"A\D^MIN@D3UM=G$,Q!`/PV MA:#=J?F>:``%>+7/PRH*;^R+C#O-BG:0;#-(\P"XU)- MAP".1J]IA%4>4D#'`,R24=M8!1"`2B4H^,6\;)0C$4BMI- M8%9S_,;#%0/;%+I8UN>-?I7U4V],!2[3@6D9X6C;AU1'Y:(VC[QK!JRHI"2. M6F(6SV%;UW4NLF'3G%)3]-187$(SNYA^NWHP1.64JZH#+GI2<(1,2:YM&)?W MT+/!M1V188<--NR9F&(@1(P"&I"@J+E!/^NI::0A..358E$L3Y&B,?QXKKBB M$V_I)=#+,N$?I4GFSF>M:HO/GU5T:G M2)@`'*VHC.C`CR$F:!*/WKB@\UE"@6?`&)-&614./E-RD*%Q#,D[C"'(P1-> MV(F(J?_SG2)3_:QF'V*#X6&2J;3VO(A/INZC,RF`[%D@$S!:%KI(@DD/N=UE M20(AB"\&(BN311.ZSJ9]&[^5#.7/@FRE`-X*2I MTP_Q-)[$'`GW@U?W(+]R'*>:G5*84V%A*6=&F@W=2_[2;,CWHJ4ZQ.C'!%GY M#F)Y!`I$0.DE!$'[#RH4YK;5VA[OA\'7=@BL9^5=?[=F_IG[?$'T2*FO[B(9'`6T8"9>M$,+RM&CH9XR:-B:AMKH&-\(J.ZY*A M1/-M$X$P/TB@\DC.6L(79-P>$,5\0[&90P=RLLU1JW0&BVGUK/R&@>_SLJKL MQN-.TA3]KXF+K7E:LO3SC=@Q(^*;HO/\8>7R@^8R7B[$#D.*A0>&/BRL2>$3 MW*4A1V1RJVR,6]5_V--X*@=`+(DHK/?;66Z+BH`'Y60:[NCGV_D19YUXQ5LG M8+G#C+/;*5-(W)86:BK_S!>-D(`CVDM&)"`3OI!:F@,#]]E(AB`Q+Q"21.WC M)EXJ2B%)PWRQOF>R6W93YFA(5:;$RU]9.E6<7"H^>54S?Z>E=9D<.L6_53GN MX\.@D@W?L/%@T5H!B[M(FM?9,?@VTZ.,@EK`CV4>#(EM2(Q2IX<6.SZ_?JFY2HF1*T8U2MU0/02R) M9%=5?W5K5E>OUD[IRW^]Z"YWR+-+9N)K[GIY!55&?R@"AU\O_N5YC`T&YBI"!F#PR"4=,(6;IJRB<*:N1N@GBQL>O- M/\:(DWU2\L-XYQDEJ\*K'>$QFQIES.8Y8,`RK8:M*0ZJ;&)Y],6E[:6SNDY6 M4H&=']_PS.KF+ECDN17^MV*030Q@C<-MQ3[)ZSG[ZP7_ZKEM46B0EV++[26O M-/';ZVKWOJ_3F"WMHTU$*RYN8O/?!-775QJB^W>>JL07%&,2&&;!9M?2%`Z: M>>TO+&'SZY[B+_QGW."Q*-$$7_Z2322;2#:1P+"OY%NK$%$>Q2?VE?W.0A:[ M096UO,:R0K*3I!ID)X^]4-EPFIH"HLI6TD)E/<-MQ3[)ZW06*N7[1>_9Y<`?=$\MK9G>N5KT\=/![2)5LT+*EJ/S-/ M7\AE@9HE`CB2O9]2V=B!N!K-?X40]R!.0E%-*'II68[:0/IY$T%21*&`AR1Y MG<<"@8@?^FR`37?RG9BI^_WL%@CT,O@4-A"**&Q8(VS0*J>[732_IVYTU5N( MHU59`H/V8*#\28%\@.1U'OG31Y;*SEBT!OM,-B]4CGXIAR+P4.IT4A&#`R[) MC[)^P`[C`K<<3Z&807>)E8`K_URK`R_UU)KJ<#Y8MTL]M53D8+VH^`A._H1[ M:GT$C9I]HI9::J%&H^Y-U%)+P4FAEEK44NNTEU]4:J?4Z^BZB$XXJ%?NCMGL M]33%1I6MU'"Y1.\7!B2OK9=*M'K!0JVV-K86^K*E?11*K;84B3E:'5WWQQ,< MZH"#3,$!NW!H'V02,VV5%<-R^PU=6W(0("H`1"VV7.ZF@*B MRE[2&6LA:\9>GZPHD`40,@'+/9TA40Y-(5<%$DKYU= MNEYY^]3)YSNU7^+&KY]IY]=S`2U0LT0`QRI'*:A\V6KV=J!/M5T\A)\#XZ=Y MDGL(=A.I%=`@I1/NM*#0"_G?&?1$S8/E(R%(#;F#I&OO* M587S_M,B51S`2]NTK;9"%G\Q3*#@X/C!P;G$!K3N4--P6[%/\CJ=5PGSJPS4 MHU,O^P]!0J?=4ML)T/*"R@@ZF^4%"B$HA%!;7E6@U6J=@7K+'MVNZUIN2V`@ M,)#W5LD;D;S.8P$`>\OFV7^>]E.I@69]0FD1@(!#N?^)10^Z=TTEB>T00<@_ MU^HS*WK(_K#1[#I]9I>WL9T+3MK-)0/NTP9`DR'[[CH9&.F`$7B>C.3>&[OANXH<>,9,3$8V/X,QL##S"D;[@)R"H(HD?X M)35$KTW#L4P#VRL*$O[(0F8X#?$-?/]2#!%E"?R6_/S*6!(*G7Q[X)+Y+%K\ M-C9O\=O9O$'NIM\?8>CUTH$C!#9K/'[]@73IR5G=/[?HKGM2;51/;_+0^I;F MKK$X=TIV6]5KY7X60;7\U[*P/>MFXPT@>6> M.%:G[ZJN+QD(#76@P79TQ8/V/OS:\Z(LA.PV9A[C#V+QX*QL(KV!)>.H!RQZ M;5W[/FD6&-Z&#S!4%#^1)21+2)90/5A89J.CTB:WLXH8Y6;FMUDF MW%H)W),Y)%A4F<,&M6A>%P3+B*,]@"2Y<^Y]((]D(#^OA$$G/T^PJ""I:3:: M)Y3VD*3$/(FM)UI*LI5*PL%HGM/N-%F%I M$58_R6F6!\F7J^3:U;'AY-H)%I6)4+MC:PH-84`ZG1X(L]/:)A1\M(VG;9*U=-KG%)\]\;G)+N].'OYYWI-X[O+VH_/ M.?;N3_54+=U4NG1T]G^YB9<%;BQ5JS]EZ[FC7\E?^SA=ZV]#PPT-"*^B6.R. M9>%(MIU/(^_;*`H`#0B?*8WLL'GL81A$CN,(R2E'NR97XT&:4C-QA# MR#=\`J;#;.!Z:1;C0/TLX2&#Z"HQ\6'7DY@'16_[QMR8/G]@"7;/]UBA=&7

1(W@&N!+!#Q,`I@K%P3,+E.`C\'<.+R,LA0)&>-[*BZ@XHZQX,E@?V?`.#S/;OU4 MC!5"$"Q%D7\AQOJ+`PSOKC^#?"(_\T#BD#@(Z2\EI<_21\9"XX\L>#*L?)Z? MG6H@9V"!P8)]G(9<.JBP@)ILF"5I<4A"X\JXR>\8<3Q+(8LOQZ!!(_D$CM28 M<]"::3\P/1N4%6RA>!!._Q6&`J;3@`MP[>_)R$+4(A`\+7H1BX.@X`!'CF0LA)YSQ[&0G^>TUQ!3"&Y,BLCD,W(]2&D`5,P#/F` M>ZZD!CE$H?#P(0H>6#'M>'/IW(J2T;MZICY#%N*%V)%D`J+YSL?P`0A]T6H+ MS./SAG&4H+Y$`Y[*L[L^N+.)3D=QE`U'BS-FQ"P0SP7QI!4"N-KJ4`MY%LGA M[2Y,82R-!R(T5YXB4AR*D@CAQ"S)@I59^)S/SD%;B#8$/[.19.E<%9F-E+*.T@WK M9AS%/=:*LUCV]?TQQJY(WU:G:9MD]ZHN'LSV+K0/<>3&;U$\HQ5T>?;A(R\? MQO$!M3N9?7Z'^BV>DA_/47WPBFJ'=9P@?N;M5F$)U3O47UZE#Q>IZ2Q M"FT9T^LURW2297E%S!Y8B$L31>.N5:LO*OG&/8I$G85U>LU":)A1TG:ZFN*A MRDIJ_;)%[]H`DMR9E$Q.G?O;*,D/TBUVD;W2SKO3MO!SWA:.",9UQF&$2XCX MOD,3V.[?W:H2CU!T2K"H(,GN.IH"0S/O_H4E;'YE5?R%_XP;R..#:()O\+&R5*B9WS>:UBB4_N/$WAO5#IO&[J*T(JDSHM3_F(1E/,IYD/-6# M!6T?I[506@NEM="M7W1ZSU9$!3\Z+8B>KG4GIT^PJ&K=W3ZE_EKD],GI:R>Y M*B!KE?M/PX#;T(O&;.7^@+.-"`H9O5@E@2,Y@2EQC1V(J]$K%.0MG=.M*"88 MU04CJ[-#;:NZ0#JYB$/W/=HDNX/O;[?7V0:VSBZPY9O,CK7-T85_N,U1;K[& M98Q@UAAOU58]'GI!YHM-L6)_'NZLQ?!0[&;LNX'E*)&;R>*;GB0B78(AT)2/N`. M5-6!IMVIJ@-1>Y/57E&U%E53,[:)M%ZC)&$^R=-K*IR\,.(8-?JYVV-(D$,TJ0"0)BN2$]_CW[`WW^+><#MS7X`Z[O?^")PC83AIP> M0X=9.0_EU:AKP>DTE3BA23E^*PF:%-(4'2;E^)JRVJ,=J^E*O9=7\*QIB==%7*!Y9.H&*[O8DM8FOKZ]9+%K8V*LZ^C^,H;(GH[/E\66]N MI5,LZY&A.57H$ELZL:5]//.Q>&,@:C5+/;7I'*`UQZ[OY)>VTS,[W?;&!!WU M[!<5,MF308!E=AM=TU*JZ0=AX+`8L$VKUS,M1Z4]N82!PV+`,;LV^().4R\, MU)R&U1$+O0Q$;0E?

-K`2&N5#)569 MQUI7W_?]X@\?TR]23\P\!4?]*6_GDUX&.FQGGUN1WX[&`^QI7PPUMR)4HZ!3 M#^A89L^VS&:W1>`A\&P*GJ;9:S?-ID/@(?!L#![';%L]TV[V3@@\59&?UHFQ M[EU$#I^ZD,1(8B2QU1*K,),5YE"9%[!37W##PFC,0RJOW\Q'U1LU$5O$UHFL MNY7L2ZGD_GF9O7%I/(I]3J M0`@4!`H"!8&"0*'W<9K[#KC>#0;,2V7OU"!+^0/V-O.R6+14?:5),$69`K%U MTFP=/*]K[=G,?$VQR6V8<0OUHQO';IA2OG9LAZNKHZ7HB\!`8"`P$!@( M#,?+Q_8>*(E%;`/^L?B!^6(1?)"E6%0EQ8SI`JJJ0+910(#@8'` M0&`@,-#>1EWV4AV^N([D1?(B>2UCO\H\:E5CA8_IXQ^+Q5;+NYI6E5OA(CX, MD(WEJ6+P;<*C4$BG/Y73^:2IP?.#:U>(XD@AR93*^;?LVQ&I["G`)Q#-$IH( M380F0A.AB="T@N*J6%3K5%WW?5V'3Z9(8B0QDMAJB568R9(Y/)L#G2I<@'H[ M3+'A4M[D-V_Y.UN%6.40E5Q1M5'-FDGWW9MUC4;LG5N&J<4C>N$UIM5!TW=I-P0[C9`C=D M;P@W6^"FM<,YZ-K"WJNUEQ)M4YAWUZO"R$\.\DWQ.>D%W6`TB8 M2-AJ(^E<';LV`'(Z!"`"T`ZNS%$;/U3R<@+5$'VDE*]6?16'WC:H&>.ICAN;CCHCW&R!FS;AAG"S!6Z:W1/"346,I'<* MJ7M]]N&#?)(828PDMEIB%6:R9`[/9M>$IO7,-[*9PZM5[E#)-\]4(DMLG31; MJ^VJNJ4ME07-VIF7?4M%]UN`AN-<`?^21#Q?A.>.A M.-4MP=N?C,>AB>^I:.,AB=B4\IORQHNWKNGR8SK^+S M!_SPRW^RY'+HNI-7[W)*/[-8''I^!R)^$T3>M]?__(=A_#*];#!@7OII\"X_ M_?R+F[)/X5LW&5V'/O[W[N^,`\2`C03/H<.9^L(&OU[<9/)=]7WGWKJW&U;C M_BZZ=^X=\<&Z,+*0RPO_A#\L^\+PF- MBNN;/TWC3BRHJ"6FZUYM$7,*(NNF#*?8$'-L?&`NSO!8H'&CT',#F]H^CDG] M%!I_9,&389F&W6AT36'?WD9@9,,GP_6C"1I"_.ZWZZ]O+GF28,V+FZ6C""RN M*\SO,..^&X)IQ/,R\=(!BNY!B`[,]("'\"MW`SP9DX$$T5P&W.WS0-CL*^-N MQ!-@`[YW8Q\T%NX`ZDM/P3M8@G+DR0A^Z,G,6C,)E&<8A$V#A^S MXNE/.#X/)UEJC,MSF"7(5"0(2N9&PJ>A,UA.JI2$L5H253P(9P*^*@B0T$G, MA3-QT]R]])%PC\%C?$E%*(DP#?@P<;D@.(W=,!F`XW&G9#V9Z,#PT?!(D/,$ M!`UWC*,DA?E[`&_D#ED$S@F`](V!XY07E^1A^&#W)&LSL<[$[>.#D4=`S1Q' M8&]&1>=/."@@$!^K<>(E.ET0-UX91>#DO M>.V$ZH!0_PR?RR^,4H@?XCB"R,%%>?6?"IL`!L`5EC]F(#TT1!#XQ(4]15&" M*04U!#T6W_09&I<'%\0J!X"[QE*IR]^*:ST>>]D8K3M,#MHJ+\C\^4?_&X#\ M&`HJMI/VL?*1MRQ.7>!SYN)XF*1Q)DVBM&1QS!&Q*/MD:GTA0@0R$WE*M'@S M*&?$#83[`*L+R#.-QQ%'XS"9Q-%WB&+3>?OKPS]I&SEF(N`!+U,6CTVPXL,1 MJ%``MA7<1NBF8*6%C4W8'(%R+I#(9"340OS!9D&O"9KA11E>*WT33FSIRXG[ M-/TF1G?(OD^0+;@1G+!@:>+&@!W`'BNN+FGOSK;KF(EH$23Y#*4.[MZ7[OQY M!(3?1*""&.$@\GW63^=G=?&*'`@+;A5\+:`-?Q_CG.;Q#?XBY%N$7V]XY$4^ MRX>9"KNP#F6W?66\>3(N\LFH^!UR`29P#(:!Q=(B1,9%IJMYN;@R_LL*W.-\ M\42RQE#M^LQS,Z$CTTF=/BE)Q53Y"U,;9;&4,\AIP&.D.TW96$;-DB/7N/"B M\3@*025!3YCX;18%C1E$D'X41,.G"WPBX")XPF%C@0POBX$X](@SUO.`J`"@ M.*9>T,#3T=3;(?W2V3V#S322#:)P*&R&O'\V%M"%G,W9(T/(2FIU3H'KP40F M7/`!I'NY.2R"D\$4BO_WA#DI/O8&[,BX#W!S\HQ#4E)^$J[A8*Z:FU4)I2)V M9O&5\<$-(:85H2N8S^E<@NX-P7%+7,Q,,F`CG:KA-+,)9583/4#`&RQ[#:,'2\S23D>PLC!^[WUAIJ@99Z"<2"5/]+/$F]HW"G.-O#/+9 M0ADVF$E3!DZ`2P]S!9`^L"=N$5B'`4/A9"`D`K;`I;`\<$*F4-1X_46N_!?3 M2^66!A,C4YG,@`_K@[0*IS3&-U$&IB594J4P0DUR_2\90I!B)F)^Y'@L5O$` M>8+2"CN:4XBF1;JG\13\7IL$LAZJ"0"Y30`GG`G2%JDCE$5HA MS:6)MF4!YRLDG-M]"94$O3F`%>PM MY)[AD(.5`.Q*U]I*BT[`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`5O./@@6JX&?7>XOOEO>#;/-5N/Y_)?'6D++.UF4]X:%;,#W25`5,?.#[4#1 MKF^5]T_1KB_(:I/1CHG*CRF*F9NP&R;_OPVO\_K/S[*@\SKTKV7]Y_M26?4> M;76KXSCST=`6!-7.U(:YLF79K5;K4%Q]F9;O[G-BVK:]F.[_H,PC>+]HK[9[/1:W564EL;]7WM?V]RVD73[_5;=_X"K]=;*59`" M@"1(.ING2I'LQ/O$D>-FB5!+5+ MO:Z)V_WVLX66$9R/Q:6]_:9#INL(%7+[;ZMM]N6N^#!%FK:0(R-9EJ]MKUX7/Y<*3;J'DZ[:_6W88SUIE1=M]->5PJ> ML]<("]OMN566X&HV%&#-W/JNU>E8JPF@QH3[Y\8#V[VVTUU8L,T+7JO*E95L MM]U6N]=9M4JU1E2S["W$A=F+#5Y=WW.DVLPSM+8KU&;HM/L[,=5Z?L/NKBO4 M;V+L!1\XQRA.F*1";K>-13CT04"Q$4KL5'4G8^+=,8F"N.-Z`I4J-)1)73.=V,9I M--2S@D`,TTQ)P3_=%]6;!J?ZB5AFB,G0/^8JFO\JIK,@NE>D"\67\Q1-+8E* MB2OR2R.A4J`&(O#%G9AG`)%[B((LS[[C9U4&T()._,](YHB1[?P_12!3+:6N M'C\F8DG-,;H3;)Z<72DL9\O]+2EL9I8RX(J\*4-2<"19H)+^YC?BG!NG-X)3 MO:)49JC:EDY6)&L&"=?R\Z^_RI9)%UIT*'G&Q+:%*EOUXSAVDE MU[GD;1_9^EESHF+;5L]URGOAC^[@/%WCR@-+K^]VV^7=I54J)*/S].XZ79HOM2O%J*SMV;*M/O1:';=O]:P:9+M4:;//FLIV:/79KP:( M+GZ#ZE=?O_1[=JO3VJAZCG&NP0#M/G60ZM:8U["9$"N;H=]S;:NZ$5:0X?KV MBEQZE'C!+W&4S=[GF>B5IZ(U8,9VNW;;J19W$UFVK=@F!Q3UJA2%X\\BGEZ) M05J#_9UNC_Y?DO5A\9O4O_I:U&[W.[:[H0#U=-MVQW(M^Q$C/-IG5A5C(\2L M(,#ODA'E^G8>HX`5T^KKDGYC5TSSV&FCU+0O<-7$!#QR9LZJ#LL,0DNT%RI` M0D[V!T*$O+J9>?&<468L=7K+XJN,RXP5_*%VOSO1O,NO99(H&)C"A=9-4 M4#''J--R)B-A+B,_O`VBKXE:7?[A)Y='+Q137P.E!3>Z@UB5@H(K3,_E8PL"F9"06ELFY([\6W_H2_K2[*K1#`- MHDF6N!-!-.-^I!;JWHA)3I*4L-D\U'0KN@\%XB&/CNH=E1U[%,F-@9S'2U%V_CO+`Z/D,EIS-E7T8$FCXL6Q M]"(%@\B<65`R_$P5TY?<"V&/).U5U0OG*G9.: M-F=->1(3UUFG*[K->%SGG03R`3G^=&>79#_AF2HD MR68<9Y]SPT@69[W6HU:^O:4WI=N36DLRH(AW9=[S3H=LK(@T3?TQ\\L\=*.2 M&C0Q<^HL12=(`)N1WY.#4^[W)#E:2)5._!D]/V5:(^GJYNJ7/)^BXR&)J(/_ M*>O3N&>.(?D/(>DS(!8T%WS]I(W%K.CD92;FK%P?3X1A.3][%? MER?,RQMG0G)(L^TK=\#86NPOR>LP4#7'^#F7]S>F&H_805`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`Z3KZN*:W9 MA#K`46,,K2!+;MM]U:0OD** MK4B_9E"RZW:=UM:$GP\/0C"GG"=D$+IN*IB^$P MFV8R5$IF@?!C-`\28>+?:6*Z#Y)L?8WSTP9H54S?.'3\?7BIMCD/4)-+2?LO M(XD.4/I/'*47BE%^)^%J*C2QG_Q++GG2%36HK1'J(:)\2H8H+$Y%U3/UIQN= MM>R.:Y>;\[%*GR7;A@,#38;*/"G;D6W#3--6RREG[FW5;FMBK-NU.OT-1$M% MGHS\247H?O1B.4'1)X-B5$-<5;G_K5YCG:*N0?YO+5`R;"SO]:+Y:Y_%=6B] M66[QBOHV%&C#CNO25+@[YT$-_KTXX+GE[.XKY!?K+[O>ZIKZ;:?G)A<+I M[]_YN(S/5!S+LL^-?_GI)#\X&T7#3,48+8K)/24_->==;C[)%5Z81Y&IDY\T M,;Y.(I8U^BKO/&/_OA??FICQ,OGGI#DX*\+!;[_N/1(A8H5SV@S M5?W$Q\G&C3R!Y(.._.O3$_[AY'71*.5V.#7-^<7[#K?7SK[^RR1Y!\'U^ M?&_J'IG?1CV/V_'"Q\)V9+@`/_R9&5;E"9(\R>'\/(ZN-#Y1!^63T7>Q#(TZ M/;F<)^]=OBY'?A>SXJ*O3K:?T(^:&63MV\J:0HY[5)B?+`MCR(3H4" MZWTN&@N1'U4S/$)O*D,IRN&'D8I#DP$37,BY<>.S&ARJI"ZKT]&Q,@^1 M'8D,0)7H]5-YR1E9JQP\K`\HKQ:OZ+/M%4*,=2`9GTFJL_`B<%`&Y,FQ1\6L MCDKY&N4S[@=QJ_KH3NM%II(43/;2V MV/FEKPJX\]CVB>"0R2&C75W)9QH<[^9SP"T[*OW80CCQ/)Y(F/HM>M3,\YD5 M+[1V$E,]PE(!Q6G];&%,+$3A(!P=A3A):+FE2D-Q!Y5.M$4!/('Q:# M[_.Q2TEV&EZXU3.==Y=7>1NECZ6PA#&'#<7LJDX/SE+)Y$.$-!1$@8!0&UU M$Q94%!$I'5)#%L(KC\1Q-9Z^=U@.K?_.8C\A>RKCWA71U[`-: M),HVGD@A+1%C'6&^-PXC:L=API.XRRN> MQ.E9V%EYOELUV9=CMYY[YVBB(O+Z5)A]HOSE(].WIZ?2]\8_+F[*,A;33?J> M:^3:=.].=)0V+6?)SEJ]4?%J.0Z1XV+)7$6\)G5+V?'SD+-E_:OT69C@DV$_ MO)=EJ:<$P5CBHC5`>3,:1A:+*@26D#+Y^.<.[]`&3_OA_)* M6CGS6CWXS'PXH9GK-N\$G*HDY^FQ&!8;?#J[0=YO6TQ!\SP=7=BLM!I?D\:@ M[GV>I5TD=KV*X:R.%-EVSVV7,I0?EKY![6NPZ[06*+%6JKWB#/6=NIM9O3.\ M_SQ?JI')Y5]J1+PH4F]*E-<^LP4O@09/LMMD&=*??+:=. M'Z/A-MHH;]E]R[5@N,:$;J!!FA5U`OOO/E8&-M]EA`\,O[^`I&,T^&;GYX[E MMMO-F.'=T)HZ^:2R>^N]$<3ME^]%J*IL4W&>>_M&G;(\]]Z-+=AEXQLWOB_+ M1T_R0R:?HXNAW.?,B6#?AS>E`T6^#6).5%#CM0.+E\QL(LV6]=D8!UO0Y:/: M^B5O4OM]!7UW(4'HNU77*>F:MSPM9@.M*RE[8^EM9=_X&"5I+)C_A@NY8@I^ M,=+WTGP,R!W73CVXS/I7BT"[T7%C9L-MZ!B+6\&<37(._]&+KV,Y&1K]P=L24#R07Z@SLOV*TCA4? M2.=82U&K3]?U3+D>-=OVY7K//#S/L]5WI%$U/$.2U:WS;$DDV(QOB?\F](.? M3M(X$R=KNLT?:BC_*9?UH'P9.2-OWRM%4]\SM6.-`^V"91^OL2;9UMQN?=`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`5]7EK#'G"LO0R"9 M7U??L*:=Z0_YKQ/4G<5B6*;35*Z6H&7((D-2.=:('ZP'Z/"_!Y MJ5(A+_GDG`?!P8SW,XYU#&A`(!B,Y^4NE5,:'^B9*9.B:9)+E1>B6;$76G2] M&,`U9J_+T]Z9WIV]OBW?E%#C&G&)4^RQ&FN0:TV^L$ZGV^^L+YAB0Z7%Q-4\ M5+9^F@7;[O><;JLLWA,5/UO&C9;?+69IMU-15P,V"A%D?&F_=!_UOK^S'7:5MM:--_W*JQ!P#5V0+HMM]RTF6^ALU4CK M]4G7TW4>:;#-!ZH?.LPQ2)V">99`:8?)0#I4Q\BG/2\'> MXK-V\#J-W5O4#4TKBO>EY*`7MJ]86B^7-WUD=OJ:>S'+"^;ENRY*N53REB25 M.TA+NI!7U('.])+H+U(,N>-JTFJ]]#)&OES^A>D\(32*C43$.H_MD'8K5LW+ M-*L2,\TU,C/?<";CZHF7Y[O)O'QQ^977W\FO+&RZHYQ*>;.UND7J9215'E3O MON%;^;CY%D\WA$>@8L>F[GW3=P,,Q-#+:$4J?UWP?_Q8*5=_[O]*Y`+:%>8) M_*D83D+)`U!<'+"I:[0>,90AC<+J:@,KRWG3V8_A()E5%+_MB4T^(1CR]F?\ MV#Q'O]%IJYF0\=0T0^E;U.(\_DI=WZ-J5(VJ:ZZZ-"%_8N&CY5GP_P\]NUWE MYE99LFQ8_,85L4,ESTE?.$Z5:WSV&&=7KI;*%$%R0C1G@I)SIRA+:(!*7AMG M\LW8^$%%-Y28L4J+C+GZM-K88)W8S#;=O"4/7!,8:JGX(_=,[BX<$RTQX3EV M8NFE93>LOA.K%WL*L/=.[/V90ZSV;NOC&#D6-POR[8>_J)0BPYY],^0F M$U.!'6""]\'W#HE=%7]`C6*C49K7*"^GI[S(YD&?:6"CO)P^\X(:!3VE@8V" MGM+`1ME_3WEZO301_GB2_G32>_0,HO3(W'QM/+ZMQRO:RQB,Z84H_NGD+\.A M$+>W)Z46+$>&J9>6SK07CO_/;#$M3K4Y@.R-P=_4`_\'*:HRCC`QC5"D;Y[J M"+.]3U,K*EKE#&\;SVW9$4.MO:GUXA6$6E`+:FT2@]&8T5N3VW%4+@_>!S)6 MUZ3\JW7KSA<1,<_LZI3$,?MN;VUIPNAK[,U^.E'_K7525W=#;7F5^5)PT#); M_0YP`!R85O_8_0$0L80(JWWDB``.TA\M8``8``:.'@.N:;DN<``YAPHP``P``Z*:`0B$-^/( M[=`VQK"1"'LUP%ZP')`&>\%>^Z\.]MK>D=MAY;%Q,?*@[3)*]%V30EW@GH#( M[PA(JZ`6X`BUH!;4>G)0;_(0SB,W7T0XCOC^O8XZD`",1)``P``\#PG?C*3K\% M0``0N4AMT^H>JH=0'P_X+.632(07#R=+2O,_QI6X$T$TFY(L#_7'[LQN)]@V M]F8`ASD`0VE" M>;!T">KCP03"?/#B/T7JAV/3^$6$(O:"JIV8B]'4#Q]JC#V8'1]RMMK'?OX- M0"P`HNL"$`!$"1!VNWOD@``T*D7J.=BQ!1SFGL(!<03@4((#EM^`PWS;WG0Q M7``094!T[1>T(W-8,3*_1-'HJQ\$AC^=>7Z,>)@&=`@<7@`,``/``#!@P%A) MI+Z%!3?@`"\!,``,``/``#"\[%F#^@@ZW]U65_'H6I;;NP*PUXNV%RP'I,%> ML-?^JX.]<(.F%QC#!Q2^4I]!H1D.V?:W^FF9G`8=JD5S3=3!<`!"%2#W3ZAWJ M@*$^XO"M(5MDV%*$O1I@+U@.2(.]8*_]5P=[X2[-I>.XT]^B)'EM^.$PF@KC M-HZF1C03L9?Z48@SN>8LBTX[O28MDU]C=;P?&-BFW:@;=P"$/6VC=HZ=*`#` MJ/80[4Z3&`/@'_8U4#3JV`TPV!L,FG31Y[0=IU.1&R@+<0/`L4P"4`#(?K M$M3'@SDH>1^F(A9)J@]%'FJ%W10X/S@_@`%@`!BPFP)8-`T6``/``#!4)J$" M#``#/`/`\&(\@_IXP)$KQ6Z+CD=]J"BV6W:[O=BDKH`#ASV!H(H``N`6`HN00P.0$%![>$4!]!W++;ZBH>7U<`]GK1 M]H+E@#38"_;:?W6PUY$3MZB;R*,E^I92E/*@T`X':#A`P^IWGR`XM-4O4(!M M48P0@`5\Q*Y'"AR@`04_GK8.C.8<*,#)&5"PI06D#"AB#L MU0![P7)`&NP%>^V_.M@+]XA7WB.NKQ$?B-LH%D;J?1.X0[Q!"Z%.OTE;I5@/ M[VL];-K])MT>#2#L!PBX0QS`J/80N$,<,"`8.-:!;9P"!EN9+[B``6!PZK;Z M@`%@8)L]"XS)V^7PD;LH\^T3;)KL#^]-VC%!S7`7K`$!<,EH?X4'B\%BZ)]`&RP&B\%BQV*QTL1/??2HZ$II](&7E,9V:":8'X$I%=X8 M%G]7.5NLD#$O7M:WI/`P"@)OEE`1^2>:W*K??CJQ:)XK@B"9>4,_'!=_S[S1 M*/_[JS]*)[0XL:R_%K/\H>"KYD_*$]S21%:_T;'_NO(D-G_'>?R5NKY'U:@: M5==<=4[ZPG&J7&,AQ*8;#O9B^,*-&$^I=.,F]5+! MGQ(CNC6NBY`%X]0/C70298D7CI+7QIE\,S9^X)=_]T-Q-B4))HDAPI$8&1^\ M>#B9:]^R3:GS(S$/S=G9JK_X4D,>N"8PU%+Q1^Z8W%WXI;>75_`<.['T311& M4S$Z>YL,O2`*8?6=6/TRBF<1C;%/W@P(>]=F;WDYX]YM?1PCQ^)>0;[Y4!%) M_-148`>8<"S;V3LD=E7\`36*C49I7J.\G)[R(IL'?::!C?)R^LP+:A3TE`8V M"GI*`QME_SWEZ?721'!@X$\GO4>/($J/S,W7QN/;>KRBO0XTK?.3N!-A)A+3 M"$7ZYJF.T,C$S56#/.M^;LN.&&KM3:T7KR#4@EI0:Y,0C,:,WA_C:)0-4R-6 M@_>!C-4U*=^<])J^Z7:;E%=;>T,AS6JU='O+;#LM`.'H@=`SW7Z3DFWW@0,@ M8@D1'7@&X*!)9$S``#``#.QIJM@S6ZX+(``(?=/J'BH0U,<#/OZX3BV[LJKF)"UY@C-"YFP!\DXTA^EB;3 MB*0F@T(G'*WM;]6#$&4`XD&L<@L;(T!$.4050#;`7+`>DP5ZPU_ZK@[VV=^IV6*EL7(P\ M:[N,DC0QO'!DB&\S$28B`9W?$5!702W`$6I!+:CUY*#>Y"&<1VZ^C7`<1:.$ M)S>C`QFNZYK"-&_SLFLZ[K$?B@,0"X#HMA!(!4`4(K5-NW?L@``T'H&&:V'P M`"`0*0$P``P`PU-!$K;9;B-L!HB8(\(Q6ZU#183Z>,"G*9]$(KQX.%E2FO\Q MKL2="*+9E&1YJ#_V9W;:2UJ]0^TB<)I;@$.GW08<`(=BL^[H,]P`C$J1W`[\ M!."`I3C``#``#$^MPDW;Q@H#@"@#HM\[4$"HCP<3#O/!B_\4J1^.3>,7$8K8 M"ZIV8RY&4S]\J#'V879]"GZPW0)^P@H+<("7`!@` M!H`!8``87O:L07T$K>]NJZMX="W+[5T!V.M%VPN6`])@+]AK_]7!7KA,TPN, MX0,J7ZG/H-`,AVS[6_W8MMEK'SOS%Q!11D3+["!R#8@H1Z98SK%'P0,:CT## M[2)C!H"81[EBZ``<$/0,.%3GR%BFTW*`"""B0(1C=OHO*>P9!W#85H2]CME> ML!R0!GO!7ONO#O;"O9I+1W*GOT5)\MKPPV$T%<9M'$V-:"9B+_6C$.=RS5D7 MG3JFW6U2G.IK+)#W`X26:;>:M*<*(.P'"*Y[J-LD&"JV/%0T*7X#[F%?XT2C M3MX`@WW!H%$G;H#!GF!@FST70``0:/G0L9L4O+4"$-1''*LU9/,+FX6P5P/L M!(5A%I0"VHM/ED_#N'']^<.!C-UUS6F:MV79I*B7?1QS M`PP``\``,&#``"S@(]:F+P$8`(;B]+O;I&1CQ$#`)<`EP"4\.QHF_[J)>RF< M7V1$H7'E)[,H\0(CNC4NDD2DR4,%L;&R6^CWFI1!@-$0JR6,A@`#=E0`BZ;! M`F``&``&@`%@P(("*'BA+D%]/."PE?=A*F*1I#K^]*&>V%]!1\#8"#``#``# MMED`BZ;!`F``&``&@`%@`!@`AI<-!O7Q8,)8BKT5G>3[4"ULKNQVK]EV#XS& M".YO*V27;<``,#C441"#!&`!'[&KTVD0X@(%<`D`0WGVB(@5P.#P%A'J(RAQ M=UM=Q:-K66[O"L!>+]I>L!R0!GO!7ONO#O;"39-+)+F?HY2SORNI+2`@NV@H(6[ MR0$#@H%]8)>-JH\X4&O(MA>V"6&O!M@+E@/28"_8:__5P5Y'?L?D*1,IY^=E MQD#<1K$P4N^;4#S*.#QKQ+K',=L.CL\`A-.6V>HBM!A`<-TFH0!':(T!QJG3 M:1`PX![VA((VPBP``X*!TP,,``/'M/M]``%`:)F]5I.";'""=FC[7-@7A+T: M8"]8#DB#O6"O_5<'>R$E+>=RE&=H\\,S')GM;ZG3I%7./K;'`0:``6``&#!@ M`!;P$0`#P``P``P``\``,%1NM>!,#3N%L->E?:[ M2(W3H)R9=AM'4V-(Q?IAYH=CXWHF8B_UH_!H\]1>-689A/2T(V]_9*4==?LC M&0UX0`X:&E\U/E+/CKKUD7%VQ*V/1+/C;G_DE^U_Q[TU^V:,HFP0B-UL66U8 M7\6C^]KC@\5@,?1/H`T6@\5@L6.Q6&GBISYZ5'2E-/K,2TIC.S03-!8.QMPV M?Z4?4EJ],:SRA+&&F>SGB3`NH^G,"^^-2)Y]T8M^:*3T_41X03H9>K%@*?X4 MJ6DD,S'TR=#_Y;,R_=A(W(D@FDU):),>#+-;;YAF])(7CO2+_'1T:YS:KZF2 M23KQ@JD_-*9BY`^]@`OPAU0M/S^;>/'4&XHLY9^2'XU3A\_JSN[\-(Z,D>^- MPRBAWXS3D_=_7)WP;TD:9URY/+:3A0RC,,FF;/?$N(UB(TL$"SNA[]0#=R(5 ML1]Z\3TI.?72*(C&]^?&=6A>ITLHGZ]QY?L`Z20WF;ZI68PO'(LD"*I6K$=0=,H^K MCL6890WNC<&](;Z)(9GVCELT],:"Q6#3C*A91US&)/IJI!&MY()HR.)0F5$6 MYZU#&"+]^#FJ5$H7#H52WAL.HRR45IIE\(0WI3>3.ASE#"0 MDF'L#TAFC2QJQ"FW$9634-_V;PD3)&]55?3&.Y+'L*VS_Y7&X??O!;61H.XT M,OZ1A2)O5ON,=[` M2^B1;,9@ISY$MAM)_-+C7FI,R)P#(4)#).QY_&1"#P_NRT#.=?##89"-N&F- M,)L.1,PZ<.>-8M7<5`1IE^K&7RQ>&X`D(MV]V2SPOR.WA$DRMZ146=ZO^-67 M_5,*4[3]W/2Z@'/CX5)[UEB_>I7%C$_6))W$0IQ)$X9DDK,IE3CA#N1'HT3# M\X,74X.T;(E/1S[+0#6-MY=7U"]B0HUR/3$YVS#3<0NJ"Y%'H'9;Q0\.@BBB M;T40&$4/XN?4]P39X#[Q"_=/[>/)CD%>=T`.DU!*8\'(C^YR]S>BAO,2#8_O M>M>;*(S(Y9^]3'3*WSE_!'X*EB/_CO_X^P]914)ZI/:5E+;:TGM=.V.V[?V)W6W0FKG>U)W7;?OM.R]V]I92VK'=6SJ.\^4 MFF9T(KG.4AJ/0CG'*`MXD7RYOOWB?FE9RJCZK2\WY,;D^/GV/YF?WO/(%84\ MC%Q\\Y/B*?J:O.E-2IWI@^`1;%FCLD+O?W]'#=%QW':K#)]E\=:7OK!G\Z3G MLB"CYX_>AY?>C$>XU51QNVZ_W>\T M19?O`OR!FR1\-T3V3R+U:+8V>NO%-&L;)RMBR77:5MNRVPW1XE]>'-.2:47I M[6ZKU7:MFF5?>;BQ7'FJ;I^1Q?>0#MN+;_;'A[;>93&Z[4>BYV367RPFDI_XFC MME9=IZ\]DWRJHF>)M/KL`L``00E#@``!#D!``#M7=MRXCH6?9^J M^0")!;=ZW+F'+07.,Q$AR$L[7CR0,,>"+9$B0 MG'X*@2U9:Z_E[6UI6_[\Z_,T\AXA98C@RT;GJ-WP(/9)@/##92-F3?__C\KV;SSZO1K1<0/YY"S#V?0L!AX#TA/O%ZE#`6(@J]\=P;H4?(O3L2 M\B<@ODGZ]\Z..D>=TX]';6_"^>RBU7IZ>CJBTI8EID<^F3:;R=&N`!.]BW;J ML,='G=4OO>3(!%]X9ZW.6>NXW3GV/EQT/EYTSKSNMY7A-X$D1*66$<)_C<71 M/.$-S"X;J>$]CVET1.B#:-@^:2T-&PO+BV>&UJR?3I:VG=:?WV[O_`F<@B;" MC`/LO[22W62UZWSZ]*FE?A6F#%TPU?Z6^(`K?DK'Y>5:R/^:2[.F_*K9.6Z> M=(Z>6=`0/O"\SY1$<`1#3PW@@L]G\++!T'06R8&K[R84AI<-R*9^4_JQ?;)H M_\L=%W1(3?0(#B`6M(D/C$0HD#1=@4BBOYM`073#DX?Y;=1?0P.9#R*"IS"0 M"FA)DY91IZW7A;#ZE0W"P0Q2QL.3U_H:@>H!-OD3DZ54PI3I_*TB#\&XB MXLF$1($(/C?_BQ&?[QU:]D$2B*)7/XX4E;<"4`)+=K]?Y:==")\Y%"V"U;>( MR\.):-1N>TUOU:_XO.K:2_?M)9U[2>\*B@`3$7_M0)$,282NDY6@4G$G!&RL M@H^XACP`,)-QM]."$6?+;R2MG6:[D\2@7Y*O?W092^&*P!A&ZDJT]F/K8`/K MQ90*#Q:.+['Y<7YR^N'X_/RD_>FL3E5O321(7K8/*9ENNR\Y&#$9.*%"Y")%:'@Q$^,A,WDL$#6\)X@> M)ES],J.(4'$27#:.#\21[Y-8Q)P1]"%Z!.,(?H>\A+*")K8R6#2\#&Y-$3I! MM;RH='$@_\C(^P@B>;'I\AZ@="[2U]]!%,,>0G3:I!Z>EB!+J3JRF;L`GD.I<5+<-ZT&C)JZ$S%.KR5S`&(37B,T( M`]%72N)9'_M1+*<2Q+<^P1SA&`:K&QR=3*I*A_40QY[Q)R(ZLUI$7Q`63KQ% MCS#H8P[P`Q*YRL(1^>&]N)&M8LBBO`(2)Z[17PD)GE`4Y1"X_-DEJ@K'[,35 M=TB)B!M\/A3W^UPDB#(YG,FY@?PSK:B)2^09XWCE*_#V))?\YD>/B"Q/C/`[ MX?>D1Z8SR*',Y&/&R1326\0RN#)HZ0)EN\)QXK+7QP$,\V/_S7-RT2^)HZ;= MN,#_7K$E8CBW6@P5\K[O!/O[SJ5?^G1))OL'FFCF@]6:N45@C"+$$60B+MYQ MXO^UL2:1*8OR9@<&4SYN^\2IRT5:MF6`G)B/38$HOK/?-K2:1**Z#V^9IK7R^.#3`Z,>MR2_##/:33 M:S@N60'-L*P1M;KHG)BU$;?`PQ-.3%"E@)?.-63:6BT"<_;UY@S<20_*2\GD]ES@13K0G';<-K=:!]AR>)BXGR!1WP_$T5EFR$K-<)>`.$3D0"H=PIP?$G,\(&6;%`Z'-KXUG/5WX`-.]QX30;N4^"'NL^"?IR M%&\0>JGC'$#CR_-V"*EZXO8*,.3GB#O']C"%?M`,Q<-5G>'YA(QZ*\V8MD5LQ-W8YN^ MN491S%]B?$D@7%D?7O$YIW8RPIV#8;J?-;8_MC_:I_`-%HT#8BG:.H9$8ZD8 M]5@CT>R.VXG0*`"]X,XK?5FW.9S*A>-OGF&JN2:X$_OC59=SBL8QE]5']V0$9X0*TX<;T2!WG6QO_3NKEM?";A;/#B2O M(27B_"@(9B\&#A)<,G@GIM/+<[,K&!(*5Z$/LIMG3H$`AS"@\[YPGUKZ%RV% M9\7X'OJ80PI9\>7@58YHGX9*)%(E5]ZO=\RRZM-#U0MCLL`OT4C@R04XMSHX MQ]X^@;PUW]N*,W.6@W=AB]GV;Y!/2"#W'&)*XL6%51Y;+`98FEDT["%VJ(8 MYN_RM&%EGRIT.=EF4P>:$TF9JBK6HS/+U#Y.=0:8<7;J8G."U#00N8]1P9Z' M6:9U(54;FQ,QMT>8*D!+24`:A4N4=B?(*+S:L M[.-2BY%L(LMP.1%I1Y!!X2^Y+_JU"#014;L_%L]P%+:I#<7F*)V(PG=0)?]? M(19!+!+@NL$48<2X#&F/)7/B>HUK(X$=X+HQ*9)L$=F?S@"B4MX%M\G9QK7A MV@!>Q?F/0];&IUX[E28AMS3^I%IIO#R,MSB.-:]!&4)!12!2-0H!@]=P\3D6#N:OX;DYO`?D$88%\$JZXO0E/1EI'Z'5AX;E=@>&V9 M5H9G`-VP%.]P6]G[$`9JDCBUN=>\ M0`!%3=Z!"(SA.Y'EY[AI-7-1]2J1T8%]&GFEJX0N=B<$H@DPN^"T('FJW*=] M,MI1!AF31GOWCQ,)B;X?LY8U=XY/69V^`[&]@H.<"&S7<$:ACQ0,\3F"BD8< M=*>R&OYO]7V.IG2:NJP<;:*WU539-4Y$J)\/L-BMO@,_!&/%G=U[+$=^>VU5 MJ%G.G^*WY>&\M1N>/MYXB8.,XEM;_N<+J4)G[U=9^W*6$Q67^7A?WK9NK*N7 MIC]59.::TAV[+`U/RS=ZFT2A5)N?,M'T2>D.7Y;J0U4ZOCBOJ(9?K_%/Q9@Z MI_1-@%9(QW@?C'!-5I6RV%FS"$/A^$-\_^!.`'.`(<#G#V`F&.0$RZL$\VNZZ% M[HS>B4+(G)-K,0.TPW)Y1@?UD\B.V)V8VQ@FA4+WI.L+'U$HT`:Q!`8+[T!* MV]DGAQWIS*BPJ>0#-[8^V\*V?*BVC^_B,4,!`G3QZIQN&*((B>BI+16-KMZC M>JJZQ7"99R6H@Y5M#T*U$67VZY:*R[=/CMY+JKX0*D:9O+_4G]]3@!GPDRH(]5]" M3_#?>+%HF-I75O_Y@[ZY]YS M]7%M+CXO(X:>B%14\('EM5P+$>Z+@/+IP(J5C95/J?7YCU]_N?C-MK]_N;M& M@?#CB'"-?$FP)@%:4#U#(RF4"JDD:/*,[N@3T>A>A'J!H24='_5:7LOK?FJY M:*;UO.\XB\6B)0U6I="6+R+;3JU]P0I&AWZ)V7;+RY^,4LN"]U'/\7I.V_7: MZ&/?^]3W>FAXDP-OP).0[D4RRG],P!J":'`UL`KTEA/)6D).H:/;<3*@M4+V MEXJNH1>=#.LYWV^N[_T9B;!-N=*8^R^]S#!E_;SS\W,G>9I#P7R@PW*F?09"1X0#@K#A1*,!D;1 M_.DXO)]!/LP$"R!Y+O^-J7ZVD#'[]]W5FG=$^9@)'I'`)(]C(,Y!1IR5BUCZ M=;VLB&0FD`EA+W%^!D-(/YX0.Z!`P$P*"Z6&BG[EHU"N'8`Z*<8I'>"(A',K M=B`B3%_)=KOW::B2$,=,OYEKUOV89)-XV!&))D2^DNAZUR.2Q(R]CEK2(24$ M4:2H M:.YWE!I,G`5WF?#7;#.S$`M9&ODD?B%6DR2(L,E.,9Z;C[ M7KKR?DB;'W-2#WCRHBW#$\*2+;L4Y+PGT56L1B*:"PZW:KBD:A_O\CZY&R_I M-93K#D$R9F.G>?G&955(4!K.1-EHH111=8!3"J*V*[$"8F)N7,#L?03:(/8U M7:1+A:G`'DF0[9VCIAJ[4JTH3H4[_P=1'L\ZW8_ML[..>][SSL^ZW:Y["IVR M7?,40I6ZV`#M@&8D^+T6_H^;='\NU:T$=RR!UD\+N\79F7I%44KX-R#ZW["4 M&%)I9^@W02>->_O`N&^2;T#0AT%`5_9O,0VN^`C/J<9LIP9[^IQ4DLZ!DNSQ MI0$*W1$-W$EPB26G?+I[>E2!3ZI)]T!-JIQH@!A#WX^CF)GJ8JQG1!IOH*HP MF^@3N>)0!)'=4Z=^_Y-*UCMT&M7WJP$JYJ<8J&W)%5SN+6<*P"/IDA3?-0]? M6[1+ZY:TLMF(]^HM0=\77$.!?7TP-(R?K?R$XXGI:\' MMD3:!C;A6%!7KFWV-$V,JE/*GT(2.N6C6$K"_><'J-<4>&@"SX/DCB5?Z(;!/['2 M)E&S8-P2_T"WXQ-^(TY ML-.OGR?;]H=NT_)XN9Q3F>32."R\-,O>XVQH4:]+$^JZW;ML/3^:-F<2>N.$ MPBW#'/B;+X*[:H82\$G%.3NX;BCQ8+\L%\[ZQUWS#YK\;R5P\Q]02P,$%``` M``@`NXBO0,8R--!-)```J24"`!4`'`!E?$/MNSCYJZFJ))2.8-16I(RK'WKS\\2`H4\10?#>]] M2$66NIO]`[L;0*,!?/>GIU6"'G%>Q%GZ_:OCMT>O$$[#+(K3Y?>O-L5!4(1Q M_.I/?_S7?_GNWPX._G9R%<4BSC&Z?T8W M\2,NT6VV*+\$Y)M*/OKF[?';X]_\_NT1>BC+]8?#PR]?OKS-*6U1D;X-L]7! M0?6TDZ`@T@D?>^R[M\?-+Z?5D[/T`_KF\/B;PW='Q^_0[SX<__[#\3=H_JDA M_$20+&(C91*GO]R3IR'2&FGQ_2M!O:?[/'F;Y4O">/3^L"9\Q2D_/!5QB_K+ M^YKV^/!OGRYOPP>\"@[BM"B#--QR43$RON-OO_WVD/U*2(OX0\'X+[,P*-G[ M,>J%E!3TKX.:[(!^=7#\[N#]\=NG(GI%V@"A[_(LP3=X@9@"'\KG-?[^51&O MU@E5G'WWD..%7(LDSP\I_V&*E_35T"=\2Y]P_%OZA*^JKR^#>YR\0I3RQYL+ M):!O6[(JIL/)M/R,R[T4W?)5NB;TKTNB4TM;_%3B-,)1K2\5H7FW[`G,)IA0 M*C8+6P(3:B!9WL:/BU5X0*W]Z#U_RU_1;WX^J[QWGD;G:1F7SQ?I(LM7S,#F M]T69!V%9"V+J-BI1UGK?U#/*P%DT^&F!7%(=A1CQG71XDO&4Y^R+/ M5DZ*56ID#DP_)_?)+J(6G!P7V28/L]*^[S#($2VBXZ2LNMHB$#M(D='8P60>FGM0<^Q[S!RYC.*]/R<["2 M=1=RLNDM0:=N;08RFDEM0*U`QP"J*?Z6%E'B:5_^*3'`/$@NT@@__1=^5@+J MT$&]?H7"[?>_0P1@`%(-5!90$2-&C0CY5#9PNLGS5KQ2CQG5I--;@DGMVAA4 M=)/:@UZ)CDE4Y*U.8>HQ)#?+CW&"\U/RV&66JP/##A546)`JVPX*+1*`D"!Y MOBH@,%)4TT[<(V2K59;>EEGXR^U#0)KA:E/2)3VZ3*H.=UHFL+["`LI.QZ'A M@.A%C.HHNQ3&B1CK#'%F)'![D$6^6GR,TR`-8S)]RHI8LRCGQ@J<:;:`)'%4M:\*(@J!I/; M)8(Q+KFJHAFU*28W&-GCNTE11J1Y]X.H6>*\P)>]=;V]/;^[A3/.TZ!XF*<1 M_>_\UTW\&"3$&XMY>1KD^3.)WW\)DHUJ^=62%\:4G8")%F[%.+GA.VC5#96$ MB=4OL`\"^PP%):HE("9B%%=9U_ELG;L,@C"D'["($)-OLP7B*HR(CG1E>0F` M[QXOXS2E[V]6:(<,U0Q00 MI'@D`":_'^-5@/OX1?I(U,CR9Z*5`G>;!,:'96J*/BO^/KF/=A_>,82&A+U^ M&`=T4Q/,S9Q;$]R'KLH'G//YG+YWE!'"^)-:9=&KNE23^Y9*A8Y-,$+$*8%[ M.D>=PVJM)6`QZX;MM6TZOTFZ:CLOT"O*;-*;7OHZIY&C M?+XF.K+M7;]NXC5=)%-/X/0L,`9L`T.T9QW]Y.9M5J9C1#7+##$FE@-LV,:; M%%KEUD>!,Z/U0C3F5VNND,GUD0">-,GU,3$:1RP]T/%]JUM88)/^D=X0\'#B MARR+OL2)"O3V9Y@8O*N>&&_KWR:/K>T'=]YZ_3-8EAQMBC);X?PR+B3I'B=. M@&.CW$`U!T?9L<$<'>6BFZ1&G3.C-"M1F:&0\_-*MTH"2H@(YC(3'R`U#++/ M'-FI@*R6@"X9LK%BV"/.[S-Y%)OPS79^M=(M/^F23>\2*AVZ M=D(H#X@QKA"E;@W.3,^H#,WQI!K?$ZR]D!R&2HDS2@(L(.T]D-^0K` MAU]D&HZ+Z^"9[I"YP0G=K'\=Y%2UTX1TV>Q&`;T?.TF`\>\]0(I^[\`^>3QP MUDTR?2(24"5BABHAJ)("7!3<'UZ-9QW0LIN4R",?F3R8Z#'X"X.>OU4[[2I] M[':I[A+#[D^5JR[;F=JF!-N3*E-#O06RL10O=J&ZZ0[JJL,TMP\>FF]P)$P[ MC$ZJH@?S4SV`'5>5$T-XJTX3F051>B0PP/OL7@CPTYJ>`065C!JPW<&=5U!J MP`V"O:6")[F&VBK84R1D2FS`+61BINSE[1RP'OJ*[)-(F>J9M&[$22ZZPH@#;]4E5C=E`=7Z`#(;+`Z%=[KD\H"G`"S()\##K M$C:]"H/68E3RZ5P.*3)\79=XSLLRC^\W)5V(I?N$K@,V M\X.N_'0'1R_NJ1C8<3'E\P?($[#P`I/>A=>LZJZ@D%)"G7>E5+I]S%6'#.!T M*X4.DB-X*LKZAJ?JW/J+HB`S%<@#K89!X-,9+L-A\N;8*G=`!0?T[T=OCXZ. M:2T=>J1\?T#O9D='1_0?*O@E8\&F?,CR^!\X^@-*L_K;>#S#M#CB:J@7"#R- M%:Z#T][_TR$#NNI'H6[K5I\=FNDO\)$J(-EX+-ZGYTFT[:^[3W%V"#2>1%@W M*,K8^OX;77#]W>R;=[^=_>;]415<6;8NVU[Q2.^U^43<]0&]/YXA>M0%H_C/ M38K1^R/VS3'0/3X#O&G@4/S7(*GTE<4Z/;KK5PTUHN0H3E'%`#=T&0J!3P.8X3!Y,HS9 M&]":D!\00.&(9F8N`Q_L=0"/-6YP&=#5UO,@IS91S,-PL]JPG6-T'3:,56EI M&T:8F&L/20R_9J[)([&M2I)MB9P1U9SHM<"+*N9QCB6UBM!C(_,I+N^!) MU?FY2@';V;D=62@[@@])J*>L,.=Z35NT0>X!`? M%KA/_0MX4WC2_0S?#AF_R+'5#@D1`;;S%/8]`_==W?H&ZT((?PIE[`ID/"B, MZ5\0`]0T9O+W0UQAYK+7FA72%4%GU=E19Y40$J/1)/@=G, M!EXKJH7C<@BC=XVB%A+.KW(2R,B0@:V37N.< ME0Y:5<2HF7VHV#-!4Q?QJ3B!Z_KT:IEKD@@_RG+$)?!E<41D(";$AXJRO0%6 MA1!-!80OWL6T+^9-[855*W29?/`F%12U%^UR`'N/7!VSUW`^M&7TP5. MTJD&\LM3>(V.0PO4#/YX2!N"R3LXM1>>(:IB[14C%C+NY1&6(-K>X$^)<>\W M`9[($2KT'(>65IS@]<@N@TH+-LBJ9->207F(YTFI[AR=CQKUA^#=:[$#1#A65U)YX@GJ0J""%]P#MH$1F_:/N M[);S2?MW2.J)WH[AU*W33)-=Y"-;/J:ZV\GA#)=O\"+4=@DC9X, M9C@H14D-TQL8E!<[`@7IY'V`5@^)W:01/8D_0N13D25QQ";Z#7N!KA;;`YP+ MS0$I$Q81!0DN;O`C3C?X,S99E)(:J)Q(KWRKIDA..GUAD4X/21DU(^1E9^#G MZ3BI3C7..7$!>(J.J/0/61;1,O>55MEUC4=J$VWE>B6RU%2U)@U MHV;6#6_2!LVO\RS:A(U-`Y6=#=#2X)-;5F6[$TP4>.6D,"ZI4UMT21G=Y"ZI M5J)C*+SH6>QI8'S1666%)X*-G>RZ31]Z%(O.!+H?4;]\>$MUTK-@I_O#=Q=[ M*CIESK-@IW*<5]>9&:8B:G*H7*=>_7:>4TX+D./4*2*9X!;5:2XU`_BD9&\$ M]:UY@',3JLS5@HW,;K-$O2ZW0P5GWQ)E=\U:(`&QYL[SI29`MW`Q.D0)X2S7 M7MLET[8835MS1GB_M@6?;=SBA,A<_H!3G`<)B13S:!6G,8T29?R(J[BAZD`M MF8&&=$[06B,]*\[I!X`.:G4GO)R93'4Y.XOR;0%UMP4T;.R#[E.0_X)+AF\I MX`M:(H!&F1.]-?!0J`.!+("TSP+2,``< M`V341C+)X3S,O@0NV)#0&TFTY8(Z(6;X=P'NZ'3X\B5.DHO5.HASJAK=_:]H M`14QC&OK51=]6DXYN3/KU.A83DT\0UMR=#G:"10F]]U+=Q0WU%`U$4/K#9!K),_<#-1"W6KVX4[^1[`=2]>^9$NMV?3J)9"9)1`JUYJ MI5N+7EVRZ=>\5#ITUX]JRO;I/C#V;*\V_0G1UX.RIH@(>!F7ZVR?M3=U%>??,$0QDP&8XM_Z]$=B!$:C0TTJKCN&U^A`>GZMSP+@$)(@8 MUI^^Y$$/^`@*1_0IR`-EJS*=88N M+T]AXD8?E-4KBU,H<*9QPB"OD)[62!=H8#!:3$W[H+S<%]R$F:4@3@NJ)RZN M4E:><;68D[^4G8".`2C#9(30RC(IJ:?/-!E4Z68^*`./ZYA$=KJSBQ55$A/C M?%#1?"\D5/^BUC\807_KK)FK]MRO4Q3%Q3HC$,8&8(K$PQN2(N,]63YP)'N: M37GG*&:`VJT MZ*@__[F:5$+:.E=$O_#3YZM<_RH*QRTS.25L,N;SM MDZ[FZ=4^5@"^5/TY2[-V`ED?%C3T,`'""$`,%4KBR8.&09/N=DB!OEEUJ%B` M%AY<(?`5M6PGS0K?&XH)@],L)7`V!-%VG_4)7F1Y=2'$7?"$B_.G,@^R/(K3 M('^^*/&J($U!3+4D[9:PQC`,'D=\H@_9W%$:49T#'O1QP)GC$;#8Y)NWCQ7/ M%[AG#ZZC#7OT#+4>CMC39ZC]_)''Y6Z)SBE:=)O8#K<-F74:LJ2/@HYT!&\5 MID]PBA?*ZRB5U)`11JE\-SIT2($\6Z&'RBL)>3TV1*\KCI'Z=[O5$%O]K_/L M,2Z(N2-BZU6O+K?X*:/`$*T//D8G34OTT-3[B`10IW+OJM@^A;O^%>#4[?:C MI>>,[-S11?Y,-NPVNNLLIQ&\2?<0#CQN[JVYS2A9?(@P3FY? MZC?%W6W[UFV,UTK)MI4BL974$6;(%B`(/&B$Z=#O5\\R/'!J]S&0!>PW&_0] M3@`OY'KH*1.FPG%IK*S?H0%*>>6J,F[8(X.XN M!M?0(ICTT7$ZKS\/0IHQS^0N"7A+U3"@3VT29[XL<0W_%H5S[^M8"YP7=YFMN$(-7'RA`_+FC`#%9*!2L_E?#GM.\ MVD&]&=+N#]QJPN[M=-798QTE^N"[>S5"CTFK1_Z\AZZ#3F>\\_,A&N0E3UZG M?-_>35TK[=P&:YX-Z!T&\KX,X-T'[GY,8_7J>S21_2N.EP]T7O%(/'.)/V]6 M]SB_6G1NDM6E;AQEP/C$7D!%3W$2,+G_[*%=QRQK&:@2@K@4&J6Y'#'%.&K6 MR-0Q#XHVJ-!6]R`?H'NX=!C4:P3O;Q7`Q3&'B-^M^=12O(I%)K`6T4@EPI=X MI->OKRF/.@38,R;MB[@3E2+(\0WDZP2/3+TZ!X^)AD7TS'`.M9@&Y3 MLH#1ND-)0S_]S4E&9?:[K9X*0TR:%[?5DYD!U8CM58UP=/+$]'_(FV.T)Z' M9?P8E['Q'.I]!($5B^$>:>BW%$*1-GY7BI*IX_,;FM1Z/X9O:;2R*SR#6H$ MHJU$\.6LP<`+#LM/ZI6@!5SKFD?_NZD.<:5[3JC]QPEN59K?9<.X^#B/@@D" M8S:;&";&>,[D@60\$!UO$QY%][PT#T/=_3'DYY<6E.`:,F\:,JU7[,FW(6V_ MM=!^VQ.U@FVKD=&R=(L\8-0[PVN"*&9ZD,\)IA_H18DKNN?N'^Q[Q3NP8X6) M2BZPQ"ACPS=YU+!7JKMJ);"2:5G-S*^R%-AAO'@@8/RZT='1F&;:$[PF#R;4 M6?C+U9KJGSS)*@(FS6HWN9;64&&4Y^C&-2\2Y$&4# MOEC8!<-IMJ(_^)Q**5MOJ_G15@#@\4W[@FM0Y`WEC,Z&?8D7@P.!#`OT M*HB4/"U6WBALX/$E$$B`Z".`P."!ZW>TL?5Y@=$?7[=!PRF>O7)M/_2V*,\= MP7K`)_^2D1D]<7^;4M7=%F?+[$NXTD$SS!DDG!X$,+5:UG,%=K^"L!X`>M-< M+X0<2KC)Z4E@?%J0I62K%^9+"'6!;C<9U$GR(,3:J^D\8:Q$\A4!+A0)4GV)5CU:H(&Z M%J`&%=0J=^I-`(-[T^`ASKX>2+:]MG>1D5RH[P5PNJ;8KQA.)M'CPCBUND,4 MR M*P;05EY2ZA(F%'N:889/8[1()TZ\%JK2WFBBAH]GIELV4.\X[/_XH=]8P>-Q MP7!C`-\[^SX=NW=>R"\H'V!;BU:05UYI`=G".S52?/%2HXJNWMH(]*F"?##P MN]M:9&@!"TVN@^>J3'X>_KJ)Z=VD_$:YB_1V\!NW2^XAYSI;R+<6\GN79N5*%IO60EK[B"DO9,HCZ>H&HE0"T$# MHN>^2Z6Q-89PDP0YNL,)?L!!4CZ@3T$:+-D6U!FZO#R%B5S_;'B-EU!Z8=W@ M>==.,Y"N*]K0+@9K%]XM^#P)T2I`VGB\RP0??.4:6=GBEA5X<7UO4$27![JX MD2W0(GZBIV$`KJ:_#!3.\6](`P,/:_;C\-X#>?\GE/TFDAY/((>;.'J5YG%# MRM(\KS$YM?!PG:0DF%.M-H<"BV?OYB@)C&&@,:%?CH MGD3=$..('5-^PW=R7P=Y^:P)3'H6H%2%!8Q6ED)#/WV"PJB,Q#DX"^_H*B;$ MN$8(5M;3^;Y`ZK,$U@Q(FI6X+C8%FMGW!?290&@J1L&=W7ZDU7NHYO^4H=]4 MP>,IPG!3`Z^F\FY(.^=];:?UBP:I#]/Z\\4"A^75XOPI9,@& MKG4VH!WK](<%NNC5/3U0X-X>K(\$`>!I_`$!WH8/.-HD;'E?"A;T7#!>C70= MQ*HKZ]HD4)N]NVJVMW!O?P?8F+W[<$GA6U7T16F@-D_;:[D>34OSUF>WM@0? M4/(#P.^")UQ0?4A7JT36)82\N%:F<4SJRUJRT:,BS`"&M8.CK-L%<2JRS,4M$#95:5P*[FZ M2S1]!E6N@>P^`4*'^&4//W%2($L>5.4).W_+^XB]N7'8ZDYA^%N#;2^2Y70S M\;K84>QWS?+QYZFV]M%6Z9/YY?SSZ?FLNM)W1(7)^"8O)U!YTBYC3>8!9+80 M/V(^926SU*L%F;8:)H-6G&#=BBVHG8[&Q`;1]=CI)+W:<]H125\L.-IY#1XL&EXM>-"A):#=4&2_ MOFTG!7REVP6L8LW;1@3DZK>]?L[KX`5="-_I?UC_ZL5"^%6^#-+J9O&M_GSX M>TT:O(ZT5XMJ(@IZ M^=Y!SVPG`\U-CN_P4WE"U/QEC,:5/N8%^HRFN09S'\DS7I8G*0%T,P["8V:H M]2"636CY&ADJ-@\3>Z[MX]!/](&(/1$H5S]1PTFC$5P(VBK.AL[T"BRF4756 MP&E6E`5;$+P/"GITP+--S]Q7*$QX&:8IQ^+DH6,(=27E=,07#DX"/H+= M"O6B`[9&?"(B-O6WO:5Z;O_ZQMC+`>0B_?4`G;[R@I3=,F7:2;(?#I@WH>8H M5?B><*164`0"P&+:($_C=$DWUC(XAEY-30Y44FM0OU55JZ"=OK!6JTC':*I4 M1LU%=VISK_&B^]@%8^H8-/1^F)`VF"N)P8W(%'IDY@,>95U!*%UAP(6F2[P, MDNK\+_H0140TT`(L+9D4;]:45(0PBTEZ;3HFP,B10#]V@9MR]!^"V`1N%)`?$B\=WBY7%/H1J%2C[D.TDP2_S MLPSA#NS>&*5]Y%/:IV=KT",BA7._>1AF&S9#..6GXY(IPWF>9_EIEN?8*N:[ MB8!QP'U@BA[HPC^Y"[HK)[',D`P^DF=T410;8J%;D;0D)(V"/-*EA?RR5U.' MX2C#7XO5=AI.`KRT65,X%8RT$L(2,DP,$N1XT'<,`=?&1^$<\V,0YW\)D@W> M=H>FCD//`N-V-C!$+]/13^Y49F6ZNS4)"V(\Z!,.*$=5Z.!!K)?!,<5V`X\_ M1J6-W5H&+\S*%*P$NQ*X/(C$/<&(3C+@VB[/TF](++]:8[Y;2KN^JZ<'6..U M`="L\^J(8=9ZS1K)]OY4+"AK>(2X.?&6P7X(KF0(`!9_AT(!>`E:4++:O*TN MBD`D(P2ZU$RI4*53H7K#!".G6!M&PP?L>:_T]LVG:57*-<"3X M91J1']99$20_Y-EF;;/QP$D*7*7U'F!W*ZL=1(!44COKUS%248I=!S*IQ0I` M+M(PV435V%.U36WKVJ/N=6V3N%/>6XH5/V8*U/?!HJAZN[QE(]@'ZB\-<,S*,HIOX4)/1BKHOT-%C'99!H;=C``U2&8`.D57:@8YB^ MS,"L3;>LH.%AMZJ1^1RJV(`]8@`P!Q9@IJS]+(,XQ5&];5+K'BIBJ(I.G>KM MXDT9)4"=IEH-2:D))]YN:(6U?"?EYR$9(6]XI>497L1A7'I@ZX)6JO.H];V# M/3]8P9H;P)UB-3MFB$(U%\VTUJ@Y"1RX9QD99'WHI01D]?F2:$7^)G^1#_30 M%?+'_P%02P,$%`````@`NXBO0/F"T<=#%0``RFD!`!4`'`!E(9J6PGF_.T19.0C"Q%*"#I2W[]:8"4 M1$HD"/!BD-#4/JS'!II]^0`TNH'&U[^]S3WK!=$`$__;WO!@L&:(S^T'(KL$+G6*PZ?K4M*@F"* M*;*>WJU[_()"ZX%,PU<;?I/0MTX/A@?#D\\'`^LY#!=?#@]?7U\/*&L;)$T/ M'#+?WT^^=F$'0!WZ\<\>'0Q7?[E,ODS\+];IX?#T\&@P/+(^?1E^_C(\M4;? M5PV_@R137-K2P_[O3_`U"[3A!]_V4NR]/5'O@-`9=!P<'RX;[L4MO[P%.-/Z M]7C9=GCXK^]W#\XSFMO[V`]"VW?6O1B9O'[#\_/S0_Y7:!K@+P'O?T<<.^3V M*>7+*FS!_K6_;+;/?K4_/-H_'AZ\!>X>Z,"ROE+BH7LTM3@#7\+W!?JV%^#Y MPF.,\]\]4S3]MH>"N;//]#@XCOO_\2J!Q/+_(]^]]D,D/69-#.6J'=9E^"`%#C/XE\5WD`];@AX!XV&78NK`] M9K*'9P3HE.==B>A'BC"!T>6'SRC$P'0K\FQ\H67A5G\-QM/Q`E&.BL8,543] M`X6ZM(/G&X^\MB)3BOA'B32>/CP#0IZ)Y\)RX<#Q2!!1!,LNAH],*`K@A[\AF_^:S916V"P@UR"K,[*"' M"%11Q7UWTHI!;R$"'\%=_1:'[#N#P>!\8.U;2T+I'X&H%5.U MTF0Y]\"_1YS,%SRVYR2T3/?L-[^)^!X]!2&%Z6I)R+.?D!=3DNQWJ,1BHFJ^ M]PV03DX&*0[3(!C1++(D MMCC28(NE0.!E8@(RN5?@@@A&1Z9=_VTC+U9BHV.--KK!;%6)6;V!WP4".VVU M-<=6>[1##,Q_/"'/<^;_/*: M]=]&TE(E!CK39J!+D(RR+;R+WOZ.W@LMM-'.%!/)B)78Z),&&UU&E&:&>K$7 M4=2T_Y92DBPQUF=M`^H&>XA>`GLS0HN'4Z95_TTD*U1BG7-]TQT/0/#X`X_\ M!N,H9)EE%F4MGOL$G4RQG;*,RTWNH,"67P\W`SKUPSQ*J6&I:,]PP*(]*[KP M\XJTE:9M)<2MA'IEN$[MX(F;-0KV9[:]B#&+O#!8_F83O,FO?TMEZ&ZP#\Q@ M\-1)@`4Q(K6NU<=@=:%&00#J+&$_VZ@S(ZZ*8=B@4Q"K,)($8DX1+(ON7:RJ M0C&X#"&B`>(M]5B9Y&E3^@X3#,\4%!A?JF_G,"%A MVVU`5!>U!9PL*"84%@8>E]$R-<2YKH!EP$`73Q[Z@<+$%RR:*`1=S("(LH2% M\<\>(^/6?P%QP<<$V0N0D&YBAN5+)2J,HO;8TN/P&=%87>*1O]W0#*M+RE48 MD>VQ[6.IQ],K'"Q(8'N_4!(M;GW'B]B>)#<77K(Z5"9H!I8:EK\PMMP$YDYT M8DX&1@8B0\+8VW%J16.3T/:Z,L%,*`&3P._$.*^8L\K0,'RSV987"A-83A];:,C79L`%TVQCT-TAU^0>PN: M]F<8-D2Q$J[?DG6MQ):J9,RP>2-2%P;S>^QTWA0KI7A5$'].M<.C'!0[!(5VD]]=RD\H9R1ZE(-H M&!_5DA&U\^2=6D\F2]:Y,D27O'):=@X@]9T122%-O,R5NEXLO.RWT/IH_U6G)94H6(>HII00%,9@"[!:UNQTOM@\T`B*6-3 M[$*4;'8R%!U28AIRNC]/\O@I&`5$Q!V,1H-`Q!;"9)HCZ(I+B41/ M8[!15=86@F::02*Y@@AZF`@*E;6CR4A8)\`@7#@*6IL+@O(EH\E852<`4)YR MZT6IZ\:A()EIJQNSRA8QT!5G*'J85RK&<"1;+WO]%6L\M5+?T5(JB$6H5QR5 M!!0*6VN),-L>"N[1"_(C5NFU+!:2W[IS`[?$()FHLH)(AD0"TB*S`DR"RD-Y M33MG;143B@$@%-'$.]P\V[:AOP(HY#4U#`K2(IIXVUH.!68#0,'V[=2%.=/E MR`?\7-CU&WM;'96]EU'4O'-H4/`#E&0R)/C+9!Y/^:+W0+SBC7NF5>>,K&2Y M?,.7B=?JTJ_IMLT#\CQ6@1/YL'7R0'\C=XY]_IY@B%]0HLVB94"JLVE0J2%U MJQZ#)@3=@_U`]^Q)F2M8,SW"ZSB+@2/L8QI>U(5M]SA*T_6Q_N M+0H[;+?L'`H4MAFRXK2PR]067XI%E=]>BCOUVOKJDAER<&`-]QM07GS\]CL* MGXG+WAT+0I[)$29,2OIV#A85;+T-F.JBF[AE_<7&?L"4@8*QSV-UXZFP5G5Q M!S/AHBBOB=>`U^,B5N:M#^S!;PKGEOSF9N)#25H3]Z)+@<5!BHU6IF*A7,BZ MSL=Y#`$?S=B9C2T0?-)5N-HG63=<#(?"]F8"0TW<5G>GFE*A6:_K,BY/"MI8 MGS*Z0%-"DYNIC_8;"J[?0,6@"^S;]/T6=@*\@!?T!.D\KLB29:BU+W8.I`K[ MI8]62PM@UH=?4$ M95YC4*-B('241%V"I_FZ3=/W%\A8-_!7#GPLX'M/Y.O682S+Q;+^D0E)NXY]H MJJ0A$Y^<_-@;\3N.M>H*JWLEJ,0A^ZP-?!39`;I"\?]3.DZ>?BTO8BU)H',P M;&TO7%,G)CZWO*V2D>.0"`8;C'^$7]C&2!IAVUT[AZV:$)#!E*066MY(:BI4 MNZT.-G_[\#5<6$1,V&<7$50F?MV=8%^@PV_+KZ=]42$9N3,0B^.0R-@>?T:K?*2)R*VBZBKK!<3=Y+R#FW>>=S:.?D\HIW# M9)OYV:;UU!1&NU1215)'^>F4`HC6HKD["&U>32V\7Z@=H/+JKSUA[@[T:NJD MJ=(L79H("U02AR$;.#0G(-0YW#5T:$Y59$->;P'?-XFECYS_1)BNJCG>^@_1 M4X!=;+,M/O.-IU/PB4'7A;6!*I#J')H:0L>BYOB,F(-0YW#7D MB*F*W$+&4\\[6(MD_AY/[X@_>T1T?H6>BO!2U+QSJ&C(RMOP4=*`F8E,4*J# MD,N/H]PCC[$VL6GX+L"-J,ON8$=9"R;>X9?7;NTU:W>055,G)OI(U],IH^;VL(:4K@^7P\CF)]J!,I#M%AX7&VVMU3;K3\E=![;KJ3FAESO MWL\J=>0TI-#],JL0&+1?FZS77=- M*6V5G.V%A``0 M]C$2#^H2&W/$(K2QC]QE@6XA+O(;&PD(!5$-22V-'">:1SSOSZ^>,K7!%@DV M4O@E>0=8/&G(]C<2+_6D;^'>CY:L=E9_5V0.8Z@H?9W7UDAHR$MJR(O)*Z7= MP0S*7PHOVS>N&G87`)4VBV*Y"CU,;378?77,@V[:S2Q_O,,)R5;0YO! M[8RO]G-)LD]*=/_1B.H84'DDHN[NL(,0R/%<5E5WQ?%HB9[FP*2JL";6[^S_ M*P-5K;F-BP][5N`%T2>2@P%-E:B+=CTWA"(\\R\C$,QWWA^I[0>@S;AV,O^7 M%QMZ5<,R]8Z<_*G&C_J\PJ[?FU8O65XW M5EKD/NE$0V/AEZZ'8\_!E0J7]XLK+F-097=*?0?D933(*M:9&5G\&4?N"N`X&5]EPH5E;7 M(T%$T84=8/"4)BEB4D[2<`#_@6.TI@3_X,28)Y0AIV,)H#/;3]X57#ML\=R0 MYFT\30IIV-[:E2OQBQJBK65EK,/ZVM*/@(D+8//W-C24\YG.S3B-PBNSV'V$ MYEIS\]J=J7A\`V88Q"=WF)=5)JNC[M2UZ26E*7 M)`@#OK=_8NPN"W.63%1UB6IYDU>6YXLTSV434DVJG9M_FH%+YH'>%C34TWF& M;8^7)]=AJ\"EEIQECK=GF3@*9"T)6D`QOC^K8YK9%*MD`BENKN6`]`8W98.^ ML'WGAG.963('HI6DZNL01#/;2VHJ,F$EA]_)]O#CE*PTJ2;RTYO\%8RCDK8Z M!A'GYKL=,HOR;3)[6V6&P)-$I:NH5-_.#"XI0Z5'5G7Q>CK*'M`L+L61*L$A M.=).<]SI)34K34Y']B-FY!XM".55Q$O2'(7-M20Q-[B1WW1+].S,V)0U52:U M65&^G@[.=!7A5&Q;;8_/A*#%*5IIDEINSN9*5[:C+>^FYQIP/E?R8U>! M0@;C)\='VL>PK"FS%X3KR=O;,>T`$>_]-@@BY":OA<)4]L`.:]C4E?5S/^6- M[IBT%=.VUL2M-74]%Z,3/BYY[6'F65U32N@E`3-)#7HU$IIN?Y=R6#8%*-'H MW"10Q'&QI37//V.;/9O'E:3G`8^;T\#C)S%Z5D9@AH&Q4JR M-8-E(UW<1RX$].^1YA_+7O[<:=F8X29LB#B#QJ]GB(30<;`^A M-+W*@ZBY+.6V:."SP!\6)+"]7RB)%C+Y624JFA*R*5YN?<>+W"3ZLLV[_(ZW M+MG.#/R:D-C(P3:ODYY.'ML7W8+T33?)623GB-J:<')BGY&.SX)82^+M7&', M""!:H:6[?L1=R_(A79%*9T9P%7/)7LCLYBC]>LB$8&=#X!__#U!+`P04```` M"`"[B*]`;W_8>T4&``!V+P``$0`<`&5S;6,M,C`Q,C`S,S$N>'-D550)``,Q MQ;)/,<6R3W5X"P`!!"4.```$.0$``.V:76_;-A2&[P?L/W"ZV09,EA77;6W8 M+1(W'0(X'TBRK7<%+=$V48ET22I._OT.*$C9;.@DTL4RH-1Y_^[GGP:_N.ZGB_LQ"GF0 MQ(0I%`B"%0G1DJHY&@DNY90*@B8OZ)X^$84>^%0M,5S)]%&WY;?\5V];;317 M:M'WO.5RV1+:5F:FK8#'KINU=H$EJ(.?:?:LY:_NC+*6.>NCKN=WO;.V?X;> M]/VW?;^+SJ]7AM>0R93NM93!G,0805\P.70*P2T[+2YFX-3VO4_7XP=CYZ2& M_>>)B.B&N;Z2.W0\RJ3"+""Y?439%XNYOCV!E%?R)?LL&K_7ZWGFKH,4%C.B M;G!,Y`('9,.61^YB#^0*4XB-72^)C@R#!V$E1)TDBBR89"PM0G`1&B` M&>,**QARYEQ?62PHF_+L%"[HWNL+'I%'"`+I@[_NKVR]H4V\!U`U$8XX"PF# MX0D'DD4)?!4ETA.,ZLMU^ MV=4(+P\& MO':T\^T&G>Q MF5]1VE`#O@S^0U9[YO_/67C)%'36%;S=16R22`G7LK2C;/`AB*%5# M!;D&V#=53'?P"#`U)XJ"S,'ETZ;WOEJJ>TPMA7[;:.3WAO/?)-7&P&_:8;:LA735)3C;]^U@7I7!&`54D&B`6&`4$57QVF=D1O2XCRH2044(%J0:3'5,`Z48O5U(F)#P/ M`I[``I?-H!AF(19A:9;;[V!']Z8*72J)4DVT%D4KU8:BC>)'3,7?.$K(-<'Z MW*QBMLE5&]EIO2W3TC+(Z*"B4`/(!@@6FC">$QC2V[\M[+&QX^F5\:Q5FA\+ M:L+11VFO07L[\>RPL@+RVV5`19T&44U$E\\+FG:4^0`40X>95>8_6,";7FVS MVF=NAU;QS6$MF'T;TI+I0A=EHO\#@/J/WJIP3Z;(;$3HZ]_RAXZD\2+2&QC, MM;D@TZ&CMQFX^5Z"S]!VZSF.!OAILUFPM@$90T2MLDO(7@\'PI M2J27AYX+**JT^X=5(TBW(O]`.((HO>^6.'`^-/'MH7&BU(M?STZ4?(0GAR8/ M+B0Z8=9CK7^B=.')/#3=K8?Y1$F/UJU4IC[PBAMEX&QS(\T`,N="(5:YW6C7 MYJ=T<]68!T;(XJ+/W-S/U9=<_\SM^*UG&>8Q'A+"NA,."R'W.S@$HR5)T)KQ M)YBVJ-Y"Y;MMW]6;J';$4.FC#]RU\Q$=4+V_JDX_%#UO4D?=$3W=$?[KXUCT MTD'.R$POS>O%$0FQX75P$%,L)T8ID>X,XT5M&I6.'HF4S*_L8I/M7S-%B)X2 M/MM^?3Z?2"5P`#6+CGW]B_4>6QK!U*@?9B42&-KIG&2V(O;!!LK]*T5B_8&YG

FQ\KH7*97ZSR99[3?K/3CKMU(EL#+Q`P M8BPC;T_@ZQ7*(WE6%Q'?LJM_LN_5`_X8UUV_9@K6_^WXW; M@9>^<^#P7U!+`0(>`Q0````(`+N(KT!'*9:Z[ET``"D`!P`1`!@```````$` M``"D@0````!E`Q0````(`+N(KT"=8&84Z0H``(.B```5`!@```````$```"D M@3E>``!E`L``00E#@`` M!#D!``!02P$"'@,4````"`"[B*]`P>@4[\H$``!5)```%0`8```````!```` MI(%Q:0``97-M8RTR,#$R,#,S,5]D968N>&UL550%``,QQ;)/=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`NXBO0,8R--!-)```J24"`!4`&````````0`` M`*2!BFX``&5S;6,M,C`Q,C`S,S%?;&%B+GAM;%54!0`#,<6R3W5X"P`!!"4. M```$.0$``%!+`0(>`Q0````(`+N(KT#Y@M''0Q4``,II`0`5`!@```````$` M``"D@2:3``!E`L``00E M#@``!#D!``!02P$"'@,4````"`"[B*]`;W_8>T4&``!V+P``$0`8```````! M````I(&XJ```97-M8RTR,#$R,#,S,2YX`L``00E#@`` ;!#D!``!02P4&``````8`!@`:`@``2*\````` ` end XML 16 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6

Basis Of Presentation
9 Months Ended

Mar. 31, 2012

Basis Of Presentation [Abstract]

Basis Of Presentation

1. Basis of Presentation

Escalon Medical Corp. ("Escalon" or the "Company" ) is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the "Company" collectively shall mean Escalon and its wholly owned subsidiaries: Sonomed, Inc. ("Sonomed"), Trek, Inc. ("Trek"), Escalon Vascular Access, Inc. ("Vascular"), Escalon Medical Europe GmbH ("EME"), Escalon Digital Vision, Inc. ("EMI"), Escalon Pharmaceutical, Inc. ("Pharmaceutical"), Escalon Holdings, Inc. ("EHI"), Escalon IP Holdings, Inc., Escalon Vascular IP Holdings, Inc., Sonomed IP Holdings, Inc., Drew Scientific, Inc., ("Drew") and its subsidiaries. All intercompany accounts and transactions have been eliminated.

On January 12, 2012 BH Holdings, S.A.S. ("BHH") a wholly owned subsidiary of Drew, initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France ("Commercial Court"). The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH's activity for three months and named an administrator to manage BHH. Since BHH is no longer controlled by Drew it was deconsolidated in the December 31, 2011 consolidated financial statements and prior period amounts are presented as discontinued operations (see footnote 10 to the Notes to Condensed Consolidated Financial Statements for additional information).

The Company sold certain assets of the Vascular business for $5,750,000 on April 30, 2010 to Vascular Solutions, Inc. (see footnote 10 to the Notes to Condensed Consolidated Financial Statements for additional information).

The Company operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes and hematology. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the "FDA"). The FDA and other governmental authorities require extensive testing of new products prior to sale and have jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing.

Management reviews financial information allocates resources and manages the business as three segments, Escalon Clinical Diagnostics ("ECD"), Sonomed-Escalon and Escalon Medical Corp ("Corporate"). The ECD segment consists of Drew Scientific, Inc., and its wholly owned subsidiary JAS Diagnostics, Inc. ("JAS"). ECD develops and sells clinical diagnostic instruments, reagents and chemistries. The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations of the consolidated group. The Company began including redesignated reporting segments beginning with Form 10-K for the year ended June 30, 2011, and prior period segment information has been reclassified to conform with the current period presentation.

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS140-4/FIN46(R)-8

-Paragraph 8, C1, C7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Name FASB Interpretation (FIN)

-Publisher FASB

-Number 46R

-Paragraph 4, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 2-6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 17 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6

Condensed Consolidated Balance Sheets (USD $)

Mar. 31, 2012

Jun. 30, 2011

ASSETS

Cash and cash equivalents $ 562,880 $ 1,684,746

Accounts receivable, net 3,452,402 3,802,316

Inventory, net 4,463,485 5,184,272

Other current assets 173,694 248,642

Assets of discontinued operations 0 2,342,137

Total current assets 8,652,461 13,262,113

Property and equipment, net 373,737 540,919

Goodwill 218,208 218,208

Trademarks and trade names 694,006 694,006

Patents, net 30,277 52,931

Covenant not to compete and customer lists, net 600,391 808,640

Non-current assets of discontinued operations 0 1,699,527

Total assets 10,569,080 17,276,344

LIABILITIES AND SHAREHOLDERS' EQUITY

Current portion of long-term debt 4,149,516 278,278

Related party note payable 300,000 0

Accounts payable 1,819,125 1,746,951

Accrued expenses 1,712,712 1,897,441

Liabilities of discontinued operations 0 1,671,422

Total current liabilities 7,981,353 5,594,092

Long-term debt, net of current portion 0 4,506,018

Accrued post-retirement benefits 986,102 986,102

Total long-term liabilities 986,102 5,492,120

Total liabilities 8,967,455 11,086,212

Shareholders equity:

Preferred stock, $0.001 par value; 2,000,000 shares authorized; no shares issued

Common stock, $0.001 par value; 35,000,000 shares authorized; 7,526,430 issued and outstanding at March 31, 2012 and June 30, 2011 7,526 7,526

Common stock warrants 132,114 1,733,460

Additional paid-in capital 69,353,173 67,694,959

Accumulated deficit (67,368,449) (62,404,014)

Accumulated other comprehensive loss (522,739) (841,799)

Total shareholders' equity 1,601,625 6,190,132

Total liabilities and shareholders' equity $ 10,569,080 $ 17,276,344

X

- Definition

Covenant not to compete and customer list, net.

+ References

No definition available.

+ Details

Name: esmc_CovenantNotToCompeteAndCustomerListNet

Namespace Prefix: esmc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS115-1/124-1

-Paragraph 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e681-108580

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 12

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Topic 210

-SubTopic 10

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

-Section S99

-Name Accounting Standards Codification

-Publisher FASB

-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Concepts (CON)

-Number 6

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6801-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Section 45

-SubTopic 10

-Topic 210

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

-Publisher FASB

-Name Accounting Standards Codification

-Paragraph 1

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The aggregate value (measured at the lower of net carrying value or fair value less cost of disposal) for current assets (assets with expected useful life shorter than one year or one operating cycle, whichever is longer) of a disposal group, including a component of the entity (discontinued operation), to be sold or that has subsequently been disposed of through sale, as of the financial statement date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1107-107759

+ Details

Name: us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The aggregate value (measured at the lower of net carrying value or fair value less cost of disposal) for noncurrent assets (assets with expected useful life longer than one year or one operating cycle, whichever is longer) of a disposal group, including a component of the entity (discontinued operation), to be sold or that has subsequently been disposed of through sale, as of the financial statement date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1107-107759

+ Details

Name: us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The aggregate sum of gross carrying value of a major finite-lived intangible asset class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph a(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6905858&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-Clause 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 68

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts (original costs for current and prior period additions adjusted for impairment, if any) as of the balance sheet date of intangible assets, excluding goodwill, having a projected indefinite period of benefit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6905858&loc=d3e16323-109275

+ Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 25

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesAndStockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22, 23, 24, 25, 26, 27

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of current obligations (due less than one year or one operating cycle, if longer) arising from the sale, disposal or planned sale in the near future (generally within one year) of a disposal group, including a component of the entity (discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 46

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1107-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

+ Details

Name: us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of the portions of the carrying amounts as of the balance sheet date of long-term debt, which may include notes payable, bonds payable, debentures, mortgage loans, and commercial paper, which are scheduled to be repaid within one year or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k)(1))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a)(5))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

-Subparagraph 1

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 2

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e2410-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e2417-114920

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6410544&loc=d3e1703-114919

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

+ Details

Name: us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 7

-Section 03

-Paragraph 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 12

-Paragraph 5

-Subparagraph b, c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Value of warrants and rights outstanding. "Equity warrants and rights outstanding" represents derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph i

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 00-27

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 98-5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_WarrantsAndRightsOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 18 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6

Condensed Consolidated Statement Of Shareholders' Equity (USD $)

Common Stock [Member]

Common Stock Warrants [Member]

Additional Paid-In Capital [Member]

Accumulated Deficit [Member]

Accumulated Other Comprehensive (Loss) [Member]

Total

BALANCE at Jun. 30, 2011 $ 7,526 $ 1,733,460 $ 67,694,959 $ (62,404,014) $ (841,799) $ 6,190,132

BALANCE, shares at Jun. 30, 2011 7,526,430

Comprehensive Income:

Net loss 0 0 0 (4,964,435) 0 (4,964,435)

Foreign currency translation 0 0 0 0 319,060 319,060

Comprehensive (loss) 0 0 0 (4,964,435) 319,060 (4,645,375)

Expired stock warrants 0 (1,601,346) 1,601,346 0 0 0

Compensation expense 0 0 56,868 0 0 56,868

BALANCE at Mar. 31, 2012 $ 7,526 $ 132,114 $ 69,353,173 $ (67,368,449) $ (522,739) $ 1,601,625

BALANCE, shares at Mar. 31, 2012 7,526,430

X

- Definition

Expiration of common stock warrants.

+ References

No definition available.

+ Details

Name: esmc_ExpirationOfCommonStockWarrants

Namespace Prefix: esmc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e540-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A5

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 8, 9, 10, 11, 12, 13, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6508144

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e557-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity, net of tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b),(c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 24

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 19, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 13, 20, 31

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares issued and outstanding as of the balance sheet date.

+ References

No definition available.

+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A3

-Appendix A

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph A240

-Subparagraph i

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_StockOptionPlanExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 19 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "
"+ text.join( "

\n" ) +"
"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "
" + text[p] + "
\n"; } } }else{ formatted = '
' + raw + '
'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+'
'+formatted+'
'+ "\n"+'
'+ "\n"+'
'+raw+'
'+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 20 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6

Condensed Consolidated Statements Of Comprehensive (Loss) (USD $)
3 Months Ended 9 Months Ended

Mar. 31, 2012

Mar. 31, 2011

Mar. 31, 2012

Mar. 31, 2011

Condensed Consolidated Statements Of Comprehensive (Loss) [Abstract]

Net loss $ (639,786) $ (1,921,485) $ (4,964,435) $ (3,619,249)

Foreign currency translation (206,446) (59,716) 319,060 (3,269)

Comprehensive (loss) $ (846,232) $ (1,981,201) $ (4,645,375) $ (3,622,518)

X

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e540-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A5

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 8, 9, 10, 11, 12, 13, 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6508144

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e557-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency of the reporting entity, net of tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b),(c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 24

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(3)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 14, 17, 19, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 52

-Paragraph 13, 20, 31

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 21 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)

Mar. 31, 2012

Jun. 30, 2011

Condensed Consolidated Balance Sheets [Abstract]

Preferred stock, par value $ 0.001 $ 0.001

Preferred stock, shares authorized 2,000,000 2,000,000

Preferred stock, shares issued 0 0

Common stock, par value $ 0.001 $ 0.001

Common stock, shares authorized 35,000,000 35,000,000

Common stock, shares issued 7,526,430 7,526,430

Common stock, shares outstanding 7,526,430 7,526,430

X

- Definition

Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 12

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 129

-Paragraph 2, 3, 4, 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 02

-Paragraph 29

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 22 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6

Discontinued Operations
9 Months Ended

Mar. 31, 2012

Discontinued Operations [Abstract]

Discontinued Operations

10. Discontinued Operations

BH Holdings, S.A.S

On January 12, 2012 BHH initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France ("Commercial Court"). The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH's activity for three months and named an administrator to manage BHH. Since Drew no longer has a controlling financial interest in BHH it was deconsolidated in the December 31, 2011 financial statements and prior period amounts are presented as discontinued operations.

The Company incurred a loss of $2,216,000 related to the deconsolidation of BHH. The disconsolidated loss was calculated by measuring the difference between:

a. The aggregate of:

(1) The fair value of any consideration received, (there was no consideration received);

(2) The fair value of any retained noncontrolling investment in the former subsidiary at the date the subsidiary is deconsolidated; and

(3) The carrying amount of any noncontrolling interest in the former subsidiary (including any accumulated other comprehensive income attributable to the noncontrolling interest) at the date the subsidiary is deconsolidated (there was no noncontrolling interest in the former subsidiary).

b. The carrying amount of the former subsidiary's assets and liabilities.

The following table summarizes the results of discontinued operations of BHH for the three-month and nine-month periods ended March 31, 2012 and 2011 (in thousands):

0000000000 0000000000

For the Three Months Ended
March 31,

2012 2011

Total revenue, net
$ 0 $ 1,102

Costs and expenses:

Cost of goods sold
0 181

Research & Development
0 0

Marketing, General & Admin
0 1,034

Total costs and expenses
0 1,215

Loss from discontinued operations
0 (113 )

Loss before income taxes
0 (113 )

Income taxes
0 0

Net loss from discontinued operations
$ 0 $ (113 )

0000000000 0000000000

For the Nine Months Ended
March 31,

2012 2011

Total revenue, net
$ 1,970 $ 3,499

Costs and expenses:

Cost of goods sold
574 521

Research & Development
0 0

Marketing, General & Admin
1,945 2,938

Total costs and expenses
2,519 3,459

Income (loss) from discontinued operations
(549 ) 40

Other income and expenses:

Loss on liquidation of net assets from discontinued operations
(2,216 ) 0

Income (loss) before income taxes
(2,765 ) 40

Income taxes
0 0

Net (loss) income from discontinued operations
$ (2,765 ) $ 40

Assets and liabilities of discontinued operations included in the consolidated balance sheets are summarized as follows at March 31, 2012 and June 30, 2011, (in thousands):

 March 31,
2012 June 30,
2011

Assets


Cash
 $ 0 $ 230

Accounts receivable
 0 965

Inventory
 0 1,076

Other Current Assets
 0 70

Fixed assets
 0 110

Covenant not to compete and customer list, net
 0 1,481

Other Assets
 0 109





Total Assets
 0 4,041





Liabilities


Accounts Payable
 0 370

Accrued expenses
 0 1,147

Other Current Liabilities
 0 155





Total Liabilities
 0 1,672





Net assets of discontinued operations
 $ 0 $ (2,369 )





Discontinued operation of Vascular

In an effort to enhance stockholder value, improve working capital and enable the Company to focus on its core in-vitro diagnostics and ophthalmology manufacturing businesses, on April 30, 2010 the Company divested certain Vascular Access assets held by its Vascular Access subsidiaries to Vascular Solutions, Inc. The total sales price was $5,750,000, consisting of cash of $5,000,000 at closing and $750,000 payable in cash upon the successful completion of the transfer of the manufacturing to Vascular Solutions, Inc. plus a one-time earn-out payment in an amount equal to 25% of the net sales of the VascuView TAP products sold by Vascular Solutions, Inc. between July 1, 2010 and June 30, 2011. The manufacturing transfer was completed on August 31, 2010. During this four-month transition, the Company continued to manufacture product in its Wisconsin facility under a supply agreement concurrently entered into with Vascular Solutions, Inc. The supply agreement ended on August 30, 2010, and the Company has had no significant continuing involvement in the operations of Vascular. Vascular Access generated approximately $565,000 in gross profit from May 1, 2010 through August 31, 2010 related to the supply agreement.

There was no activity from discontinued operations for the three-month periods ended March 31, 2012 and 2011 related to Vascular Access.

The following table summarizes the results of discontinued operations of Vascular Access for the nine-month periods ended March 31, 2012 and 2011 (in thousands):

 For the Nine Months Ended
March 31,

 2012 2011

Total revenue, net
 $ 0 $ 638





Costs and expenses:


Cost of goods sold
 0 283

Research & Development
 0 29

Marketing, General & Admin
 0 155





Total costs and expenses
 0 467





Income from discontinued operations
 $ 0 $ 171





There are no assets and liabilities of discontinued operations included in the consolidated balance sheets at March 31, 2012 and June 30, 2011 related to Vascular Access.

X

- Details

Name: us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6390789&loc=d3e2443-110228

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 144

-Paragraph 43-48

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

+ Details

Name: us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 23 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6

Document And Entity Information
9 Months Ended

Mar. 31, 2012

May 14, 2012

Document And Entity Information [Abstract]

Document Type 10-Q

Amendment Flag false

Document Period End Date Mar. 31, 2012

Document Fiscal Period Focus Q3

Document Fiscal Year Focus 2012

Entity Registrant Name ESCALON MEDICAL CORP

Entity Central Index Key 0000862668

Current Fiscal Year End Date --06-30

Entity Filer Category Smaller Reporting Company

Entity Common Stock, Shares Outstanding 7,526,430

X

- Definition

If the value is true, then the document as an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, POS AM and Other.

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: esmc_DocumentAndEntityInformationAbstract

Namespace Prefix: esmc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6

Expiration Of Commons Stock Warrant
9 Months Ended

Mar. 31, 2012

Expiration Of Commons Stock Warrant [Abstract]

Expiration Of Commons Stock Warrant

11. Expiration of commons stock warrant

Common stock warrants in the amount of $1,601,346 have expired and were released to additional paid-in capital.

X

- Details

Name: esmc_ExpirationOfCommonsStockWarrantAbstract

Namespace Prefix: esmc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Expiration of common stock warrants disclosure [Text Block].

+ References

No definition available.

+ Details

Name: esmc_ExpirationOfCommonStockWarrantsDisclosureTextBlock

Namespace Prefix: esmc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6

Condensed Consolidated Statements Of Operations (USD $)
3 Months Ended 9 Months Ended

Mar. 31, 2012

Mar. 31, 2011

Mar. 31, 2012

Mar. 31, 2011

Net revenues:

Product revenue $ 6,065,931 $ 6,399,159 $ 18,365,885 $ 19,075,536

Other revenue 0 0 0 6,933

Revenues, net 6,065,931 6,399,159 18,365,885 19,082,469

Costs and expenses:

Cost of goods sold 3,593,302 4,068,483 11,446,127 12,335,468

Marketing, general and administrative 2,621,482 2,715,690 7,669,231 8,157,077

Research and development 413,874 395,656 1,116,414 1,198,273

Goodwill impairment 0 905,810 0 905,810

Total costs and expenses 6,628,658 8,085,639 20,231,772 22,596,628

Loss from operations (562,727) (1,686,480) (1,865,887) (3,514,159)

Other (expense) and income:

Equity in Ocular Telehealth Management, LLC (532) (37,600) 612 (71,745)

Loss on disposal of assets 0 0 (86,885) 0

Interest income 17 83 119 194

Interest expense (76,544) (84,186) (247,094) (244,064)

Total other (expense) income (77,059) (121,703) (333,248) (315,615)

Loss from continuing operations before taxes (639,786) (1,808,183) (2,199,135) (3,829,774)

Provision for income taxes 0 0 0 0

Net loss from continuing operations (639,786) (1,808,183) (2,199,135) (3,829,774)

Net income (loss) from discontinued operations 0 (113,302) (2,765,300) 210,525

Net loss $ (639,786) $ (1,921,485) $ (4,964,435) $ (3,619,249)

Net income (loss) per share

Continuing operations $ (0.09) $ (0.24) $ (0.29) $ (0.51)

Discontinued operations $ 0.00 $ (0.02) $ (0.37) $ 0.03

Net income (loss) $ (0.09) $ (0.26) $ (0.66) $ (0.48)

Net loss per share Diluted:

Continuing operations $ (0.09) $ (0.24) $ (0.29) $ (0.51)

Discontinued operations $ 0.00 $ (0.02) $ (0.37) $ 0.03

Net income (loss) $ (0.09) $ (0.26) $ (0.66) $ (0.48)

Weighted average shares - basic 7,526,430 7,526,430 7,526,430 7,526,430

Weighted average shares - diluted 7,526,430 7,526,430 7,526,430 7,526,430

X

- Definition

Total costs related to goods produced and sold during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 2

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Total costs of sales and operating expenses for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_CostsAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=6945512&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 11, 12, 36

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net gain (loss) resulting from the sale, transfer, termination, or other disposition of assets during the period, excluding transactions involving capital leases, assets-held- or available-for-lease, and other real estate owned which, to the extent appropriate, are included in gains (losses) on the disposition of assets in nonoperating income (expense).

+ References

No definition available.

+ Details

Name: us-gaap_GainsLossesOnSalesOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Loss recognized during the period that results from the write-down of goodwill after comparing the implied fair value of reporting unit goodwill with the carrying amount of that goodwill. Goodwill is assessed at least annually for impairment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 20

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-Clause 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 47

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13854-109267

+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 10

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 11, 12, 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

This element represents the overall income (loss) from a disposal group apportioned to the parent that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items after deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph b(2)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of net income (loss) derived from discontinued operations during the period, net of related tax effect, per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 8, 9, 10, 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income or loss derived from discontinued operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section E

-Paragraph Question 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6382870&loc=d3e33749-111570

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 19

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 6

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 45

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cost of borrowed funds accounted for as interest that was charged against earnings during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 34

-Paragraph 21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 9

-Article 9

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher OTS

-Name Federal Regulation (FR)

-Number Title 12

-Chapter V

-Section 563c.102

-Paragraph 9

-Subsection II

-LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy. It will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 115

-Paragraph 14

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(b))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_OtherIncomeAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Revenues from the sale of other goods or rendering of other services, not elsewhere specified in the taxonomy; net of (reduced by) sales adjustments, returns, allowances, and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 1

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a),(d))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherSalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A1, A4, A5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph c(1)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph g

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 2

-Paragraph 12, 13

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 86

-Paragraph 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 1

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a))

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueGoodsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 1

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_SalesRevenueNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 43

-Chapter 4

-Paragraph 5A

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6386349&loc=d3e3636-108311

+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 171

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 26 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6

Segmental Information
9 Months Ended

Mar. 31, 2012

Segmental Information [Abstract]

Segmental Information

5. Segmental Information

During the three-month and nine-month periods ended March 31, 2012 and 2011, the Company's operations were classified into three principal reportable business units that provide different products or services.

Management reviews financial information, allocates resources, and manages the business as three segments: ECD, Sonomed-Escalon and Escalon Medical Corp. ("Corporate"). The ECD segment consists of Drew Scientific, Inc., and its wholly owned subsidiary JAS. ECD develops and sells clinical diagnostic instruments, reagents and chemistries. The Sonomed-Escalon segment consists of Sonomed, Inc., EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Corporate segment includes the administrative corporate operations of the consolidated group. The Company began to include redesignated reporting segments beginning with Form 10-K for the year ended June 30, 2011, and prior period segment information has been reclassified to conform with the current period presentation.

Separate management of each unit is required because each business unit is subject to different marketing, production and technology strategies.

 Segment Statements of Operations (in thousands) -
Three months ended March 31,

 ECD Sonomed-Escalon Corporate Total

 2012 2011 2012 2011 2012 2011 2012 2011

Revenues, net:


Product revenue
 $ 2,968 $ 3,395 $ 3,098 $ 3,004 $ 0 $ 0 $ 6,066 $ 6,399

Other revenue
 0 0 0 0 0 0 0 0





Total revenue, net
 2,968 3,395 3,098 3,004 0 0 6,066 6,399





Costs and expenses:


Cost of goods sold
 2,094 2,562 1,499 1,508 0 0 3,593 4,070

Research & Development
 114 172 300 223 0 0 414 395

Marketing, General & Admin
 1,349 1,769 1,147 822 126 124 2,622 2,715

Goodwill impairment
 0 0 0 906 0 0 0 906





Total costs and expenses
 3,557 4,503 2,946 3,459 126 124 6,629 8,086





(Loss) income from operations
 (589 ) (1,108 ) 152 (455 ) (126 ) (124 ) (563 ) (1,687 )





Other (expense) and income:


Equity in OTM
 0 0 0 0 0 (38 ) 0 (38 )

Interest income
 0 0 0 0 0 1 0 1

Interest expense
 (1 ) (84 ) 0 0 (75 ) 0 (76 ) (84 )





Total other (expense) income
 (1 ) (84 ) 0 0 (75 ) (37 ) (76 ) (121 )





(Loss)income before taxes
 (590 ) (1,192 ) 152 (455 ) (201 ) (161 ) (639 ) (1,808 )

Income taxes
 0 0 0 0 0 0 0 0





Net (loss) income from continuing operations
 $ (590 ) $ (1,192 ) $ 152 $ (455 ) $ (201 ) $ (161 ) $ (639 ) $ (1,808 )





 Segment Statements of Operations (in thousands) -
Nine-months ended March 31,

 ECD Sonomed-Escalon Corporate Total

 2012 2011 2012 2011 2012 2011 2012 2011

Revenues, net:


Product revenue
 $ 9,675 $ 10,423 $ 8,691 $ 8,653 $ 0 $ 0 $ 18,366 $ 19,076

Other revenue
 0 7 0 0 0 0 0 7





Total revenue, net
 9,675 10,430 8,691 8,653 0 0 18,366 19,083





Costs and expenses:


Cost of goods sold
 7,261 7,735 4,185 4,601 0 0 11,446 12,336

Research & Development
 386 544 730 654 0 0 1,116 1,198

Marketing, General & Admin
 4,198 5,284 3,109 2,517 363 356 7,669 8,157

Goodwill impairment
 0 0 0 906 0 0 0 906





Total costs and expenses
 11,845 13,563 8,024 8,678 363 356 20,232 22,597





(Loss) income from operations
 (2,170 ) (3,133 ) 667 (25 ) (363 ) (356 ) (1,866 ) (3,514 )





Other (expense) income:


Equity in OTM
 0 0 0 0 1 (72 ) 1 (72 )

Loss on Disposal of Assets
 (87 ) 0 0 0 0 0 (87 ) 0

Interest income
 0 0 0 0 0 0 0 0

Interest expense
 (164 ) (244 ) 0 0 (83 ) 0 (247 ) (244 )





Total other (expense) income
 (251 ) (244 ) 0 0 (82 ) (72 ) (333 ) (316 )





(Loss) income before taxes
 (2,421 ) (3,377 ) 667 (25 ) (444 ) (428 ) (2,199 ) (3,830 )





Income taxes
 0 0 0 0 0 0 0 0





Net (loss) income from continuing Operations
 $ (2,421 ) $ (3,377 ) $ 667 $ (25 ) $ (444 ) $ (428 ) $ (2,199 ) $ (3,830 )





The Company operates in the healthcare market, specializing in the development, manufacture and marketing of (1) ophthalmic medical devices and pharmaceuticals; (2) in-vitro diagnostic ("IVD") instrumentation and consumables for use in human and veterinary hematology. On April 30, 2010, the Company sold its Vascular business. The business segments reported above are the segments for which separate financial information is available and for which operating results are evaluated regularly by executive management in deciding how to allocate resources and assessing performance. The accounting policies of the business segments are the same as those described in the summary of significant accounting policies in Form 10-K for the year ended June 30, 2011. For the purposes of this illustration, corporate expenses, which consist primarily of executive management and administrative support functions, are allocated across the business segments based upon a methodology that has been established by the Company, which includes a number of factors and estimates and that has been consistently applied across the business segments. These expenses are otherwise included in the corporate segment.

During the three- and nine-month periods ended March 31, 2012 and 2011, ECD derived its revenue from the sale of instrumentation and consumables for blood cell counting and blood analysis in the areas of diabetes, cardiovascular diseases and human and veterinary hematology. Sonomed-Escalon derived its revenue from the sale of A-Scans, B-Scans, pachymeters, digital imaging products, ISPAN™ gas products and various disposable ophthalmic surgical products.

X

- Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 27 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6

Legal Proceedings
9 Months Ended

Mar. 31, 2012

Legal Proceedings [Abstract]

Legal Proceedings

4. Legal Proceedings

The Company, from time to time is involved in various legal proceedings and disputes that arise in the normal course of business. These matters have previously and could pertain to intellectual property disputes, commercial contract disputes, employment disputes, and other matters. The Company does not believe that the resolution of any of these matters has had or is likely to have a material adverse impact on the Company's business, financial condition or results of operations. (See footnote 10 for details on BHH court proceedings related to the insolvency declaration).

X

- Details

Name: esmc_LegalProceedingsAbstract

Namespace Prefix: esmc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.

+ References

No definition available.

+ Details

Name: us-gaap_LegalMattersAndContingenciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6

Fair Value Measurements
9 Months Ended

Mar. 31, 2012

Fair Value Measurements [Abstract]

Fair Value Measurements

8. Fair Value Measurements

On July 1, 2008, the Company adopted the FASB-issued authoritative guidance for the fair value of financial assets and liabilities. This standard defines fair value and establishes a hierarchy for reporting the reliability of input measurements used to assess fair value for all assets and liabilities. The FASB issued authoritative guidance defines fair value as the selling price that would be received for an asset, or paid to transfer a liability, in the principal or most advantageous market on the measurement date. The hierarchy established prioritizes fair value measurements based on the types of inputs used in the valuation technique. The inputs are categorized into the following levels:

Level 1 - Observable inputs such as quoted prices in active markets for identical assets or liabilities.

Level 2 - Directly or indirectly observable inputs for quoted and other than quoted prices for identical or similar assets and liabilities in active or non-active markets.

Level 3 - Unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity's own data.

Certain financial instruments are carried at cost on the condensed consolidated balance sheets, which approximates fair value due to their short-term, highly liquid nature. These instruments include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, related party note payable and other liabilities.

The Company determined that the fair value of the outstanding debt approximates the outstanding balances based on the remaining maturity of the note for the Biocode debt and other Level 3 measurements. By "other level 3 measurements" we are referring to "unobservable inputs not corroborated by market data, therefore requiring the entity to use the best available information available in the circumstances, including the entity's own data". We included this reference because in determining the estimated fair value of our debt we first attempted to use a "commonly accepted valuation methodology" of applying rates currently available to the Company for debt with similar terms and remaining maturities. The long-term debt currently on our balance sheet is related to the acquisition of certain assets of Biocode Hycell on December 31, 2008. The acquisition was 100% financed by the seller. Management concluded that given the financial state of the Company and the overall state of the credit markets there is no financial institution that would make available funds to us for the 100% financing of a foreign entity with similar terms and remaining maturities, or in fact, on any terms. We then considered whether there was any "level 3" considerations, as defined above, which might aid us in determining the fair market value of this unique form of debt. We determined that there was not and came to the conclusion that given the weakened state of our Company and overall market conditions there was no other source of financing available to us, from any source on any terms, other than the willing seller of the Biocode assets. Therefore, we concluded that the fair market value of the debt remains equal to its book value.

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 159

-Paragraph 17-22, 27, 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15C, 15D

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13504-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15A

-Subparagraph a-d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 44A, 44B

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 3, 10, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 15B

-Subparagraph a, b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 157

-Paragraph 32, 33, 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6

Related Party Transaction
9 Months Ended

Mar. 31, 2012

Related Party Transaction [Abstract]

Related Party Transaction

6. Related Party Transaction

The Company and a member of the Company's Board of Directors are founding and equal members of Ocular Telehealth Management, LLC ("OTM"). OTM is a diagnostic telemedicine company providing remote examination, diagnosis and management of disorders affecting the human eye. OTM's initial focus is on the diagnosis of diabetic retinopathy by creating access and providing annual dilated retinal examinations for the diabetic population. Through March 31, 2012, the Company has invested $444,000 in OTM. As of March 31, 2012, the Company owned 45% of OTM. The Company provides administrative support functions to OTM. For the three-month periods ended March 31, 2012 and 2011 the Company recorded losses of $532 and $37,600, respectively. For the nine-month periods ended March 31, 2012 and 2011 the Company recorded a gain of $612 and a loss of $71,745, respectively.

At March 31, 2012 OTM had total assets, liabilities and equity of $1,000, $80,000 and ($79,000), respectively.

During the nine-month period ended March 31, 2012, Richard J. DePiano, Sr., the Company's CEO participated in an accounts receivable factoring program that was implemented by the Company. Under the program, Mr. DePiano advanced the Company $300,000 which represented 100% of an amount due from various Drew customers. The receivables were not eligible to be sold to the Company's usual factoring agent. Interest on the transaction is 1.25% per month, which is equal to the best price offered by the Company's usual factoring agent. The transaction excluded fees typically charged by the factoring agent and provided much needed liquidity to the Company.

X

- Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for related party transactions, including the nature of the relationship(s), a description of the transactions, the amount of the transactions, the effects of any change in the method of establishing the terms of the transaction from the previous period, stated interest rate, expiration date, terms and manner of settlement per the agreement with the related party, and amounts due to or from related parties. If the entity and one or more other entities are under common ownership or management control and this control affects the operating results or financial position, disclosure includes the nature of the control relationship even if there are no transactions between the entities. Disclosure may also include the aggregate amount of current and deferred tax expense for each statement of earnings presented where the entity is a member of a group that files a consolidated tax return, the amount of any tax related balances due to or from affiliates as of the date of each statement of financial position presented, the principal provisions of the method by which the consolidated amount of current and deferred tax expense is allocated to the members of the group and the nature and effect of any changes in that method. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(k))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 3A

-Section 04

-Paragraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 57

-Paragraph 1-4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 4

-Section 08

-Paragraph k

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6

Recently Issued Accounting Standards
9 Months Ended

Mar. 31, 2012

Recently Issued Accounting Standards [Abstract]

Recently Issued Accounting Standards

7. Recently Issued Accounting Standards

In January 2010, FASB issued ASU No. 2010-06, Improving Disclosures about Fair Value Measurements. This update provides amendments to Subtopic 820-10 that requires new disclosure to include transfers in and out of Levels 1 and 2 and activity in Level 3 fair value measurements. Further, this update clarifies existing disclosures on level of disaggregation and disclosures about inputs and valuation techniques. A reporting entity should provide fair value measurement disclosures for each class of assets and liabilities and should provide disclosures about the valuation techniques and inputs used to measure fair value for both recurring and nonrecurring fair value measurements. Those disclosures are required for fair value measurements that fall in either Level 2 or Level 3. The new disclosures and clarifications of existing disclosures became effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances, and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for interim periods within those fiscal years. The adoption of this ASU did not have a material impact on the Company's consolidated financial statements

In April 2010, the FASB issued ASU 2010-13, "Compensation—Stock Compensation (Topic 718): Effect of Denominating the Exercise Price of a Share-Based Payment Award in the Currency of the Market in Which the Underlying Equity Security Trades," or ASU 2010-13. ASU 2010-13 provides amendments to Topic 718 to clarify that an employee share-based payment award with an exercise price denominated in currency of a market in which a substantial portion of the entity's equity securities trades should not be considered to contain a condition that is not a market, performance, or service condition. Therefore, an entity would not classify such an award as a liability if it otherwise qualifies as equity. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2010. The Company does not expect the adoption of ASU 2010-13 to have a significant impact on its consolidated financial statements.

In May 2011, the FASB issued ASU No. 2011-04 which provides a consistent definition of fair value in GAAP and International Financial Reporting Standards and ensures that their respective fair value measurement and disclosure requirements are the same (except for minor differences in wording and style). The amendments change certain fair value measurement principles and enhance the disclosure requirements particularly for level 3 fair value measurements. The standard will become effective for the Company during interim and annual periods beginning after December 15, 2011 and should be applied prospectively. The Company does not believe that the implementation of this standard will have a material impact on its financial position, results of operation and cash flows.

In June 2011, the FASB issued ASU No. 2011-05 which requires an entity to present all non-owner changes in stockholders' equity either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. This standard will become effective for the Company in fiscal years, and interim periods within those years, beginning after December 15, 2011 and should be applied retrospectively. The Company does not believe that the implementation of this standard will have a material impact on its financial position, results of operation and cash flows.

In September 2011, the FASB issued ASU No. 2011-08, Intangibles—Goodwill and Other (Topic 350): Testing Goodwill for Impairment, which simplifies how an entity tests goodwill for impairment. Under that option, an entity no longer would be required to calculate the fair value of a reporting unit unless the entity determines, based on that qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. The amendments will be effective for the company for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 and should be applied prospectively. The Company does not believe that the implementation of this standard will have a material impact on its financial position, results of operation and cash flows.

X

- Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 1.N.Q3)

-URI http://asc.fasb.org/extlink&oid=6369664&loc=d3e30840-122693

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 45

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=6368906&loc=d3e21914-107793

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 154

-Paragraph 17, 22, 25, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 1

-Section N

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22644-107794

+ Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6

Continuing Operations
9 Months Ended

Mar. 31, 2012

Continuing Operations [Abstract]

Continuing Operations

9. Continuing Operations

The accompanying consolidated financial statements have been prepared on the going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred recurring operating losses, no longer have the benefit of cash inflows from Vascular and on May 11, 2012 the BHH debtholder informed the Company that it intends to declare the BHH debt, which is guaranteed by Escalon, into default, as such, the entire debt of $4,149,516 is recorded as a current liability (see footnote 10 for further information on the Biocode acquisition debt). These conditions raise substantial doubt about the Company's ability to continue as a going concern. If the Company is unsuccessful in its efforts to raise additional capital in the near term, the Company may be required to significantly reduce its research, development, and administrative activities, including further reduction of its employee base or consider the sale of certain assets. The financial statements do not include any adjustments relating to the realization of the carrying value of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. Our continuance as a going concern is dependent on our future profitability and on the on-going support of our shareholders, affiliates and creditors. In order to mitigate the going concern issues, we are actively pursuing business partnerships, managing our continuing operations, and seeking capital funding on an ongoing basis via the issuance of securities and private placements, although we may not succeed in these mitigation efforts.

The filing of the insolvency declaration at BHH will have a material effect on results of operations in subsequent periods. BHH's product line revenues from operations were $4,763,056, $5,254,574 and $2,647,877 in fiscal 2011, 2010 and 2009, respectively. Losses from operations, net of taxes, were ($1,232,904), ($635,952) and ($1,068,040) in 2011, 2010 and 2009, respectively.

As part of ongoing austerity measures that have been implemented over the past two years at Drew, management decided in June 2011 to outsource the manufacturing of Drew's instruments and cease all manufacturing out of its Dallas facility. Research and development activities performed in Dallas will also be eliminated and will be outsourced on an as needed basis. Management continues to work with outsource partners to perfect the manufacturing of Drew's instruments and anticipates that the Dallas facility will cease manufacturing activities on or about June 30, 2012.

If the Company is unable to achieve continued improvement in this area in the near term, it is not likely that its existing cash and cash flow from operations will be sufficient to fund activities throughout the next four to six months without curtailing certain business activities. The Company's forecast of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves risks and uncertainties, and actual results could vary as a result of a number of factors, including the factors discussed in "Risk Factors" of the Company's Form 10-K for the year ended June 30, 2011.

If the Company seeks to raise funds in the future, the Company may be required to raise those funds through public or private financings, strategic relationships or other arrangements at prices and other terms that may not be as favorable as they would without such qualification. The sale of additional equity and debt securities may result in additional dilution to the Company's shareholders. Additional financing may not be available in amounts or on terms acceptable to the Company or at all.

X

- Details

Name: esmc_ContinuingOperationsAbstract

Namespace Prefix: esmc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6003-108592

+ Details

Name: us-gaap_NatureOfOperations

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6

Condensed Consolidated Statements Of Cash Flows (USD $)
9 Months Ended

Mar. 31, 2012

Mar. 31, 2011

Cash Flows from Operating Activities:

Net loss $ (4,964,435) $ (3,619,249)

Adjustments to reconcile net loss to cash provided by operating activities of continuing operations:

Income (loss) from discontinued operations 2,765,300 (210,525)

Depreciation and amortization 458,921 486,631

Goodwill impairment 0 905,810

Compensation expense related to stock options 56,868 87,156

(Income) Loss from Ocular Telehealth Management, LLC (612) 71,745

Change in operating assets and liabilities:

Accounts receivable, net 349,914 622,300

Inventory, net 720,787 (447,958)

Other current and long-term assets 74,948 251,858

Accounts payable and accrued expenses (112,555) (57,333)

Net cash used in operating activities from continuing operations (650,864) (1,909,565)

Net cash used in (provided by) operating activities from discontinued operations (566,953) 1,024,365

Net cash used in operating activities (1,217,817) (885,200)

Cash Flows from Investing Activities:

Investment in Ocular Telehealth Management, LLC 0 (45,000)

Purchase of fixed assets (66,723) (96,805)

Net cash (used in) investing activities (66,723) (141,805)

Cash Flows from Financing Activities:

Principal payments on long-term debt (155,795) (50,538)

Proceeds from related party note payable 300,000 0

Net cash provided by (used in) financing activities 144,205 (50,538)

Effect of exchange rate changes on cash & cash equivalents 18,469 205,122

Net decrease in cash and cash equivalents (1,121,866) (872,421)

Cash and cash equivalents, beginning of period 1,684,746 3,008,485

Cash and cash equivalents, end of period 562,880 2,136,064

Supplemental Schedule of Cash Flow Information:

Interest paid 170,550 168,694

Income taxes paid $ 45,000

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7

-Footnote 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3044-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 8, 9

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6361293&loc=d3e6676-107765

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 7, 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The increase (decrease) during the reporting period in cash and cash equivalents. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

This element represents cash provided by or used in the operating activities of the entity's discontinued operations during the period. This element is only used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in operating activities reflect only cash flows attributable to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The effect of exchange rate changes on cash balances held in foreign currencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 25

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Loss recognized during the period that results from the write-down of goodwill after comparing the implied fair value of reporting unit goodwill with the carrying amount of that goodwill. Goodwill is assessed at least annually for impairment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 20

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-Clause 5

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 47

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13854-109267

+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This element represents the overall income (loss) from a disposal group apportioned to the parent that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items after deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph b(2)

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6382870&loc=d3e33749-111570

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 19

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 18

-Paragraph 6

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 9

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 27

-Subparagraph f

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 29

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net cash inflow or outflow from financing activity for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash inflow or outflow from investing activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net cash from (used in) the entity's continuing operations. This element specifically EXCLUDES the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in operating activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3536-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-Footnote 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 17

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 17

-Subparagraph c

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquireProductiveAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 19

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromRelatedPartyDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 18

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 20

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph A240

-Subparagraph i

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

+ Details

Name: us-gaap_StockOptionPlanExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 33 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6

(Loss) Earnings Per Share
9 Months Ended

Mar. 31, 2012

(Loss) Earnings Per Share [Abstract]

(Loss) Earnings Per Share

3. (Loss) earnings per Share

The following table sets forth the computation of basic and diluted net loss per share:

 Three Months Ended
March 31, Nine Months Ended
March 31,

 2012 2011 2012 2011

Numerator:


Numerator for basic and diluted earnings per share


Net loss from continuing operations
 $ (639,786 ) $ (1,808,183 ) $ (2,199,135 ) $ (3,829,774 )

Net (loss) income from discontinued operations
 0 (113,302 ) (2,765,300 ) 210,525



Net loss
 $ (639,786 ) $ (1,921,485 ) $ (4,964,435 ) $ (3,619,249 )



Denominator:


Denominator for basic earnings per share - weighted average shares
 7,526,430 7,526,430 7,526,430 7,526,430

Effect of dilutive securities:


Stock options and warrants
 0 0 0 0

Shares reserved for future exchange
 0 0 0 0



Denominator for diluted earnings per share - weighted average and assumed conversion
 7,526,430 7,526,430 7,526,430 7,526,430



Net income (loss) per share


Basic:


Continuing operations
 $ (0.09 ) $ (0.24 ) $ (0.29 ) $ (0.51 )

Discontinued operations
 0.00 (0.02 ) (0.37 ) 0.03



 $ (0.09 ) $ (0.26 ) $ (0.66 ) $ (0.48 )



Diluted:


Continuing operations
 $ (0.09 ) $ (0.24 ) $ (0.29 ) $ (0.51 )

Discontinued operations
 0.00 (0.02 ) (0.37 ) 0.03



 $ (0.09 ) $ (0.26 ) $ (0.66 ) $ (0.48 )



The impact of dilutive securities was omitted from the earnings per share calculation in all periods presented as they would reduce the loss per share and thus were anti-dilutive.

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=6945512&loc=d3e4984-109258

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 24 109 1 false 5 0 false 3 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.escalonmed.com/role/DocumentDocumentAndEntityInformation Document And Entity Information true false R2.htm 00100 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.escalonmed.com/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets false false R3.htm 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.escalonmed.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Condensed Consolidated Statements Of Operations Sheet http://www.escalonmed.com/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements Of Operations false false R5.htm 00300 - Statement - Condensed Consolidated Statements Of Cash Flows Sheet http://www.escalonmed.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements Of Cash Flows false false R6.htm 00400 - Statement - Condensed Consolidated Statement Of Shareholders' Equity Sheet http://www.escalonmed.com/role/StatementCondensedConsolidatedStatementOfShareholdersEquity Condensed Consolidated Statement Of Shareholders' Equity false false R7.htm 00500 - Statement - Condensed Consolidated Statements Of Comprehensive (Loss) Sheet http://www.escalonmed.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss Condensed Consolidated Statements Of Comprehensive (Loss) false false R8.htm 10101 - Disclosure - Basis Of Presentation Sheet http://www.escalonmed.com/role/DisclosureBasisOfPresentation Basis Of Presentation false false R9.htm 10201 - Disclosure - Stock-Based Compensation Sheet http://www.escalonmed.com/role/DisclosureStockBasedCompensation Stock-Based Compensation false false R10.htm 10301 - Disclosure - (Loss) Earnings Per Share Sheet http://www.escalonmed.com/role/DisclosureLossEarningsPerShare (Loss) Earnings Per Share false false R11.htm 10401 - Disclosure - Legal Proceedings Sheet http://www.escalonmed.com/role/DisclosureLegalProceedings Legal Proceedings false false R12.htm 10501 - Disclosure - Segmental Information Sheet http://www.escalonmed.com/role/DisclosureSegmentalInformation Segmental Information false false R13.htm 10601 - Disclosure - Related Party Transaction Sheet http://www.escalonmed.com/role/DisclosureRelatedPartyTransaction Related Party Transaction false false R14.htm 10701 - Disclosure - Recently Issued Accounting Standards Sheet http://www.escalonmed.com/role/DisclosureRecentlyIssuedAccountingStandards Recently Issued Accounting Standards false false R15.htm 10801 - Disclosure - Fair Value Measurements Sheet http://www.escalonmed.com/role/DisclosureFairValueMeasurements Fair Value Measurements false false R16.htm 10901 - Disclosure - Continuing Operations Sheet http://www.escalonmed.com/role/DisclosureContinuingOperations Continuing Operations false false R17.htm 11001 - Disclosure - Discontinued Operations Sheet http://www.escalonmed.com/role/DisclosureDiscontinuedOperations Discontinued Operations false false R18.htm 11101 - Disclosure - Expiration Of Commons Stock Warrant Sheet http://www.escalonmed.com/role/DisclosureExpirationOfCommonsStockWarrant Expiration Of Commons Stock Warrant false false All Reports Book All Reports Process Flow-Through: 00100 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Condensed Consolidated Statements Of Operations Process Flow-Through: 00300 - Statement - Condensed Consolidated Statements Of Cash Flows Process Flow-Through: 00500 - Statement - Condensed Consolidated Statements Of Comprehensive (Loss) esmc-20120331.xml esmc-20120331.xsd esmc-20120331_cal.xml esmc-20120331_def.xml esmc-20120331_lab.xml esmc-20120331_pre.xml true true

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2012	Jun. 30, 2011
ASSETS
Cash and cash equivalents	$ 562,880	$ 1,684,746
Accounts receivable, net	3,452,402	3,802,316
Inventory, net	4,463,485	5,184,272
Other current assets	173,694	248,642
Assets of discontinued operations	0	2,342,137
Total current assets	8,652,461	13,262,113
Property and equipment, net	373,737	540,919
Goodwill	218,208	218,208
Trademarks and trade names	694,006	694,006
Patents, net	30,277	52,931
Covenant not to compete and customer lists, net	600,391	808,640
Non-current assets of discontinued operations	0	1,699,527
Total assets	10,569,080	17,276,344
LIABILITIES AND SHAREHOLDERS' EQUITY
Current portion of long-term debt	4,149,516	278,278
Related party note payable	300,000	0
Accounts payable	1,819,125	1,746,951
Accrued expenses	1,712,712	1,897,441
Liabilities of discontinued operations	0	1,671,422
Total current liabilities	7,981,353	5,594,092
Long-term debt, net of current portion	0	4,506,018
Accrued post-retirement benefits	986,102	986,102
Total long-term liabilities	986,102	5,492,120
Total liabilities	8,967,455	11,086,212
Shareholders equity:
Preferred stock, $0.001 par value; 2,000,000 shares authorized; no shares issued
Common stock, $0.001 par value; 35,000,000 shares authorized; 7,526,430 issued and outstanding at March 31, 2012 and June 30, 2011	7,526	7,526
Common stock warrants	132,114	1,733,460
Additional paid-in capital	69,353,173	67,694,959
Accumulated deficit	(67,368,449)	(62,404,014)
Accumulated other comprehensive loss	(522,739)	(841,799)
Total shareholders' equity	1,601,625	6,190,132
Total liabilities and shareholders' equity	$ 10,569,080	$ 17,276,344

Condensed Consolidated Statement Of Shareholders' Equity (USD $)	Common Stock [Member]	Common Stock Warrants [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive (Loss) [Member]	Total
BALANCE at Jun. 30, 2011	$ 7,526	$ 1,733,460	$ 67,694,959	$ (62,404,014)	$ (841,799)	$ 6,190,132
BALANCE, shares at Jun. 30, 2011	7,526,430
Comprehensive Income:
Net loss	0	0	0	(4,964,435)	0	(4,964,435)
Foreign currency translation	0	0	0	0	319,060	319,060
Comprehensive (loss)	0	0	0	(4,964,435)	319,060	(4,645,375)
Expired stock warrants	0	(1,601,346)	1,601,346	0	0	0
Compensation expense	0	0	56,868	0	0	56,868
BALANCE at Mar. 31, 2012	$ 7,526	$ 132,114	$ 69,353,173	$ (67,368,449)	$ (522,739)	$ 1,601,625
BALANCE, shares at Mar. 31, 2012	7,526,430

Condensed Consolidated Statements Of Comprehensive (Loss) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011
Condensed Consolidated Statements Of Comprehensive (Loss) [Abstract]
Net loss	$ (639,786)	$ (1,921,485)	$ (4,964,435)	$ (3,619,249)
Foreign currency translation	(206,446)	(59,716)	319,060	(3,269)
Comprehensive (loss)	$ (846,232)	$ (1,981,201)	$ (4,645,375)	$ (3,622,518)

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2012	Jun. 30, 2011
Condensed Consolidated Balance Sheets [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	35,000,000	35,000,000
Common stock, shares issued	7,526,430	7,526,430
Common stock, shares outstanding	7,526,430	7,526,430

Document And Entity Information	9 Months Ended
Document And Entity Information	Mar. 31, 2012	May 14, 2012
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2012
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2012
Entity Registrant Name	ESCALON MEDICAL CORP
Entity Central Index Key	0000862668
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		7,526,430